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ERCCl-XPF is a structure specific endonuclease that acts in nucleotide excision repair (NER), and is 
also involved in repair of DNA interstrand crosslinks and removal of non-homologous 3' tails during 
recombination. The ERCCl null mouse is runted and dies of liver failure before weaning, at about 3 
weeks old. By three weeks after birth, some ERCCl null hepatocytes have developed polyploidy. 
The liver phenotype of the ERCCl null mouse is not observed in other NER deficiency models, which 
indicates that the loss of non-NER roles of ERCCl are responsible for the liver phenotype. 
Development of liver polyploidy in the ERCCl null hepatocytes has been tracked from before birth to 
death using FACS analysis and nuclear area distribution measurements. This has been compared to 
hepatocyte polyploidy development in wild type mice. The ERCCl null mice undergo an accelerated 
development of polyploidy compared to age matched wild type mice. The cell cycle status of ERCCl 
null hepatocytes has been investigated using a fluorescence immunostaining assay for centromeres. 
This reveals that the enlarged ERCCl null hepatocytes are primarily in G2/M. Enlarged old wild type 
hepatocytes are also primarily in G2/M. However, normal ERCCl null, old wild type and young wild 
type hepatocytes are primarily in Gl/GO. The premature polyploidy liver phenotype of the ERCCl 
null mouse is very similar to that seen in a transgenie mouse that overexpresses p21 in liver. 
Immunohistochemistry shows that p21 protein levels are increased in ERCCl null liver. The increase 
in p21 protein levels tends to be confined to the enlarged, polyploid nuclei. However, no increase in 
p21 levels was seen in old wild type livers when measured by immunohistochemistry and Northern 
blot analysis. A p53-ERCCl double null mouse was made to test if the ERCCl phenotype was 
dependent on p53. ERCCl-p53 null hepatocytes have the same accelerated polyploidy and increased 
p21 levels as ERCCl null hepatocytes. FACS analysis and centromeric staining assays have been 
used to confirm that ERCCl-p53 double null hepatocytes have the same phenotype as ERCCl null 
hepatocytes. In order to compensate for the loss of ERCCl, proteins in other DNA repair pathways 
may be upregulated, if they have overlapping substrate specificities. The levels of MSH2, a protein 
involved in recombination and mismatch repair, and REF1, a protein involved in both base excision 
repair and redox regulation of various proteins, are upregulated in the nuclei of ERCCl null 
hepatocytes. The role of ERCCl in recombinational repair rather than NER, may be the key to 
understanding the phenotype of the ERCCl null mouse. To investigate this role in vitro, the role of 
ERCCl in the formation of UV-induced chromosome aberrations was studied. ERCCl and XPF 
deficient cells have more breaks and less exchanges than wild type cells, but cells deficient in other 
NER proteins have the same as wild type. This indicates that ERCCl is involved in a recombination 
pathway that affects aberration formation.
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Chapter 1 - Introduction
In order to succeed and proliferate, organisms must ensure that the information 
encoded in their genome remains intact. The information in the genome is constantly 
subject to degradation and attack by various agents and mechanisms, both external 
and internally generated. As a result, all organisms must have mechanisms for 
repairing their DNA. This thesis is concerned with ERCC1, a mammalian protein 
that acts as part of the nucleotide excision repair pathway (NER) and in some forms 
of recombinational repair.
General Types and Consequences of DNA 
Damage
The causes of DNA damage and its forms are various and many. Both chemical 
agents, such as free radicals and alkylating agents, and electromagnetic radiation, 
from ultraviolet light (UV) to ionising radiation (IR), can all damage DNA. These 
agents can alter the structure of nucleotides by modifying, fragmenting or 
crosslinking them and can cause single stranded (SSB) and double stranded breaks 
(DSB) in DNA.
Reactive oxygen species, such as superoxide anion radicals, hydroxyl radicals and 
nitric oxide, arise naturally during cell metabolism and through exposure to physical 
and chemical mutagens such as IR, UV or HzC^. These species can cause strand 
breaks, abasic sites and oxidised bases and sugars (Cadet et al., 1997; Demple and 
Harrison, 1994; Epe, 1996). Alkylating agents, such as mitomycin C, can modify 
nucleotides and if bifunctional, as is mitomycin C (MMC), can crosslink the two 
DNA strands (Friedberg, DNA repair and Mutagenesis). UV radiation causes 
cyclobutane-pyrimidine dimers (CPD) and (6-4) pyrimidine pyrimidone 
photoproducts (6-4PP), of these CPDs form 65-80% of the total (Friedberg, DNA 
Repair and Mutagenesis). There is even some evidence that UV will cause DNA 
interstrand crosslinking (Nejedly et al., 2001; Pospisilova, 1997). IR will cause 
SSBs and DSBs, which may result from the production of oxidative radicals.
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DNA damage can result in disruption of normal cellular processes through blockage 
of transcription bubbles and DNA replication forks. Mutations can also be caused if 
the incorrect base is inserted opposite the damage during DNA replication. A 
distinction must be made between DNA damage and mutation. DNA damage does 
not automatically lead to mutation. There are some forms of DNA damage that 
cause one nucleotide to base pair like another thus leading to mutation, however in 
general DNA damage only leads to mutation through faulty action by the DNA 
processing machinery. Sometimes DNA repair systems can actually cause worse 
damage than was originally present. For instance, most chromosomal translocations, 
which can lead to cancer, are probably caused by defective recombinational DNA 
repair.
There are various mechanisms to repair DNA damage. They have differing, but 
overlapping, substrate specificities and enlist differing, but overlapping sets of 
proteins. The cellular response to DNA damage includes mechanisms, called 
checkpoints, to stall the cell cycle, to allow time for repair. Lesions that escape 
repair can be processed to allow their toleration. DNA repair mechanisms also act on 
mismatched bases and abnormal structures formed during DNA replication. DNA 
repair mechanisms show similarity between differing organisms but tend to be more 
complex in higher organisms (Eisen and Hanawalt, 1999). In general, in this thesis, 
mammalian systems are referred to, except where stated, sometimes gene names are 
prefixed with initials to denote species, ie. spcdc25 for Schizosaccharomyces pombe 
cdc25, sc for Saccharomyces cerevisiae.
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DNA Repair
In theory, there are various ways to correct abnormal nucleotides - either the 
nucleotide can be repaired in situ and returned to its original structure or it can be 
removed and replaced with the correct nucleotide. If a damaged or incorrect 
nucleotide is replaced then a template will be needed to ensure that the correct 
nucleotide is used to replace it. This template can be either the undamaged 
complementary strand or homologous DNA. Some types of DNA damage, such as 
some DSBs and interstrand crosslinks, can only be repaired correctly using 
homologous DNA. ERCC1 is involved in multiple systems using both types of 
template.
Direct Reversal
Direct reversal is the simplest way to repair DNA damage. This can use photolyases, 
enzymes that rely on light-dependent photoreactivation (Sancar, 2000). Photolyases 
specific for CPDs have been found in many classes of prokaryotes and eukaryotes, 
but none have been found in placental mammals (Li et al., 1993). Photolyases for 6- 
4PP have been found in Drosophila, Xenopus and plants and two homologous genes 
have been found in mammals, but these seem to be involved in circadian clock 
regulation rather than photoreactivation (Griffin et al., 1999). Certain enzymes 
directly reverse alkylation damage; alkyltransferases transfer alkyl groups to an 
internal cysteine residue and inactivate themselves in the process (Teo et al., 1984).
Complementary Strand Repair
Systems which use the complementary strand as a template act by removing either 
just the damaged or incorrect base/nucleotide or by removing the damaged or 
incorrect base/nucleotide as part of an oligonucleotide.
Base Excision Repair
Base excision repair (BER) acts on non-bulky base adducts, e.g. methylation 
damage, and oxidised, reduced or fragmented bases caused by IR or oxidative 
damage. BER also repairs apurinic/apyridinic (AP) sites, often formed
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spontaneously by oxidative damage (Nakamura and Swenberg, 1999). The initiation 
and recognition enzymes, DNA glycosylases, are specific for particular types of 
damage.
The damaged base is released in a hydrolysis reaction, from the sugar backbone of 
the DNA (Dianov and Lindahl, 1994; Frosina et al., 1996; Lindahl, 1995; Memisoglu 
and Samson, 2000). Simple DNA glycosylases, such as N-methyl purine DNA 
glycosylase, then require the DNA to be nicked to the 5' of the resulting AP 
deoxyribose by an AP endonuclease activity, provided by REF1 (Demple and 
Harrison, 1994; Sancar and Sancar, 1988; Wallace, 1988). The deoxyribose sugar is 
removed by DNA polymerase (DNA pol) P, which then fills in the gap. DNA ligase 
III and XRCC1 ligate the short patch. Complex DNA glycosylase-lyases, such as 
OGG1, OGG2 and MTH glycosylase, act differently, with intrinsic AP endonuclease 
activity, but REF1 is still required to provide a nick that can be acted upon by DNA 
polymerase f>.
Long patch repair is a variant of BER and involves synthesis of 2 to 10 nucleotides 
(Klungland and Lindahl, 1997). DNA pol P or 5 probably act with PCNA to displace 
the strand from the helix. The resulting flap is then removed by the endonuclease 
FEN1 to allow ligation by DNA ligase I. FEN1 is involved in the processing of 
newly synthesised Okazaki fragments prior to ligation, the flap DNA structure 
processed by FEN1 is often found at damaged or mismatched sites or in the process 
of DNA repair and recombination.
Mismatch Repair
Mismatch repair (MMR) corrects misincorporated bases after DNA synthesis, the 
majority of which probably result from mispairing with oxidatively damaged bases 
rather than mispairing with normal bases (Earley and Grouse, 1998). MMR also acts 
on mismatched bases in recombination intermediates.
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Repair of Mismatches
In order to perform MMR, either coupled with, or after DNA replication, it is 
important to be able to target repair to daughter strands, otherwise correct bases may 
be removed rather than mismatched bases resulting in fixation of mutations. Bacteria 
rely on methylation to distinguish between parent and daughter strands. In 
eukaryotes strand discrimination probably occurs by a mechanism other than DNA 
methylation (Drummond and Bellacosa, 2001). In human cell extracts, strand 
specific MMR occurs when an ss nick is introduced on either side of a mismatch, 
how such nicks might be introduced in leading strands during DNA replication is 
unclear (Modrich, 1997). On lagging strands there are frequent nicks at the ends of 
Okazaki fragments.
In MMR, a heterodimer forms between MSH2 and either MSH3 or MSH6 to effect 
mismatch recognition (Kolodner and Marsischky, 1999; Marsischky et al., 1996). 
MSH2-MSH6 recognises base-base mismatches and insertion/deletion loops, 
whereas MSH2-MSH3 recognises only insertion/deletion loops (Das Gupta and 
Kolodner, 2000; Kolodner and Marsischky, 1999; Marsischky et al., 1996).
DNA mismatches induce conversion of the MSH2 heterodimer into a freely 
diffusible sliding clamp (Gradia et al., 1999). In yeast, a heterodimer of scMLHl 
and either scPMSl, scMLH2 or scMLHS coordinates between the mismatch 
recognition clamp and other proteins, the complexes probably have distinct roles in 
repair of mutational intermediates (Kolodner and Marsischky, 1999). Mammalian 
homologs of scPMSl, scMLHl and scMLHS have been identified (Kolodner and 
Marsischky, 1999). PCNA has a direct interaction with the MSH2-MSH3 and 
MSH2-MSH6 complexes, this may facilitate the linking of MMR to DNA replication 
(Clarke et al., 2000; Kolodner and Marsischky, 1999).
When error prone translesion DNA synthesis produces mismatches at UV lesions, 
mismatch repair probably acts on the daughter strand to prevent these mismatch 
mutations being fixed by NER or further replication (Mu et al., 1997). Interestingly, 
MMR proficient mammalian cells are more susceptible to the killing effects of
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alkylating agents than MMR deficient cells. MMR probably engages in a futile 
cycle, attempting to repair the mismatched base opposite the damage, this may lead 
to strand breaks (Karran and Hampson, 1996).
Mismatch Repair and Recombination
The MMR proteins exhibit anti-recombination activity which greatly reduces genetic 
recombination between non-identical sequences and thereby limits genomic 
rearrangements involving repetitive elements (Alani et al., 1994; Ciotta et al., 1998; 
Datta et al., 1996; Harfe and Jinks-Robertson, 2000). Sequence divergence has been 
found to inhibit recombination in yeast and mammalian cells (Belmaaza et al., 1994; 
Lukacsovich and Waldman, 1999). In spite of the general consensus that sequence 
divergence inhibits mitotic recombination, there is disagreement as to whether the 
MMR machinery is important for this inhibition (Alani et al., 1994; Chen and Jinks- 
Robertson, 1999; Datta et al., 1996; De Wind et al., 1995; Selva et al., 1995). 
Heteroduplex recombination intermediates from diverged sequences often contain 
mismatches, the processing of which could require MMR. MSH2 and MSH6 
possess some antirecombination activity that is not dependent on the general MMR 
system (Nicholson et al., 2000). Mismatch binding by MSH2-MSH6 alone may be 
sufficient to impede recombination. It has been suggested that the yeast MMR 
machinery either impedes the extension of heteroduplexes by causing the immediate 
resolution of recombination intermediates or triggers a reversal of the strand 
assimilation process (Alani et al., 1994). The extent of heteroduplex formed during 
recombination is longer in MMR deficient cells than in MMR proficient cells (Chen 
and Jinks-Robertson, 1998; Chen and Jinks-Robertson, 1999).
Nucleotide Excision Repair
Nucleotide excision repair is the most promiscuous system for repairing DNA. 
There are strong homologies between yeast and mammalian systems. Research has 
concentrated on the role of NER in the repair of damage from UV light, however, 
NER will also remove most damaged bases, mismatched bases (with no specificity 
for the mismatched bases, it will take either) and one to three nucleotide long loops, 
although with varying efficiencies (Batty and Wood, 2000; Fleck et al., 1999). NER 
is the sole repair mechanism for bulky adducts, like acetylaminofluorene-guanine,
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cisplatin-guanine, psoralen-thymine adducts, and for thymine dimers and 6-4 
photoproducts. NER was discovered through study of various UV sensitive cell lines 
and analysis of three human diseases that involve increased cancer risk and UV 
sensitivity. These diseases, Xeroderma Pigmentosum (XP), Cockayne's Syndrome 
(CS) and Trichothiodystrophy (TTD) are rare, autosomal, recessive disorders.
Xeroderma Piqmentosum
There are seven XP complementation groups, characterised by hypersensitivity to 
sunlight, a 1000-fold increase in skin cancers and a 20-fold increase in internal 
cancers (Friedberg, DNA repair and Mutagenesis; Robbins, 1988). XP patients do 
not have functional NER and cannot repair UV DNA damage or free radical DNA 
damage (Evans, 1993; Reardon, 1997; Robbins, 1988; Satoh et al., 1993). XP 
patients sometimes suffer from neurological abnormalities and neurodegeneration, 
similar to aging (Robbins, 1988; Robbins, 1989; Robbins et al., 1991). The 
neurodegeneration is probably caused by DNA damage, but as UV cannot reach the 
brain, it is proposed that DNA is damaged by reactive cellular metabolites, including 
the oxygen free radicals abundant in brain (Reardon et al., 1997; Robbins et al., 
1989). About 20% of XP patients are classified as XPV, they have classic XP 
symptoms but normal NER. XPV cells are moderately sensitive to UV but excise 
photoproducts at a normal rate, however they suffer high rates of mutagenesis 
(Maher et al., 1976; Myhr et al., 1979). XPV patients are defective in Translesion 
synthesis (TLS), most patients have mutations in the gene that codes for DNA 
polymerase r| (Cordonnier and Fuchs, 1999; Masutani et al., 1999; Masutani et al., 
1999).
Cockayne's Syndrome
CS is characterised by growth failure, mental and neurological abnormalities, 
cataracts, dental caries, photosensitivity and related dermatoses. There are three CS 
complementation groups, genes for two of which have been cloned. CS A and CS B 
groups have classical CS symptoms without increased skin cancer and have near 
normal UV sensitivity (Henning et al., 1995; Troelstra et al., 1992). A separate 





















































Table 1.1 Cloned human NER genes and their names in S. cerevisiae, S. 
pombe and mouse
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the CSA, CSB, XPB, XPD or XPG genes. The lack of cancer incidence in simple 
CS patients may be due to the selective elimination of damaged cells by apoptosis, 
the transcription blockage resulting from a CS Transcription Coupled Repair (TCR) 
defect is a strong apoptotic signal (Balajee et al., 2000; Ljungman and Zhang, 1996).
Trichothiodvstrophv
TTD patients have ichthyosis, brittle hair, photosensitivity, skeletal abnormalities, 
mental retardation and sometimes increased skin cancer rates (Bergmann and Egly, 
2001). A group of patients have both XP and TTD symptoms and have mutations in 
the XPB and XPD genes. The TTD A group is probably mutant in another TFIIH 
subunit. TFIIH is an essential factor involved in transcription by RNA pol II.
Cross Complementation
In parallel with work on human genetic diseases, NER genes were also characterised 
in UV sensitive cultured rodent cell systems in which this sensitivity could be cross- 
complemented by 11 human genes. These cross complementing genes were given 
the nomenclature ERCC1 through to ERCC11, and most of them were subsequently 
found to correspond to genes already discovered in XP, CS and TTD. All the NER 
genes were mutated in either XP, CS or TTD patients, except ERCC1. This led to 
speculation that an ERCC1 mutation would be lethal or was associated with a 
different phenotype.
In this thesis I will refer to the NER genes by human nomenclature, alternative 
names are listed in Table 1.1. The NER genes have all been cloned, many following 
the cross-complementation strategy.
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In Vitro Reconstitution
The NER system has been reconstituted in vitro (Aboussekhra et al., 1995). NER 
can either be reconstituted to give the dual incision steps alone or the entire repair 
process. The in vitro reconstitution was performed with XPA, TFIIH, XPG, ERCC1- 
XPF, XPC and RPA. These proteins were needed for the basic damage recognition 
and cleavage steps. The addition of RFC, PCNA, DNA polymerase 8 (or 5) and 
DNA ligase I was needed for complete repair including the replication reaction. The 
complete in vitro NER reaction uses 25 polypeptides overall and requires IF7 and a 
type 2A protein phosphatase to optimise the reaction. The presence of active repair 
can be assayed by either measuring incision/excision or repair synthesis.
XPC is a protein of 125 kDa that copurifies with the 58 kDa HHR23B (Masutani et 
al., 1994). XPC binds TFIIH and has a preference for binding to damaged DNA 
(Sugawasa et al., 1998; Evans et al. 1997; Masutani et al., 1994; Drapkin et al., 1994; 
Shivji et al., 1994). XPC-HHR23B may be the primary damage sensor in Global 
Genome Repair (GGR) (Sugawasa et al., 1998;). XPC and TFIIH are probably 
involved with open complex formation and/or stabilisation (Drapkin et al., 1994; 
Evans et al., 1997). XPC is not required for TCR (Hanawalt, 1994; van Hoffen et al., 
1995).
XPA, a 31 kDa protein with a zinc finger, acts with RPA and this complex is 
essential for NER (Evans et al., 1997; He et al., 1995; Li et al., 1995). XPA has a 
preference for binding to damaged DNA and will bind ERCC1-XPF and TFIIH 
(Asahina et al., 1994; Li et al., 1994; Saijo et al., 1996). The affinity of XPA binding 
correlates with the extent of helical distortion. It is unclear whether XPA or XPC 
bind first during NER, Sugawasa reported that XPC probably acts before XPA, 
however order of addition experiments do not support the idea that XPC acts first 
(Sugasawa et al., 1998; Wakasugi and Sancar, 1999). The DNA damage recognition 
and protein interaction properties of XPA seem to indicate that it acts as a nucleation 
factor with XPC.
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RPA binds specifically to ssDNA and stabilises it, preventing the formation of 
secondary structures (Wold, 1997). RPA is a trimer of p70, p34 and pi 1, is essential 
for DNA replication, repair synthesis and the dual incision of NER, and is involved 
in recombination (He et al., 1995; Raderschall et al., 1999). RPA shows some 
preferential binding to damaged DNA and is phosphorylated at the Gl/S boundary 
and upon DNA damage (Clugston et al., 1992; Li et al., 1995). RPA interacts with 
XPA, XPG, ERCC1-XPF and XPC (Bessho et al., 1997; He et al., 1995; de Laat et 
al., 1998; Li et al., 1995; Saijo et al., 1996). RPA is involved in orientating ERCC1- 
XPF and XPG in the excinuclease (de Laat et al., 1998).
PCNA is a polymerase clamp that increases the processivity of DNA pol 5 and e, and 
is loaded onto the template primer by RFC, an ATPase, that also loads DNA 
polymerases (Tsurimoto, 1999). PCNA is essential for DNA replication in 
mammals. PCNA seems to function as a central factor in DNA synthesis, it interacts 
with DNA pol 5, DNA ligase I, p21 and FEN1 (Tsurimoto, 1999). PCNA mutants in 
S. cerevisiae and S. pombe have increased sensitivity to DNA damage (Ayyagari et 
al., 1995). PCNA accumulates in actively repairing nuclei after UV irradiation and 
is required for in vitro NER, BER and MMR (Matsumoto et al., 1994; Nichols and 
Sancar, 1992; Umar et al., 1996).
XPB and XPD are DNA dependent ATPases and helicases that can disassociate short 
DNA fragments annealed to ssDNA. XPB (3'-5' helicase) and XPD (5'-3' helicase) 
are found in the protein complex TFIIH, which is a 9 subunit multimer involved in 
transcription by RNA polymerase II (Frit et al., 1999). TFIIH helicase activity is 
absolutely required for unwinding of DNA at lesions. TFIIH is also required where 
pre-unwound constructs are provided for NER, implying an additional, at least 
structural role. XPA and XPC-HHR23B can recruit TFIIH to damaged DNA. The 
ATP hydrolysis activity of TFIIH is enhanced by the presence of damaged DNA, 
XPA and XPC-HHR23B (Winkler et al, 2001). Perhaps XPC-HHR23B and XPA 
activate TFIIH by tethering it to damaged DNA or by activating TFIIH by some 
conformational change. Interestingly, TFIIH inhibits the action of ERCC1-XPF and 
XPG on artificial NER substrates and this inhibition is reversible by the addition of
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ATP (Winkler et al., 2001). TFIffl probably forms a complex on the DNA and 
sterically inhibits ERCC1-XPF and XPG. Perhaps TFIffl inhibits incision prior to 
full opening of the helix in NER.
XPG has ssDNA specific endonuclease activity and is a dsDNA specific 
exonuclease. XPG will cleave ssDNA at a ds-ss DNA junction with a 5' ssDNA tail 
and requires 5 to 10 unpaired nucleotides for efficient cutting (Evans et al., 1997). 
XPG cleaves to the 3' side of the damage in NER (Evans et al., 1997; Matsunaga et 
al., 1995; O'Donavan et al., 1994). XPG performs a structural role by loosely 
binding TFIffl and RPA. XPG is a member of the FEN1 family of structure specific 
endonucleases which all act on similar but different substrates (Harrington and 
Lieber, 1994; O'Donavan et al., 1994). FEN1 family members have preferences for 
specific substrates. FEN1 will cut flaps but doesn't cleave bubbles or substrates with 
closed loops (Harringtone and Lieber, 1994). XPG will cleave stem loop and bubble 
substrates as well as flaps and splayed arms, but cannot substitute for FEN1 in BER 
(Evans et al., 1997; Klungland and Lindahl, 1997). XPG has a conserved PCNA 
interaction domain (Gary et al., 1997). The PCNA interaction domain is essential for 
XPG activity, perhaps PCNA helps to link the incisional and replication steps of 
NER. Patients with severe truncation mutations of XPG show a combined CS/XPG 
phenotype whereas XPG patients with missense mutations show only the XP 
phenotype (Nouspikel et al., 1997). This implicates XPG in TCR. In vitro, XPG 
protein even if inactivated by mutation has a stimulatory effect on transcription 
coupled repair of thymine glycol by NTH, the human DNA glycosylase involved in 
BER (Bessho, 1999; Cooper et al., 1997; Klungland et al., 1999). XPG is also 
involved in removal of thymine glycol and 8-oxoguanine adducts in untranscribed 
DNA.
ERCC1-XPF is an endonuclease complex, specific for ssDNA, that cuts 5' of the 
damage in NER (van Duin et al., 1986). In vivo, ERCC1 (33 kDa) is found in a tight 
complex with XPF (120 kDa) (de Laat et al., 1998; Sijbers et al., 1996). The binding 
between the two is so strong that cell free extracts from XPF def. cells and ERCC1 
def. cells will not cross complement, indicating that there is no exchange between
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protein bound in the dimer and free protein (Biggerstaff et al., 1993). C-terminal 
amino acids from 224 to 297 of ERCC1 are involved in binding XPF and conversely 
C-terminal amino acids 814 to 905 in XPF directly interact with the XPF region in 
ERCC1 (de Laat et, 1998; McCutchen-Maloney et al., 1999). One of the known 
XPF patients was shown to have a mutation in the putative ERCC1 binding region 
and displayed reduced levels of the ERCC1- XPF complex, supporting this model 
(de Laat et al., 1998). XPF mutant cells have a mild DNA repair deficiency and 
reduced levels of XPF and ERCC1 (Matsumura et al., 1998). The reduction in 
ERCC1 levels indicates how strong the interaction is between ERCC1 and XPF and 
the extent to which complex formation is required for protein stability. In fact, both 
free ERCC1 and XPF are very quickly degraded (Sijbers et al., 1996). Protein 
sequence comparison revealed similarity between the conserved C-terminal region of 
ERCC1 and the C-terminal region of XPF, including the regions necessary for the 
ERCC1-XPF interaction, implying that ERCC1 and XPF are related via an ancient 
duplication (Gaillard and Wood, 2001).
It is still unsure which of the proteins, ERCC1 or XPF actually contribute the 
nuclease activity, although it seems likely that it is XPF, which has an intrinsic 
endonuclease activity (McCutchen-Maloney et al., 1999). XPF has a region related 
to a helicase family, this region has many conserved acidic residues and may be a 
nuclease domain (Aravind et al., 1999; Sgouros et al., 1999). XPF is not a helicase 
but ERCC1-XPF shares the characteristics of helicases to bind with a specific 
polarity at junctions between ss and dsDNA.
In vitro, ERCC1-XPF will cleave one strand of dsDNA at the 5' side of a junction 
with ssDNA in the form of splayed arm, flap or bubble (Bessho et al., 1997; de Laat 
et al., 1998). The ssDNA arms protruding in the 3' direction were efficently 
removed from splayed arm and flap substrates. The cleavage varies from 2 to 8 
nucleotides away from the junction. ERCC1-XPF will cleave synthetic structures in 
vitro to remove 3' ssDNA overhangs, and will cut 5' ssDNA overhang structures, but 
these incisions only lengthen the overhang rather than removing it (de Laat et al., 
1998). This action suggests that in NER, ERCC1-XPF cuts the damaged strand at
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the 5' end of the bubble of deannealed DNA that contains the damaged nucleotide. 
ERCC1-XPF will cleave at stem loop DNA junctions without the assistance of other 
proteins, which shows its specific intrinsic endonuclease activity.
All excision repair mutants are sensitive to DNA interstrand cross linking agents, 
e.g.MMC, but ERCCl and XPF are hypersensitive. This has led to the belief that the 
ERCCl-XPF complex is involved with recombinational processes that could be 
involved in the repair of crosslinks.
ERCCl has 35% homology over 110 amino acids at its C terminus with an S. 
cerevisiae protein called RADIO and 56% homology over 25 amino acids at the 
centre of the 35% homologous region (van Duin et al., 1986). ERCCl also has 60 
extra C-terminal amino acids which are not in RADIO and are 38% homologous to 
the C-terminal of UVRC, an E coli DNA repair protein (van Duin et al., 1988). The 
homologous regions form a helix-loop-helix DNA binding region in RADIO, this 
maybe just a common DNA binding motif or perhaps a common region for an 
endonuclease mechanism as well. RADIO def. extracts have the same early incision 
defect as ERCCl def. extract. RADIO also binds very stably to a protein called 
RADl just as ERCCl binds to XPF, although the XPF binding region of ERCCl lies 
outside the region of homology with RADIO. Radl-RadlO has the same structural 
preferences as an endonuclease as ERCCl-XPF, and although RADl possesses the 
endonuclease activity it is not efficient without RADIO (Bardwell et al., 1994; 
Davies et al., 1995; Habraken et al., 1994). ERCCl is not inducible on UV 
irradiation of cells and this corresponds with work in yeast that shows that RAD 10, 
like RADl and RAD3 but not RAD2, is not inducible (van Duin et al., 1987). This 
implies that ERCCl and RADIO are largely equivalent in structure and function. 
RAD10-RAD1 is involved in the removal of non-homologous tails from invading 
single strands during recombination, suggesting that ERCCl-XPF may play a similar 
role.
ERCCl will complement the SWI10 mutant of S. pombe (Rodel et al., 1997). This 
SWI10 mutant has a pleiotropic effect: it reduces the frequency of mating type
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switching and causes increased UV radiation sensitivity (Schmidt et al., 1989). Full 
length ERCC1 will only complement the transposition defect, a C-terminal truncated 
version is needed to restore the DNA repair capacity as well. In fact, only the 
truncated version of ERCC1 can interact with spRAD16 (the S. pombe homologue of 
XPF) (Rodel et al., 1997).
ERCC1 and XPF homologues are known in plants (Gallego et al., 2000; Liu et al., 
2000; Xu et al., 1998). The lily ERCC1 homologue will significantly correct the 
mitomycin C sensitivity in ERCC1 def. mammalian cells and expression is high in 
male generative cells in pollen but not elsewhere.
ERCC1-XPF may possibly be involved in the immunoglobulin heavy chain class 
switch recombination pathway (CSR), which mediates isotype switching during B 
cell development (Tian and Alt, 2000). CSR controls switching from IgM to other 
immunoglobulin types e.g. IgG. The variable region is upstream of a line of different 
Ig constant region sections. CSR occurs between switch regions before each Ig 
heavy chain constant region gene and is known to be dependent on transcription. In 
vitro transcription of switch regions in a physiological orientation seems to induce 
formation of stable R loops. An R loop is formed when a short RNA strand 
hybridises with the template strand and the non template strand exists as a single 
stranded loop, this is similar to the NER substrate after helicase action. ERCC1-XPF 
and XPG can cleave these loops either to create a DSB or SSBs that can be converted 










Figure 1.1 Nucleotide Excision Repair. XPC-HRR23B and XPA-RPA 
are involved in lesion recognition. TFIIH melts the helix around the 
lesion and ERCC1-XPF and XPG make the 5' and 3' incisions 
respectively. The oligomer containing the lesion is then removed and 
new DMA synthesised.
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XPE and CS proteins are not required for in vitro NER but are required in vivo. XPE 
cells lack the UV-DDB (damage-specific DNA binding activity) which is a hetero 
dimer composed of the p!25 and p48 proteins (Tang et al., 2000). The damage 
inducible p48 gene is required for the efficient GGR of CPD (Hwang et al., 1999). 
Here lies one important difference between rodent cells and humans. Cultured 
wildtype (wt) rodent cells are deficient in the GGR of CPD and lack expression of 
the p48 protein (Tang et al., 2000). Perhaps because of their short life spans rodents 
are not as concerned with the buildup of damage that does not affect transcription. 
Curiously, expression of human p48 protein in rodent cells results in effective GGR 
of CPD (Tang et al., 2000). p53 expression is required for the efficient GGR of 
CPDs, but is not required for TCR of CPDs and p53 regulation of NER is exerted by 
p48 (Hwang et al., 1999). UV-DDB recognises, with high specificity, DNA damage 
caused by a variety of agents (Payne and Chu, 1994). UV-DDB appears to have little 
or no role in naked DNA reconstitutions (Abbousekhra et al., 1995). However as 
XPE cells do suffer from decreased NER presumably it has some role in vivo, 
perhaps when the damage is presented in a chromatin context. UV-DDB may 
facilitate recognition of poorly recognised lesions such as CPD. Cultured CS cells 
are defective in TCR of CPD and thymine glycols (Cooper et al., 1997; Venema et 
al., 1990). CSA and CSB cells are UV sensitive and incapable of recovering RNA 
synthesis after inhibition by UV. They do not exhibit strand specificity for CPD 
repair but do repair DNA as evidenced by UV-induced DNA repair synthesis, they 
seem to be defective in TCR alone. It is unsure whether the TCR defective 
phenotype of CS cells is caused by a defect in repair or by a defect in the reinitation 
or perhaps initiation of transcription, as TCR is so closely coupled to transcription 
that a defect in transcription might stall repair entirely (Brosh et al, 1999; van 
Oosterwijk et al., 1996; van Oosterwijk et al., 1998).
Further investigation of in vitro reconstitution reactions has revealed the order of 
reaction and the various roles of the proteins (Evans et al., 1997; Sugasawa et al., 
2001) (Figure 1.1). First either XPA-RPA or XPC binds the damage site, XPA then 
recruits TFIIH to give the preincision complex (this step is dependent on ATP 
hydrolysis). XPC or XPA-RPA help to stabilise this complex and XPG is recruited
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by TFIIH to perform the incision 3' of the damage. ERCC1-XPF is recruited by 
XPA to incise 5' of the damage site (Saijo et al., 1996). This dual incision reaction is 
absolutely dependent on ATP hydrolysis and gives fragments of 24 to 32 nucleotides 
long but mainly of 27 to 29 nucleotides long. The fact that this size strongly 
correlates to the length of the optimal ssDNA binding region of RPA (30nt) suggests 
that RPA plays a role in positioning incisions (Kim et al., 1992). The excinuclease, 
as the dual excision activities are known collectively, cuts at one of the 3rd to the 5th 
phosphodiester bonds 3' to the damage and at one of the 21st to the 25th 
phosphodiester bonds 5' to the damage. Repair synthesis is PCNA dependent, and 
therefore must use DNA pols 5 and/or £. Antibodies raised against DNA polymerase 
5 inhibit repair synthesis and in reconstitution experiments DNA pol 8 performed 
repair synthesis, indicating that both DNA polymerase delta and E are used (Evans et 
al., 1997).
Although NER is the main system for the repair of UV damage there is no evidence 
to suggest that the levels of the NER proteins are elevated following UV irradiation 
(van Duin et al., 1987). However the levels of NER activity seem to be inducible 
after a priming dose of UV and cell extracts from UV treated cells better support 
NER in vitro (Francis and Rainbow, 1999). Host cell reactivation of reporter 
constructs is reduced in unstressed cells, however it is stimulated in cells subject to 
UV or heat shock, this indicates that blockage of transcription on the reporter is alone 
not enough to induce TCR, in fact p53 is required for the stimulation (McKay et al., 
1997).
Damage Recognition
The exact damage recognition mechanism in NER is currently unknown (Kusumoto 
et al., 2001; Wood, 1999; Batty and Wood, 2000). The more a lesion distorts the 
DNA helix the more efficiently it is recognised and the repair rate is greater (Wood, 
1999). 6-4PPs distort DNA more than CPDs and are removed from the bulk genome 
5-10 times faster (Mitchell and Nairn, 1989). For effective recognition a lesion must 
cause distortion of DNA structure and modification of DNA chemistry (Hess et al.,
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1997). CPDs are a weak NER substrate but non-complementary bases opposite the 
lesion increase repair efficiency (Mu et al., 1997). A 1,3 GTG cisplatin intrastrand 
crosslink is more distorting than a 1,2 GG crosslink and is repaired more efficiently 
(Bellon et al., 1991). A non-complementary base opposite the 1,2GG crosslink 
improves repair efficiency (Moggs et al., 1997). Distortion alone does not produce a 
good NER response as DNA mismatches and small loops are repaired poorly (Hess 
et al., 1997; Hess et al., 1997; Moggs et al., 1997; Mu et al., 1997).
The NER complex probably assembles on the damage. An ERCC1-GFP fusion 
protein, that will correct the NER deficiency in ERCC1 deficient cells, moves freely 
through the nucleus at a rate consistent with the size of ERCC1-XPF, similar results 
were reported in the same paper for XPA and TFIIH (Houtsmuller et al., 1999). UV 
treatment of cells caused a temporary immobilisation. This indicates that ERCC1- 
XPF, XPA and TFIIH are not part of an NER holocomplex and do not take part in 
processive scanning. Other evidence suggests that there may be a sub-holocomplex, 
based around TFIIH (Svejstrup et al., 1995). In yeast the NER repair complex seems 
to be assembled sequentially (Guzder et al., 1996).
Global Genome Repair and Transcription Coupled Repair
There are two pathways within NER, Global Genome Repair and Transcription 
Coupled Repair (Friedberg, 1996; Tornaletti and Hanawalt, 1999). Although the 
mechanism of GGR is relatively well understood from the in vitro reconstitution, that 
of TCR is not, and there is no in vitro reconstitution of TCR. However, TCR and 
GGR almost certainly follow a common mechanism following recognition of the 
lesion. As the names imply, GGR works indiscriminately over the whole genome at 
a relatively low rate while TCR is specifically coupled with transcription to repair 
lesions that would otherwise block the progress of RNA polymerases. TCR repairs 
the untranscribed strand at a higher rate than GGR and the transcribed strand at an 
even higher rate (Mellon et al., 1987). TCR seems to function to repair lesions that 
are poorly recognised by GGR, for example, CPD lesions are poorly repaired by 
GGR and tend to be repaired by TCR (Mullenders et al., 1993; van Hoffen et al., 
1995).
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Some oxidative damage that is thought to be primarily repaired by BER rather than 
NER has been shown to be subject to TCR (Le Page et al., 2000). Perhaps the TCR 
reaction can involve more than just NER. MMR proteins have been found to 
participate in TCR (Leadon and Avrutskaya, 1997). TCR of UV induced lesions 
requires MMR proteins in human cells, but not in yeast, and removal of thymine 
glycols by TCR requires MMR proteins in both (Leadon and Avrutskaya, 1997; 
Leadon and Avrutskaya, 1998). NER proficient cell free extracts remove 8 oxoG 
and thymine glycol lesions, as 26nt long oligomers and the rate of removal is similar 
to that for CPDs (Reardon et al., 1997). However, TCR of thymine glycol depends 
on XPG but not on XPA or XPF and does not require the nuclease function of XPG. 
Certain XPG mutations that completely abolish CPD excision repair do not affect the 
rate of thymine glycol repair and null XPG mutations abolish repair of CPDs and 
TCR of glycols (Cooper et al., 1997).
How does TCR recognise lesions? Is it by simple polymerase stalling? In this case 
sequence dependent stall sites may trigger the futile repair of undamaged DNA in 
TCR. When a polymerase stalls at a lesion, it blocks the access of repair enzymes to 
the lesion, so there must be some mechanism for the polymerase to either backup or 
disengage from the DNA.
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Figure 1.2 Mechanisms for Double Strand Break Repair Classical 
Homologous Recombination (CHR), Single Strand Annealing (SSA) and
^nTo0,90"8 End J° ining (NHEJ) - Durin9 CHR (paq ue* and Haber 
1999), DSB formation is followed by 5' to 3' resection, strand invasion ' 
Holliday junction formation and alternative resolution During SSA ' 
resection is followed by annealing of homologous regions and 3' tail 
trimming. During NHEJ, ends are not resected to a great extent and 
joining uses only short stretches of microhomology
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Double Strand Break Repair
Double strand breaks are a potentially lethal form of DNA damage as, if unrepaired, 
a single DSB can kill a cell. If undetected, a DSB at mitosis will lead to loss of the 
part of the divided chromosome without a centromere.
DSBs can be formed in a variety of ways: free radicals, DR., mechanistic stress, by 
endonuclease action and by the actions of replication and subsequent processing on 
certain types of DNA damage. They are also formed physiologically by the cell in 
such events as V(D)J recombination and meiotic recombination or in yeast during 
mating type switching.
In bacterial systems it is known that replication arrest often leads to DSB formation, 
a primary function of the DSB repair system in bacteria may be to rescue blocked 
replication forks (Kuzminov, 1995). There is much indirect evidence in yeast that 
replication arrest also leads to DSBs. It is well known that DSBs stimulate 
recombination, in fact DSBs are the sole instigators of recombination in meiotic cells 
and a major factor in mitotic cells (Godwin et al., 1994). Various results imply that 
inhibition of DNA replication induces recombination, with an assumed intermediate 
of DSBs (Arnaudeau et al., 2000; Bierne and Michel, 1994; Galli and Schiestl, 1996; 
Galli and Schiestl, 1998; Michel, 2000). There is also some direct evidence that 
inhibition of DNA replication leads to DSBs. The methylating agent methylmethane 
sulphonate generates single stranded DNA lesions in vivo that block DNA replication 
resulting indirectly in the formation of DSBs and stimulation of recombination 
(Chlebowicz et al., 1979; Schwartz, 1989). DNA sequences associated with unusual 
structures or with inhibition of DNA replication have been identified as sites of 
DSBs in vivo (Gordenin and Resnick, 1998).
The cell has evolved various mechanisms to repair DSBs, these can be divided into 
two sorts (Karran, 2000) (Figure 1.2). Classical homologous recombination (CHR) 
relies on a homologous chromosome, ideally the identical sister chromatid after 
DNA replication, and often results in error-free repair. Non-homologous end joining
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(NHEJ) and single strand annealing (SSA) however involve the processing of DSBs 
so that they can be rejoined without the use of an intact homologous region, this 
often results in information loss.
Repair of DSBs in S. cerevisiae is highly accurate and is predominantly dependent 
on homologous recombination. In contrast, DSB repair in mammals during most of 
the cell cycle is accomplished primarily by NHEJ (Critchlow and Jackson, 1998; 
Jeggo, 1998). Cultured mammalian cells mutant in NHEJ genes (KU70, KU80, 
LIG4 or XRCC4) are moderately sensitive to IR whereas their yeast equivalents are 
resistant. Although S. cerevisiae and mammals use classical homologous 
recombination and NHEJ to different extents the mechanisms are similar between 
species (Takata et al., 1998). The repair of DSBs by homologous recombination is 
down regulated during the GO, Gl and early S phases of the cell cycle implying that 
NHEJ and SSA are the predominant mechanism in this period (Takata et al., 1998). 
In Gl mammalian cells interchromosomal homologous recombination is exceedingly 
rare even after a DSB is introduced (Benjamin and Little, 1992; Godwin et al., 1994). 
In the rest of the cell cycle homologous recombinational repair of a break could 
occur by using the sister chromatid as the intact template.
In NHEJ and SSA the two broken ends are modified to make them compatible for 
rejoining and information between the two DNA ends is lost. Why rely on these 
imperfect repair processes? Mammalian genomes, unlike yeast, have a large amount 
of repetitive DNA. This makes homology search for repair of DSBs by homologous 
recombination difficult, except during late S, G2 and M, when a sister chromatid is 
physically positioned optimally. Otherwise homology partners for repetitive regions 
might be chosen inappropriately from any of the chromosomes. A homologous 
crossover event arising during DSB repair could result in a chromosome 
translocation. A mutation in a tumour supressor gene might gene-convert the good 
allele on the homologous chromosome if homologous recombination were in heavy 
use throughout the cell cycle (Liang et al., 1998). By restricting homologous 
recombination primarily to late S, G2 and M, a DSB arising in one chromatid can 
rely on the identical sister chromatid for repair without the risk of receiving a
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different copy. Large regions of repetitive DNA may also provide an increased 
tolerance for small errors generated during repair by NHEJ.
Non-Homologous End Joining
During NHEJ the two broken DNA ends are directly joined with no overlap, or with 
minimal overlap and the use of short fortuitous homologies near the two ends (Jeggo, 
1998; Lewis and Resnick, 2000; Lieber, 1999; Muller et al., 1999). Thus the term 
nonhomologous refers to the absence of extended segments of homologies between 
the two recombined DNA molecules. When DSBs occur in DNA, the biochemical 
configuration of the broken ends can be very diverse and putting the two ends back 
together cannot usually be achieved by a simple ligation step, processing is required. 
The specific proteins that are essential for NHEJ in vivo remain to be established, but 
accurate efficient endjoining in an in vitro assay using human cell extracts requires 
KU70 and KU80, DNA dependent protein kinase and is dependent on the presence 
of DNA ligase IV and XRCC4 (Baumann and West, 1998). DNA PK, KU70 and 
KU80 are involved in the recognition and binding of DSB ends. There is a 
propensity for the joining of the two broken DNA ends to occur at microhomology 
between the nucleotides proximal to the break , however microhomology is not 
essential for joining (Roth and Wilson, 1986). NHEJ commonly causes small 
deletions that extend in both directions from the break site. Such deletions typically 
end in a region of microhomology. When the two DNA ends do undergo alignment 
at points of microhomology, then there is often either excess DNA beyond the point 
of alignment that must be removed by nucleases or there are gaps that must be filled 
using polymerases. Some of these excess single stranded regions require 5' 
nucleases, possibly FEN1 and EXO1, and others require 3' nucleases, possibly 
MRE11 (Lieber, 1999; Wu et al., 1999).
Classical Homologous Recombination
Extensions of the classical homologous recombination DSB repair model have been 
made from bacteria to yeast to mammals (Haber, 2000; Haber, 2000; Thacker, 1999; 
Thompson and Schild, 1999). A DSB is first processed by the digestion of a 
substantial portion of the DNA strands containing the 5' ends of the break. This 
results in 3' ssDNA tails that can be as long as 1 kb or more. These tails are utilised
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for the nucleation of a number of recombination factors that give a nucleoprotein 
complex that has the ability to conduct a DNA homology search. This could use 
either a sister chromatid or a homologous chromosome. Invasion of the homolog by 
the 3' tails in homologous DNA pairing and strand exchange yields a joint. The
»
3'ends of invading DNA act as primers for the initiation of new DNA synthesis. This 
process leads to the formation of two Holliday junctions, four-stranded branched 
structures whose alternative resolution allows formation of crossover products and 
completion of DSB repair. The exact mechanism of DSB end processing during 
classical homologous recombination is unknown but much evidence implicates the 
RAD50-MRE11-(NBS1/XRS2) complex (Dolganov et al., 1996; Karran, 2000).
RAD51, RAD52, RAD54, RAD55, RAD57, RDH54 and RPA are all involved in the 
utilisation of recombinogenic ssDNA substrates for the formation of heteroduplex 
DNA (Paques and Haber, 1999; Sung et al., 2000). Rad51 is at the core of CHR, it is 
homologous to the E. coli general recombinase RecA (Paques and Haber, 1999). 
RAD51 exhibits a homologous DNA pairing, joint formation and strand exchange 
activity that yields joints between two DNA molecules. In the presence of ATP, 
RAD51 assembles into a nucleoprotein filament on both ssDNA and dsDNA that is 
almost identical to the equivalent RECA filament. RAD51 is essential in mammals 
(Tsuzuki et al., 1996). 5 RAD51 homologues have been identified in human cells, 
RAD51B, RAD51C, RAD51D, XRCC2 and XRCC3 (Jones et al., 1995; Shinohara 
and Ogawa, 1999; Tambini et al., 1997; Tebbs et al., 1995; Thacker, 1999). These 
homologues may form complexes with one another and function to enhance RAD51- 
ssDNA filament assembly, they may all be required simultaneously for efficient 
recombination or may play specific recombination roles in different circumstances. In 
vivo, ssDNA filament assembly is stimulated by heterotrimeric ssDNA binding factor 
RPA, but an excess of RPA inhibits filament assembly. This inhibition is probably 
due to competition with RAD51 for binding sites on the ssDNA. RAD52 and 
RAD55-RAD57 help overcome this competition and mediate a productive 
relationship between RAD51 and RPA. RPA probably removes secondary structure 
in the ssDNA. RAD52 binds DNA as a ring shaped multimer, with higher affinity
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for ssDNA than dsDNA. RAD52 binds specifically to DNA ends. RAD52 forms a 
stable stoichiometric and coimmunoprecipitable complex with RAD51, and interacts 
with RPA in solution and when RPA is bound to DNA. Genetic evidence indicates 
that RAD52 also functions in at least two other recombination pathways, Single 
Strand Annealing and Break Induced Recombination. Null mutations in RAD52 
essentially eliminate all recombination in yeast, probably due to cumulative defects 
in different pathways.
RAD54 belongs to the SWI2/SNF2 protein family, involved in transcription, NER 
and post-replicative repair (Paques and Haber, 1999). RAD54 has a DNA dependent 
ATPase activity and interacts with RAD51. In vitro, RAD54 strongly stimulates the 
homologous pairing rate. The first DNA intermediate predicted in the DNA DSB 
repair recombination model is a D-loop structure formed between the initiating 
ssDNA tail and the DNA homolog. RAD51 is incapable of mediating formation of 
this loop in vitro without RAD54. RAD54 null chicken cells and mice are viable 
although X ray sensitive.
Alignment of the two recombining molecules is established through a series of 
transient joints called paranemic joints. It has been argued that this involves a DNA 
triplex structure held together by non-Watson-Crick bonding, or perhaps by DNA 
strand switching. The paranemic joints are believed to be an important intermediate 
that serves to capture the duplex and bring the two recombining DNA molecules into 
homologous registry (Paques and Haber, 1999). A more stable plectonomic joint is 
formed when a free DNA end is present in either the ssDNA or the dsDNA to allow 
for intertwining of the ssDNA strand with the complementary strand in the duplex 
partner. In branch migration the length of the plectonomic joint is extended. In the 
case of the RAD51 filament, branch migration proceeds 3'to 5' with respect to the 
initiating single strand, however results have suggested that migration can also 
proceed in the other direction. Once a stable joint is formed branch migration 
extends the length of the joint, resulting in the formation of a substantial amount of 
heteroduplex DNA. The resolvases that process Holliday junctions and other DNA 
intermediates in nuclear chromosomal recombination have not been identified.
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There are also several putative pathways separate from CHR, these are break induced 
replication (BIR) and synthesis dependent strand annealing (SDSA) (not to be 
confused with Single Strand Annealing) (Flores-Rozas and Kolodner, 2000; Paques 
and Haber, 1999). BIR was discovered from very long gene conversion tracts that 
extended over 400kb. It is a RAD52-dependent, RAD51-independent replication 
driven recombination process. An initial, unstable, short DNA joint strand invasion 
event in a small region of perfect homology is extended by DNA replication, thus 
bypassing the formation of mismatched heteroduplex DNA caused by more 
extensive strand assimilation, that is seen in CHR. The final result of BIR is 
conservative DNA synthesis, where the recipient chromosome has both strands 
newly synthesised. SDSA accounts for the many mitotic gene conversions that are 
infrequently associated with crossing over. The newly synthesised DNA strands are 
displaced from the template and returned to the broken molecule, allowing the two 
newly synthesised strands to anneal to each other.
While meiotic recombination mainly involves chromosomal homologs, it is thought 
that most recombination events during mitotic growth occur in the late S and G2 
phases and involve the sister chromatids (Paques and Haber, 1999). However in 
yeast there is capacity to carry out allelic (interchromosomal) recombination during 
mitotic growth and allelic recombinations seems to have a somewhat different 
genetic requirement than sister chromatid based recombination. Mutations in genes 
such as RAD50, MRE11 and NBS1/XRS2 that are believed to mediate sister 
chromatid based recombination could lead to higher levels of recombination between 
homologs. It has been suggested that when sister chromatid based recombination is 
inactivated the recombinogenic DNA substrates are channelled more often into 
interchromosomal recombination pathways. When the recombining DNA 
encompass different alleles of the same gene, then DNA mismatches will form 
giving heteroduplex DNA. Correction of the DNA mismatches results in the 
conversion on one of the recombining alleles. Gene conversion is defined as a 
nonreciprocal transfer of genetic information from one molecule to its homologue.
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RAD1-RAD10 and MSH2-MSH3 are necessary for removal of non-homologous 3' 
tails during CHR repair of DSBs, but are not necessary where there are no non- 
homologous tails (Alani et al., 1997; Bardwell et al., 1994; Evans et al., 2000; 
Fishman-Lobell and Haber, 1992; Habraken et al., 1994; Ivanov and Haber, 1995; 
Marsischky et al., 1999; Nicholson et al., 2000; Saffran et al., 1994; Sugawara et al., 
1997). When the resected tails invade a homologous donor sequence, RAD1-RADIO 
(but not other NER genes), and MSH2 and MSH3, are required to cleave away non- 
homologous sequences at the 3' end of the tails before they can act as primers for 
DNA synthesis. SRS2 and RAD59 are also required for efficient removal of non- 
homologous ends in gene conversion (Paques and Haber, 1997; Sugawara et al., 
2000).
A mutation has been found in D. Melanogaster in the MEI9 gene, an XPF 
homologue, that affects meiotic and mitotic recombination (Sekelsky et al., 1995; 
Sekelsky et al., 2000). This mutation leads to increased chromosomal instability, 
increased post meiotic segregation and lowered meiotic recombination, all of which 
could be explained by the misprocessing of heteroduplex intermediates in 
homologous recombination. dmERCCl has been identified and interacts physically 
with mei9 (Sekelsky et al., 2000).
Single Strand Annealing
Single strand annealing can occur when a DSB forms between flanking homologous 
regions (Haber and Leung, 1996; Lin et al., 1985; Paques and Haber, 1999). A 5' to 
3' exonuclease resects the ends of the DSB until the two homologous regions are 
exposed, these can then anneal to each other. (It is also possible that one resected end 
could invade the other before it is resected, in "one-ended" recombination.) This 
produces an intermediate with two non-homologous 3' ended tails, which must be 
removed before DNA synthesis and ligation can take place to seal the break. SSA is 
dependent on RAD52 and RAD59 (Paques and Haber, 1999; Sugawara et al., 2000). 
RAD52 anneals complementary DNA strands in vitro and its activity in SSA is 
stimulated by RPA (Sugiyama et al., 1998). Rad59 binds ssDNA and anneals 
complementary DNA strands, however its activity does not appear to depend on RPA
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(Petukhova et al., 1999). RPA probably acts to modulate SSA, similar to its role in 
CHR. RAD1-RAD10 will cut the 3' tails at the junction between the non-annealed 
and annealed DNA to remove the non-homologous DNA (Ivanov and Haber, 1995; 
Sugawara et al., 1997). MSH2-MSH3, but not other mismatch proteins are also 
required for the removal of the non-homologous tails (Ivanov and Haber, 1995; 
Sugawara et al., 1997). MSH2 and MSH3 probably stabilise the annealed DNA 
structure and target RAD 1-RADIO to ssDNA overhangs (Ivanov and Haber, 1995; 
Paques and Haber, 1999).
In CHR the requirement for MSH2-MSH3 is present despite the long homologous 
sequence. During CHR the invading strand can form only an unstable side-by-side 
paranemic joint with its homologous sequence before the DNA end is cut off, while 
during SSA two single strands of DNA can form stable plectonomic molecules when 
the homologous segments are long enough. As CHR intermediates are less stable 
than SSA intermediates, this implies a role for MSH2-MSH3 in stabilisation of the 
intermediate structures (Evans et al., 2000). Separation of function mutations for 
MSH2 will destroy its MMR function but do not affect the ability to participate in the 
removal of non-homologous tails (Studamire et al., 1999). MSH2 and MSH2-MSH6 
will bind in vitro to Holliday junctions (Alani et al., 1997; Marsischky et al., 1999). 
The meiotic specific MSH4 and MSH5 have a role in promoting meiotic crosssovers, 
perhaps they also stabilise intermediate structures (Paques and Haber, 1999).
In SSA, it is possible that either MSH2-MSH3 recognises the mismatch, as it 
recognises small loops in mismatch repair, or that it stabilises the annealed region. 
This would allow RAD1-RAD10 to bind and cut at the junction between 
homologous and non-homologous sequence. The need for MSH2-MSH3 becomes 
less as the length of the homologous region increases, and it is not necessary when 
the region is longer than 1kb, implying that the requirement may be due to 
stabilisation (Sugawara et al., 1997). In effect, RAD1-RAD10 is acting on the same 
substrate as in NER, the junction between non-annealed and annealed DNA is 
analogous to the melted bubble formed around the lesion in NER.
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For both HRR and SSA, RAD1-RAD10 and MSH2-MSH3 are only required for the 
removal of nonhomologous 3' tails when the ends are 30 nt long or longer, for shorter 
tails alternative pathways exist (Paques and Haber, 1997; Prado and Aquilera, 1995). 
One alternative can remove 3'ends up to 20bp and depends at least partly on the 
proofreading ability of DNA polymerase 8 (Paques and Haber, 1997). Another 
pathway can remove a non-homologous end on one side of the DSB but only after the 
other end has initiated strand invasion.
SSA inevitably results in a deletion as one of the two homologous regions and the 
sequence between the regions is lost. In yeast, SSA is nearly 100% efficient when the 
homologous flanking regions are at least 400bp, but 5% of the cells can survive a 
DSB when repeats are only 60bp (Sugawara and Haber, 1992). Repair is efficient 
even if the repeats are separated by as much as 15 kb. SSA may explain deletions of 
DNA between dispersed repeated sequences such as Alu in human DNA. These 
deletions may be partially suppressed by the divergence of dispersed sequences, in 
yeast a 3% divergence between 205bp repeats reduces SSA by a factor of 5 
(Sugawara et al., 1997). The rate of production of deletions depends on the distance 
between two repeats, suggesting an exonuclease must traverse the whole region 
(Fishman-Lobell and Haber, 1992). SSA is about 3 times more frequent than gene 
conversion suggesting that SSA is a major pathway (Fishman-Lobell and Haber, 
1992). Gene conversion accompanied by crossing over could produce a deletion 
between direct repeats, this would give a circular reciprocal product that would be 
retained only if it contained an origin of replication. Both genetic and physical 
experiments have failed to detect this reciprocal product except in very low levels, 
suggesting that SSA is the predominant route by which direct repeat deletions are 
produced (Fishman-Lobell and Haber, 1992; Ray et al., 1988).
scMSH2 has been shown to interact physically with a number of NER proteins: 
RAD1, RADIO, RAD14 and RAD25 (Bertrand et al., 1998). In S. pombe the NER 
proteins RHP14, SWI10, RAD16 can repair mismatched bases in recombination 
intermediates (Fleck et al., 1999). MEI9, the D. melanogaster homologue of XPF, is
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involved in the repair of mismatches in meiotic recombination intermediates 
(Sekelsky et al., 1995).
RAD1-RAD10 is required for mitotic but not meiotic recombination events (Schiestl 
and Prakash, 1990). RAD1-RAD10 is required for spontaneous and HO- 
endonuclease-induced recombination between directly repeated sequences, but other 
NER genes are not (Ivanov and Haber, 1995; Schiestl and Prakash, 1988). Mutations 
in RAD1 and RADIO decrease the efficiency of homologous integration of linear 
DNA fragments and circular plasmids (Schiestl and Prakash, 1990; Schiestl and 
Prakash, 1988; Klein, 1988). RAD1 is required for mitotic recombination stimulated 
by RNA polymerase I or II dependent transcription (Zehfus et al., 1990).
Mammalian 3' Tail Removal
Various studies have investigated the role of ERCC1-XPF in recombination in 
mammalian cells. Although, unlike in yeast, ERCC1 deficiency does not alter the 
frequency of either extra chromosomal or chromosomal homologous recombination, 
it is involved in specialised recombination types (Adair et al., 2000; Melton et al., 
1998; Sargent et al., 1997; Sargent et al., 2000). ERCC1 def. cells also have a 100 
times higher mutation frequency and higher genome instability than wild type cells 
(Melton et al., 1998). Like RAD1-RAD10, ERCC1 is probably involved in the 
removal of 3' non-homologous tails in recombination in mammalian cells (Adair et 
al., 2000).
A targeted DSB flanked by nonhomologous DNA was used to induce recombination 
at a tandem APRT construct (Sargent et al., 2000). This results in a greater rate of 
formation of APRT deletions in ERCC1 wt than in ERCC1 null cells. Presumably 
deletion products were formed by SSA, which would require ERCC1-XPF to remove 
non-homologous 3' tails. Without DSB stimulation, there was a higher frequency of 
rearrangement formation in the ERCC1 def. cells, than in wt. This is the same result 
as in a study using a tandem APRT construct but with an insert predicted to lead to 
the formation of large heteroduplex loops during recombination (Sargent et al., 
1997). The increased rearrangements seen in ERCC1 null cells in both studies 
indicate that these rearrangements are not formed by faulty processing of
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heteroduplex loops but more probably by the failure of ERCC1 to process 3' non- 
homologous tails. For effective gap repair or integration it is presumed that non- 
homologous tails will need to be removed. No rearrangements were formed with 
only one copy of APRT.
When the APRT locus was targeted in CHO cells, with selection for positive APRT 
recombinants, vectors were used with either long or short terminal non-homologies 
on either side of a DSB within the APRT gene (Adair et al., 2000). The expectation 
derived from yeast was that long non-homologies at least would have a lower 
successful recombination rate than wt, however only a very small difference in rates 
was seen between ERCC1 def. and wt for both lengths of non-homology. In ERCC1 
null cells with long terminal non-homologies there was an increased rate of aberrant 
insertion/deletion recombinants, this has been interpreted as being caused by 
recombination starting and then being unable to complete due to unprocessed non- 
homologous tails, which are then a substrate for unconventional recombination.
ERCCl-XPF is probably not involved in meiotic recombination. Although the levels 
of both XPF and ERCC1 transcript and protein are elevated in adult mouse testis this 
increase occurs after the peak of meiotic recombination (Selfridge et al., submitted 
and Shannon et al., 1999).
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Figure 1.3 Models for the repair of DNA interstrand crosslinks. In the top 
model crosslinks are unlinked on one strand and a form of error prone 
translesion synthesis fills the gap to allow normal repair by NER. In the 
bottom model, the crosslink is unlinked by ERCC1-XPF, possibly forming a 
DSB and this serves as a substrate for recombination, involving XRCC2, 
XRCC3 and homologous undamaged DNA. These models are non-exclusive, 
the bottom mechanism probably only occurs during DNA synthesis, whereas ' 
the top mechanism may occur at any time.
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Repair of interstrand DNA Crosslinks
DNA interstrand crosslinks (ICL) require some form of recombination to effect error 
free repair, however the mechanism of repair is largely unknown. IGL can be caused 
by a variety of bifunctional agents, such as nitrous acid, nitrogen mustards, psoralen 
(a monofunctional agent which can be induced to form crosslinks with UV), cisplatin, 
mitomycin C and environmental furocoumarins. Most of these agents cause mainly 
non-crosslink damage such as adducts, and most of the crosslinks formed will be 
intrastrand. However the cell killing effects are through the highly toxic ICL. Just 
like DSBs, one unrepaired ICL is thought to be enough to kill a cell.
Two possible mechanisms of repair have been proposed. An error free 
recombinational mechanism begins with dual incision on one strand followed by 
strand transfer from the intact duplex with ligation and dual incision of the 2nd strand 
followed by the release of the crosslink and repair synthesis. The error-prone 
translesion synthesis mechanism involves dual incision on one strand followed by a 
DNA polymerase passing the lesion and creating a 3 stranded intermediate that is then 
repaired normally (Barre et al., 1999; Greenberg et al., 2001) (Figure 1.3).
In E. coli, the NER system makes a cut on either side of a crosslink on one DNA 
strand and initiates crosslink repair, then RecA mediated recombination replaces the 
removed portion and then the crosslink and oligomer can be removed by a final round 
of NER (Dye and Ahmad, 1995; Van Houten et al., 1986). In S. cerevisiae, ICL 
repair requires genes involved in NER and recombination, as well as additional genes 
(eg PSO2 and PSO3) not required for the repair of most other types of DNA damage. 
ICL repair in yeast, unlike that in E. coli, appears to involve a DSB intermediate 
(Dardalhon and Averbeck, 1995). A DSB is produced in an NER dependent manner 
and the repair then depends on the recombination proteins RAD51 and RAD52.
In mammalian systems, there is very little understanding of ICL repair. The repair of 
interstrand crosslinks requires ERCC1-XPF but probably not other NER genes, since
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mammalian cells with mutations in other NER genes are only two to three fold 
sensitive to ICL (Hoy et al., 1985). Unlike other NER mutants, which are merely 
moderately sensitive, ERCCl and XPF def. cells are hypersensitive to DNA ICL 
agents. However the exact role of ERCC1-XPF in the repair of these lesions is 
unknown. Either ERCCl-XPF alone or perhaps the NER system as a whole may be 
involved in the cleavage of ICLs (Bessho et al., 1997). ERCC1-XPF may also be 
involved in the downstream processing of ICLs. ERCCl and XPF mutant cells are 
defective in a cell free co-incubation assay with one ICL containing and one 
undamaged plasmid, that stimulates DNA synthesis in both plasmids, however XPA, 
XPC and XPG mutants are proficient in this assay (Li et al., 1999).
The exact mechanism of ICL repair probably varies depending on the cell cycle 
status (Bridges and von Wright, 1981). In order to repair crosslinks without error, 
recombination with a sister chromatid must be used, and this is only possible in G2. 
ICL treatment tends to provoke a strong G2 arrest. Crosslinks are probably 
processed during replication, probably leading to some form of DSB. There may be 
a minor repair mechanism for ICLs that is not dependent on ERCCl, survival curves 
using ERCCl null fibroblasts indicated an ICL resistant population, possibly active 
only at a certain cell cycle stage, and mouse ERCCl mutants are more sensitive than 
hamster mutants to MMC indicating that there may be a subsiduary pathway 
operating in one but not the other (Melton et al., 1998; Weeda et al., 1997). In yeast 
incisions for ICL were comparable throughout the entire cell cycle (Meniel et al., 
1997).
It seems unlikely that ICL repair in mammalian cells involves a typical DSB 
intermediate. NHEJ mutants have normal sensitivity to MMC and only weak 
sensitivity to other ICL agents, indicating that NHEJ is not involved in ICL repair 
(Caldecott and Jeggo, 1991).
Binding assays using MMC treated DNA and nuclear extracts detected two 
complexes in rodent cells and three in human cells that bound to ICL (Warren et al.,
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1998). These complexes were missing or diminished in ERCC1 and XPA deficient 
cells, but were present in XPF, XPD and XPE deficient cells.
In vitro, reconstituted mammalian NER will make 2 incisions 5' to the crosslink and 
will remove a 22 to 28 nucleotide long undamaged strand (Bessho et al., 1997). This 
seems to be associated with a futile process of removal and resynthesis in vitro, 
however in vivo, the ssDNA region may serve as an entry point for a recombinational 
repair process (Mu et al., 2000). It is predictable that the NER system will recognise 
ICL, however to remove an oligomer that does not include the damage is unusual.
ERCC1-XPF will cut adjacent to ICL in a reaction distinct from NER and may 
possess the capability to initiate ICL repair (De Silva et al., 2000; Kuraoka et al., 
2000). ERCC1-XPF alone will not cleave psoralen monoadducts and crosslinks in a 
duplex oligonucleotide. However, if a Y shaped construct is used with a crosslink at 
the junction between ssDNA and dsDNA, then ERCC1 will cut on the 3' ssDNA side 
of the crosslink and will also cut the same strand on the 5' side of the crosslink 
(Kuraoka et al., 2000). This has the effect of releasing one arm of the crosslink. 
Either recombination or some form of error prone DNA synthesis could then bypass 
the other arm of the crosslink. Or if ERCC1-XPF also acts on the other arm of the 
crosslink then a DSB would be formed which could then be repaired. As ERCC1- 
XPF will only cleave if one side of the crosslink is ssDNA, it seems likely that 
cleavage occurs as part of NER, however this may also occur at stalled replication or 
transcription bubbles.
Measurement of crosslink unhooking rates using comet assays show that ERCC1 and 
XPF mutants are extremely slow when compared to wt and other NER mutants (De 
Silva et al., 2000). The formation of DSBs has been studied using PFGE, this 
showed that DSBs are induced after ICL agent treatment but not with monoadducts. 
However, measurements of DSB formation using PFGE showed that all NER 
mutants induced DSBs at the same rate as wt, including ERCC1 and XPF. This 
suggests that ERCC1 may not after all be involved in the initial processing of ICLs to 
a DSB, or possibly that there are two routes to ICL repair, one not involving ERCC1-
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XPF in early stages that involves DSB formation and another involving ERCC1 that 
does not involve DSB formation.
An alternative to the action of ERCC1-XPF or NER would be if a glycosylase 
activity could unhook the ICL (Bridges and von Wright, 1981).
Events downstream of the initial cleavage of ICL are also little understood. XRCC2 
and XRCC3, RAD51 homologs, were cloned from hamster mutants that have high 
spontaneous chromosome instability and 60 fold greater than wt sensitivity to 
mitomycin C as well as a greater sensitivity to gamma rays, they are almost certainly 
involved in ICL repair (Cui et al., 1999; Liu et al., 1998). XRCC2 and XRCC3 
mutants do not show defects in the repair of ER induced DSBs, although these are 
mostly repaired by NHEJ, but do show a defect in the recombinational repair of 
DSBs induced by I-Scel endonuclease. Although XRCC2 and XRCC3 mutants are 
hypersensitive to interstrand crosslinks, comet assays show that they unhook 
crosslinks at the same rates as their parents, this indicates that they are involved in 
events downstream of unhooking (De Silva et al., 2000). XRCC2 and XRCC3 
mutants cannot repair the DSBs induced after ICL treatment. XRCC2 and XRCC3 
mutants have also been found to be defective in a coincubation assay using damaged 
and undamaged plasmids, however RAD51 itself was not necessary.
It has been proposed that when replication forks meet a crosslink a DSB is formed 
by an unknown process (De Silva et al., 2000). XRCC2 and XRCC3 dependent 
recombination start to repair the DSB, but are stalled by the crosslink. ERCC1-XPF 
then unhooks the crosslink and recombination is completed. This would explain why 
ERCC1 mutants create DSBs. Obviously this model can explain repair during 
replication, but not during other times, although perhaps ICLs are only repaired at 
replication.
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Mechanisms for Tolerance of DMA Damage
As well as mechanisms to repair damage, the cell also possesses mechanisms to 
tolerate damage. Unrepaired DNA damage can lead to blockage of replication forks, 
because normal replicative proofreading DNA pols cannot insert the correct base 
opposite the damage. Sometimes the DNA replication machinery can restart 
downstream of the damage. Lesions in the lagging strand result in blocked 
retrograde DNA synthesis, however the replication fork proceeds past the damage. 
This results in small daughter strand gaps (DSGs) in the lagging strand (Schwartz, 
1989). Lesions in the leading strand block leading strand synthesis although lagging 
strand synthesis is not blocked (Cordiero-Stone et al., 1997; Cordiero-Stone et al., 
1999; Svoboda and Vos, 1995; Veaute et al., 2000). Leading strand synthesis is 
probably reinitiated further down stream. It is possible that lesions in both the 
leading and lagging strands may either be tolerated without DSG formation or that 
DSGs may be repaired soon after formation. Persistent DSGs may lead to the 
creation of DSBs.
Post replication repair is the name for the process that enables replication forks to 
tolerate DNA damage at replication. Three mechanisms have been proposed: 
translesion synthesis, recombination and template switching (Barre et al., 1999; 
Baynton et al., 1998; Nelson et al., 1996; Xiao et al., 1998). In template switching 
the DNA pol temporarily switchs to the daughter strand of the undamaged 
complementary strand to detour around the damage. Template switching has not 
been demonstrated in yeast, simian or rodent cells. A recombinational mechanism 
relies on a sister chromosome to fill in the gap. Recombinational repair may occur, 
and in fact sister chromatid exchanges may be a consequence of recombinational 
bypass, but there is little evidence for this method. The predominant mechanism for 
post replication repair in eukaryotes is thought to be TLS (Lehmann. 2000; Kunz et 
al., 2000). In TLS a special set of polymerases are used which can insert bases 
opposite the damage. TLS may either be coupled to replication or be post- 
replicative. The tolerance of lesions in the leading strand may involve TLS 
following uncoupling of leading and lagging strand DNA synthesis. DNA pol rj
39
Chapter 1 - Introduction
performs non-mutagenic TLS past CPD and a limited number of other lesions but 
not 6-4PP (Masutani et al., 1999a; Masutani et al., 1999b). DNA pol £, a low 
processivity DNA pol, performs mutagenic lesion bypass past a variety of lesions 
(Gibbs et al., 1998; Lin et al., 1999).
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Figure 1.4 Cell Cycle Regulation. CAK activates CDC2 by 
phosphorylation on THR161 and KAP inactivates by phosphatase action. 
WEE1 and MYT1 inhibit CDC2 by phosphorylating TYR15. An unknown 
kinase inhibits CDC2 by phosphorylating THR14. CDC25C 
dephosphorylates TYR15 and THRU. CDC2 upregulates CDC25C.
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The Cell Cycle
Progression through the cell cycle is mediated by a conserved family of protein 
kinases known as cyclin dependent kinases (cdks) (Forsburg and Nurse, 1991; 
Morgan, 1995; Nigg, 1995; Nurse, 1994; Pines, 1995; Sherr, 1994). Cdks are 
composed of a catalytic subunit and a requisite positive regulatory subunit termed a 
cyclin. The cdk activities that govern cell cycle progression require coordination and 
regulation. In most case positive regulation is mediated at the level of cyclin 
accumulation. However many aspects of cell cycle control require negative 
regulation of cdks. Negative regulation of cdk activity is achieved either by 
phosphorylation of the catalytic subunit or via the binding of cdk inhibitory proteins. 
In yeasts, CDC2 through its association with distinct cyclins activates entry into both 
S phase and mitosis, however in higher eukaryotes, although CDC2 is thought to be 
an essential cell cycle regulator, there are several distinct CDK catalytic subunits and 
cyclins. The D-type cyclins are associated with CDK4 and CDK6 and these 
complexes are required for early stages in Gl (Sherr, 1994). The cyclinE-CDK2 and 
cyclinA-CDK2 complexes control progression through the Gl-S transition and S 
phase respectively (Heichmann and Roberts, 1994; Sherr, 1994). CDC2 is essential 
for G2-M. Cyclin A function is required for progression through S phase and into 
mitosis (Sherr; 1994).
At the G2-M transition in yeast and higher eukaryotes, mitosis is initiated by a cdk- 
cyclin complex consisting of the CDC2 protein kinase (CDK1) and a B-type cyclin 
(probably Bl, although cyclin A may also play some role) (Clarke and Gimenez- 
Abian, 2000; Dunphy and Kumagai, 1991; King et al, 1994) (Figure 1.4). 
Activation of the CDK is controlled both by the accumulation of cyclinB and by 
three phosphorylation sites on the CDC2 subunit. Cdk-activating kinase (CAK) 
phosphorylates CDC2 on the thr!61 residue essential for CDC2 catalytic activity. 
The phosphatase KAP will act on thr!61. Prior to the onset of mitosis CDC2- 
cyclinB is held inactive by phosphorylations at tyr!5 and thr!4 of CDC2. The 
inhibitory kinases WEE1 and MYT1 phosphorylate CDC2 specifically on tyr!5 and 
a distinct membrane associated kinase is thought to phosphorylate thr!4. At the
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onset of mitosis, the CDC25 phophastase activates the cdk by dephosphorylating 
CDC2 on tyrlS and thr!4. In vitro, CDC2-cyclinB will activate CDC25C 
(mammalian homologue of yeast CDC25) suggesting the existence of a positive 




One definition of a checkpoint is "a mechanism that establishes a dependence 
relationship between two cellular processes that are biochemically unrelated" (Clarke 
and Gimenez-Abian, 2000). One can show that yeast cells slow replication after 
DNA damage in S phase, due to a checkpoint and not just due to lesions impeding 
replication forks because mutations in checkpoint genes restore normal replication 
rate (Enoch et al., 1992). There are checkpoints that respond to DNA damage at the 
Gl-S transition, during S phase and at the G2-M transition. Checkpoints usually 
inhibit the cyclin dependent kinases by controlling cyclin availability, binding of 
CDK inhibitors or CDK phosphorylation. Checkpoints can also independently 
inhibit other processes. The pathways that regulate the checkpoint responses of the 
cell to DNA damage are complex and little understood but presumably they contain 
sensors, transducers and effectors (Lowndes and Murgia, 2000; Murray, 1994; Zhou 
and Elledge, 2000).
Sensors
The identity of the sensor proteins is not known although there are several possible 
candidates and possibilities. These include the poly(ADP-ribose) polymerase 
(PARP), DNA-dependent protein kinase (DNA-PK), BRCA1, DNA polymerase 8 
and PCNA homologues (Enoch et al., 1992; Lowndes and Murgia, 2000; Murray, 
1994; Zhou and Elledge, 2000). Evidence suggests that DNA damage checkpoint 
proteins detect single stranded DNA (Garvik et al., 1995; Lydall and Weinert, 1995). 
However many different DNA lesions can activate the DNA damage checkpoint.
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Perhaps the process of repair is detected as most repair systems cause the formation 
of ssDNA during the process of repair. The easiest way to measure when to activate 
checkpoints and when to release from them may be to measure when DNA repair 
starts and is completed.
Transducers
The signal transducers in the DNA damage response are better understood. ATM 
and ATR, related and conserved protein kinases are central components (Shiloh, 
2001). They are structural and functional homologues of yeast MEC1, a PI kinase. 
MEC1 activates RAD53 and PDS1, which probably control two independent 
downstream pathways, they both induce DNA repair genes after DNA damage.
AT patients have defects in ATM and are defective in such responses to IR as Gl 
arrest, reduction in DNA synthesis, G2 arrest and p53 induction (Beamish et al., 
1996). ATM is required for p53 induction in response to IR damage but not to other 
types of damages such as UV, this response is speculated to act through ATR 
(Kastan et al., 1992). Neither ATM or ATR are thought to be involved with p53 
induction independent of DNA damage. ATM controls the initial phosphorylation of 
proteins such as p53, MDM2, BRCA1, CHK2 and NBS1 in response to DNA 
damage. However, whereas AT fibroblasts are very sensitive to IR, they show little 
sensitivity to UV, alkylating agents or inhibitors of DNA replication. There are no 
known ATR mutations in human diseases, but expression of a dominant negative 
ATR form sensitises mammalian cells to DNA damage and reduces the G2/M 
checkpoint response from IR. ATM and ATR seem to have some overlapping roles 
in the phosphorylations they perform, but they are not redundant. DNA damage 
responses downstream of ATM and ATR seem to be controlled by CHK1 and CHK2 
kinases, two serine/thereonine kinases.
CHK1 is required for the DNA damage checkpoint in yeast but not the replication 
checkpoint (Rhind and Russell; 1998). CHK1 is phosphorylated in response to DNA 
damage, this phosphorylation correlates with the ability of CHK1 to arrest cells in
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G2. In the absence of CHK2, CHK1 can impose a checkpoint delay, although CHK1 
does not appear to play an important role normally. CHK1 seems to be required for 
the G2 DNA damage checkpoint in mammals, CHK1 null cells die of p53 
independent apoptosis and cannot arrest in G2 after IR.
CHK2 in yeast (CDS1) is required for responses to DNA damage and replication 
block and homologues are highly conserved (Liu et al., 2000; Rhind and Russell, 
1998). CHK2 def. cells fail to upregulate p53 or trigger apoptosis after IR but not 
UV, however they will arrest in G2. CHK2 phosphorylates p53 in vitro and in vivo 
CHK2 helps to stabilise p53 after DNA damage.
Effectors
P53
p53 has an important role in activating either a cell cycle arrest or apoptosis response 
to DNA damage or cellular stress (Haapajarvi et al., 1999; Lowe et al., 1993; Selter 
and Montenarh, 1994; Smith et al., 1995). Activated p53 is also associated with 
senescence and differentiation. Treatment of cells with DNA damaging agents leads 
to increases in p53 levels and evidence suggests that DSBs are the specific lesions 
required for p53 induction (Kastan, 1996; Maltzman and Czyzyk, 1984; Nelson and 
Kastan, 1994).
Although not required for normal growth and development, p53 is crucial in the 
prevention of tumour development (Donehower et al., 1992; Purdie et al., 1994). 
Many signals that might be encountered during tumour development can activate 
p53, including carcinogen-induced DNA damage, telomere erosion, aberrant 
proliferative signals, hypoxia and loss of adhesion or survival signals. Defects in the 
p53 pathway are found in most human cancers and p53 null mice show a tumour 
prone phenotype (Donehower, 1996). p53 is essential for the Gl DNA damage 
checkpoint and the cell cycle arrest or apoptosis response to it (Brugaralos et al., 
1995; Clarke et al., 1993; Deng et al., 1995; Lowe et al., 1993; Siu et al., 1999).
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Figure 1.5 Regulation of p53 and associated proteins and genes. MDM2 
targets p53 for ubiquitination and proteolysis and is induced by p53. p53 
induces 14-3-3a, p21 and GADD45. ATM phosphorylates CHK2 and 
ATR, ATM, CHK1 and CHK2 phosphorylate p53 and MDM2.
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p53 is a sequence specific transcription factor that binds to DNA as a tetramer and 
activates or represses transcription from a large number of genes (el-Deiry, 1998) 
(Figure 1.5). The cell cycle arrest and DNA repair genes induced by p53 appear to 
be regulated independently of genes that mediate the apoptotic response. p53 will 
also act as a transcriptional represser, through interaction with histone deacetylases. 
It will drive relocalisation of death receptors like FAS from the golgi to the cell 
surface and a direct role for p53 has been found in the mitochondria.
Regulation of p53 expression by transcription factors such as NF-KB and HOXA5, 
and mechanisms that control p53 translation help control the overall activity of p53 
(Woods and Vousden, 2001) (Figure 1.5). However the principal mechanisms that 
govern p53 activity appear to be exerted at the level of regulation of p53 protein 
stability, control of the subcellular localisation of the p53 protein, posttranslational 
modifications and conformational changes that allow activation of the DNA binding 
activity of p53 (Kastan, 1996). The main regulator of p53 stability appears to be 
MDM2, which is a transcriptional target of p53 (Wu et al., 1993). MDM2 is a 
negative regulator of p53 and so a feedback loop exists to control p53 levels. MDM2 
targets p53 for ubiquitination and subsequent proteolysis (Kastan, 1996). 
Phosphorylation within or close to the N-terminal MDM2 binding domain in p53 
interferes with its ability to bind MDM2.
Several stress response kinases such as ATM, ATR, CHK1 and CHK2 have been 
shown to phosphorylate the MDM2 binding region of p53 (Ljungman, 2000). These 
kinase pathways appear to be critical in the activation of p53 in response to DNA 
damage such as UV or IR (Ljungman, 2000). Both ATM and ATR phosphorylate 
p53 in response to DNA damage, which enhances p53 activity. ATM activates 
CHK2, a kinase that phosphorylates p53 directly within the MDM2 binding domain, 
reducing binding to MDM2 and stabilising p53. ATM activation also induces 
dephosphorylation of the C-terminus of p53 and ATM can directly phosphorylate 
MDM2. Many other kinases have been shown to be capable of phosphorylating the 
N-terminus of human or mouse p53 in vitro including DNA-PK, INK, p38, CK1, 
CAK and CHK1 (Ljungman, 2000; Shieh et al., 2000). Interaction of p53 with
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REF1, by redox dependent and independent means, leads to the activation of p53 
(Jayaraman et al., 1997).
Target genes of p53 include 14-3-3 a, gadd45, mdm2, mck, bax, IGF-BP3, BTG2, 
p21 and cyclinG (el-Deiry, 1998).
p53 can contribute directly to DNA repair (Albrectsen et al., 1999; Lloyd and 
Hanawalt, 2000). p53 null mouse embryonic fibroblasts exhibit 35% to 70% of the 
normal unscheduled DNA synthesis indicating that p53 or p53 dependent genes are 
involved in NER (Smith et al., 2000). p53 is involved in the regulation of GADD45 
and p48-XPE. GADD45 encodes a protein which binds PCNA and serves as a 
stimulator of DNA repair and inhibitor of replicative DNA synthesis (Kastan et al., 
1992). p53 binds directly to XPB, XPD, RPA, CSSB and TFIffl. Li-Fraumeni cells, 
which are deficient in p53, have defective recovery of mRNA synthesis after UV, 
implying involvement of p53 or p53 dependent proteins (McKay et al., 1999).
p21 is involved in cell cycle arrest and in terminal differentiation (Halevy et al., 
1995; Huppi et al., 1994). It is a cyclin dependent kinase inhibitor (CDKI) and in 
most situations is induced by p53, in fact it is one of the principle mediators of p53 
induced Gl arrest (Brugarolas et al., 1995; el-Deiry et al., 1993; el-Deiry et al., 1994; 
Harper et al., 1993; Harper et al., 1995; Poon et al., 1996; Waldman et al., 1995). As 
well as being a CDKI, p21 is also thought to be essential in low levels for the 
assembly of the CDK complex (at least cdk4-cyclinD), inhibition of the CDK 
probably occurs through increases in p21 stoichiometry (Zhang et al., 1994).
Two families of mammalian CDKIs have been described:the INK4 inhibitors and the 
Cip/Kip inhibitors (Awad et al., 1997; Sherr and Roberts, 1995). INK4 inhibitors 
are specific for cdk4 and cdk6, there are 4 known family members: p!5, p!6, p!8 
and pi 9. Cip/Kip inhibitors target a broader spectrum of cdks including cdk2, cdk4, 
cdk6 and possibly cdkl. The family consists of 3 members p21, p27 and p57. All 
contain a conserved N terminal cdk inhibitory domain. The cdki-cdk-cyclin complex 
almost certainly deforms and interferes with the cdk active site.
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There is much evidence that after DNA damage p53 will upregulate p21 levels and 
cause Gl arrest (Brugaralos et al., 1995; Macleod et al., 1995; Reinke and Lozano, 
1997; Siu et al., 1999; Waldman et al., 1995). The RAS/RAF pathway is also 
involved in induction of p21 in a p53 dependent manner (Ravi et al., 1999; Zhu et al., 
1998). p21 is only induced after relatively low UV doses in fibroblasts, whereas 
BAX, a gene involved in apoptosis, is induced after high doses (Li and Ho, 1998; 
Reinke and Lozano, 1997).
There are also circumstances in which p21 can be induced independent of p53 
(Macleod et al., 1995; Michieli et al., 1994). p21 can be induced by UV light in a 
p53 independent manner in cells derived from p53 null mice and in Li Fraumeni 
fibroblasts (Haapajarvi et al., 1999; Loignon et al., 1997; Sheikh et al., 1997). p21 
expression is elevated independent of p53 in mouse hepatocytes and human 
hepatcarcinoma cells after cell stress (Kim et al., 2000; Serfas et al., 1997). The 
ERK/MAP kinase, RAF, TGFpl and myoblast differentiation pathways can induce 
p53 independent increases in p21 levels (Elbendary et al., 1994; Cartel et al., 2000, 
Halevy et al., 1995; Parker et al., 1995).
p21 interacts with PCNA and in vivo and in vitro studies show it prevents PCNA 
dependent DNA replication but will allow PCNA dependent gap filling DNA 
synthesis for NER (Li et al., 1994; Podust et al., 1995; Shivji et al., 1994). However, 
there have been observations that p21 inhibits NER and MMR (Cooper et al., 1999; 
Pan et al., 1995). p21 also inhibits RFC ATPase stimulation by PCNA, this is 
required for the loading and unloading of PCNA DNA clamps (Oku et al., 1998). 
p21 null mouse embryonic fibroblasts display reduced unscheduled DNA synthesis 
(associated with DNA repair), and p21 may facilitate NER (Sheikh et al., 1997; 
Smith et al., 2000).
A complex of PCNA, p21, CDK and cyclin has been reported in fibroblasts (Xiong 
et al., 1992). The N-terminal region of p21 binds to the CDK and the C-terminal 
region binds to PCNA, so p21 acts as a bridge (Chen et al., 1995). Perhaps this
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enables direct coordination of cell cycle progression and DNA replication and may 
help control the progression from Gl to S phase. GADD45, a p53 induced gene, also 
binds to PCNA and binding is competitive with that of p21 (Chen et al., 1995). 
GADD45 expression is related to the amount of DNA damage, perhaps GADD45 is 
also involved in cell growth arrest by PCNA inhibition. GADD45 associates with 
core histones, p21 and PCNA, and is thought to be involved with the remodelling of 
chromatin in DNA repair (Carrier et al., 1995).
Cells in terminal differentiation or senescence pathways often have increased levels 
of p21. This might be expected because differentiated and senescent cells tend to 
withdraw from the cell cycle. p21 levels are elevated in differentiation programmes 
in myoblasts (independent of p53), keratinocytes and other cell types (Halevy et al., 
1995; Parker et al., 1995). p21 levels also increase in senescent cells (Stein and 
Dulic, 1995). Cells deficient in p21 can bypass senescence (Brown et al., 1997).
Cells deficient in p21 or p53 cannot arrest in Gl following DNA damage, but will 
transiently arrest in G2, although they cannot maintain a G2 arrest and show 
uncoupling of S phase and mitosis (Brown et al., 1997; Brugarolas et al., 1995; Bunz 
et al., 1998; Deng et al., 1995; Waldman et al., 1996). p21 deficient cells can 
develop polyploidy and also undergo apoptosis. Cells over expressing p21 also 
develop polyploidy (Bates et al., 1998).
Cell Cycle Arrest
S Phase Arrest
p21 does not seem to be involved in S phase arrest after DNA damage (Kelly and
Brown, 2000; Wyllie et al., 1996). Following UV damage, DNA repair is not 
inhibited by the presence of a large amount of p21 protein in the nucleus, in contrast 
cells undergoing DNA replication contain very low amounts of p21. Except at very 
high doses the cause of the reduction in S phase DNA synthesis following strand 
breaking agents is primarily inhibition of replicon initiation rather than chain 
elongation (Walters and Hildebrand, 1975). In contrast the inhibition demonstrated 
by p21 on replication in vitro affects elongation rather than initiation (Waga et al.,
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1994). p21 expression in cells failed to provoke any obvious defect in S phase 
progression, which suggests that p21 mediated inhibition of DNA synthesis does not 
significantly block initiated DNA synthesis in vivo (Bates et al., 1998).
G1 arrest
The predominant DNA damage checkpoint in humans is the p53 and p21 dependent
Gl arrest pathway, which allows time for DNA repair before transit into S phase 
(Bates et al., 1998; Di Leonardo, 1994). Transient transfection of p21 in fibroblasts 
leads to an accumulation of Gl cells (Harper et al., 1995; Niculescu et al., 1998). 
p21 is presumed to prevent the onset of S phase by inhibiting RB phosphorylation 
and thus preventing E2F activation (Dimri et al., 1996). E2F is a transcription factor 
involved in the activation of transcription of growth regulated genes. Overexpression 
of RB can arrest cells in Gl and RB is important for the Gl checkpoint. In the 
absence of a functional RB, Gl arrest fails and cells arrest in G2 and develop 
polyploidy (Niculescu et al., 1998). p21 can also regulate E2F activity in an RB 
independent pathway (Dimri et al., 1996).
G2/M arrest
Although the Gl DNA damage checkpoint is generally considered more commonly
stimulated, the G2-M DNA damage checkpoint is also highly important (Clarke and 
Gimenez-Abian, 2000; O'Connell et al., 2000). This system provides a checkpoint of 
last resort to avoid replicated damage on one chromatid being divided from its sister, 
and thus being unrepairable by error free recombination. The G2-M checkpoint also 
allows time for the repair of damage produced during S and G2 phases. The ultimate 
target of the G2-M checkpoint is the tyrosine phosphorylation of cyclinA/B-CDC2 
(Blasina et al., 1997; Poon et al., 1996; Rhind and Russell, 2001).
p53 and p21 play a role in regulating the G2/M transition (Chan et al., 2000; 
Waldman et al., 1996). Human lymphoblastoid cells arrested in G2 after DNA 
damage accumulate high levels of CDK bound p21 and cells with ectopic p21 
expression arrested in G2 (Bates et al., 1998; Beamish et al., 1996). p21 seems to
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have a role in the G2-M transition through its effect on CDK2 and CDK1/CDC2- 
cyclinB (Bunz et al., 1998; Guadagno and Newport, 1996). p21 blocks the initial 
activation step of CDC2-cyclinB that is required for G2/M progression of the cell 
cycle (Guadagno and Newport, 1996). In G2 arrested cells p21 was found in 
complexes with cyclinA but not cyclinBl, this is consistent with the binding 
affinities of p21 for CDK-cyclins and indicates that p21 does not block G2-M 
progression by a direct inhibition of CDC2-cyclinB 1 (Bates et al., 1998; Dulic, 1994; 
Harper et al., 1993). However, CDC2-cyclinB had inhibitory phosphorylation, 
perhaps p21 causes this by inhibition of cyclinA-CDKl complexes (Bates et al., 
1998; Poon et al., 1996). In Xenopus egg extracts, inhibition of CDK2 leads to the 
inhibitory phosphorylation of CDC2 and concomitant G2 arrest (Guadagno and 
Newport, 1996). In normal human fibroblasts, p21 is sufficient for the inhibition of 
cyclinA/E-CDK2 and partly responsible for the inhibition of cyclinD-CDK4 after 
DNA damage, but is not responsible for the inhibition of cyclinA/B-CDC2 
(Levedakou et al., 1995; Poon et al., 1996).
Part of the mechanism to arrest in G2-M after DNA damage is via the protein kinase 
CHK1, which is activated by phosphorylation and phosphorylates CDC25C (Chan et 
al., 2000; Rhind and Russell, 1997; Peng et al., 1997). Phosphorylation of CDC25C 
allows the protein 14-3-3a to bind to cdc25C and inactivate its phosphatase activity 
(Hermeking et al., 1997; Peng et al., 1997; Rhind and Russell, 1997). The activity of 
CDC25C has been shown to be reduced after DNA damage. 14-3-3a is thought to 
sequester CDC25 in the cytoplasm, away from CDC2 (Chan et al., 1999; Lopez- 
Girona et al., 1999). CDC25 regulation alone will arrest cells. MDC1 activation is 
required for maintenance of extended checkpoint arrest and it accumulates after 
prolonged activation of the checkpoint (Rhind and Russell, 2001). WEE1 levels are 
not altered after DNA damage and WEE1 is not required for the G2 checkpoint 
(Rhind and Russell, 2001).
p53 is required to maintain the G2 DNA damage checkpoint arrest in humans (Bunz 
et al., 1998). This may be because p53 activates transcription of p21 and 14-3-3a. 
Cells deficient in p21 or 14-3-3a are unable to maintain G2 arrest after DNA
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damage. Cyclin Bl is subject to control of subcellular localisation by the nuclear 
export protein CRM-1 and is spatially transported during mitosis. p21 is a strong 
regulator of CDC2-cyclinBl, as mentioned earlier, whilst the binding of small 
amounts of p21 seems to be essential for CDK assembly or function, large amounts 
inhibit CDKs.
In cells with a prolonged G2 delay, cyclin Bl levels are reduced in a dose dependent 
fashion when compared to the normal levels in G2 phase (Muschel et al., 1991).
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The ERCC1 Null Mouse
To study the role of ERCC1 in vivo, an ERCC1 null mouse was made using the 
embryonic stem cell method (MeWhir et al., 1993). The expectation was that these 
mice would prove to be inviable as no human ERCC1 mutants are known. If the 
mice proved to be viable they might display an interesting and complex phenotype, 
resulting from the multiple roles of ERCC1.
Phenotype of the ERCC1 Null Mouse
The ERCC1 heterozygote phenotype is not discernible from wt. Matings between 
heterozygotes produced ERCC1 null mice, but in numbers smaller than expected 
from Mendelian segregation of non-sex linked nuclear genes. However there was no 
evidence of compromised viability in ERCC1 null embryos. The ERCC1 null mice 
displayed an extreme phenotype with severe runting and death before weaning of 
liver failure (MeWhir et al., 1993). Increased alanine aminotransferase activity 
indicative of liver cell injury and significant increases in alkaline phosphatase and 
bilirubin indicating reduced liver excretory functions were detected. Superficial 
histological analysis showed a number of grossly enlarged hepatocytes. Detailed 
histopathology revealed polyploidy in perinatal liver progressing to severe 
aneuploidy by 3 weeks at which stage the mice died. Wt runts showed no pathology 
in liver on a superficial examination. Initial analysis of the ERCC1 null animals 
revealed marginly elevated p53 levels in the liver, brain and kidney. As wt mice age 
the number of binucleate hepatocytes increases and nuclear ploidy increases, but 
aneuploidy is not usually seen. In ERCC1 null hepatocytes polyploidy develops 
early, but is not preceded by binucleation (MeWhir et al., 1993). The ERCC1 null 
mouse shows increased levels of disruption of mitochondrial membranes and 
increased levels of lipid accumulation when compared to wt (KT Hsia; personal 
communication).
In order to further investigate the phenotype in tissues other than liver, a mouse line 
was constructed with a liver specific ERCC1 transgene (Selfridge et al., submitted). 
This slightly runted mouse lives for up to 10 weeks before dying and it has a normal
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liver. This confirms that ERCCl null mice die of liver failure, due to the loss of 
ERCCl. It is interesting that the liver is the worst affected organ as although levels of 
ERCCl mRNA are very low overall in mice, they are lowest in liver (MeWhir et al., 
1993). The ERCCl null mice with a liver transgene develop kidney damage by 10 
weeks, nuclei from proximal tubule cells are pleomorphic and many are enlarged and 
polyploid, this is a common response of kidney to stress (Selfridge et al., submitted).
Three other ERCCl null lines were also created using slightly different alterations and 
deletions in the ERCCl gene, one in this laboratory by Kantai Hsia and two others 
(Weeda et al., 1997). The Kantai Hsia mouse is a deletion rather than the original 
insertion mutation, although both lines produce no detectable ERCCl protein. A 
complete ERCCl null mouse and a mouse with a 7 amino acid C-terminal truncation 
of ERCCl were made in the laboratory of J. Hoeijmakers. The complete null had a 
maximum age of 38 days and the truncation mutant had a maximum age of 78 days. 
However the truncation mutant on a different background had a maximum lifespan of 
6 months. The skin of these animals was noted as being thin and lacking in 
subcutaneous fat. In spleen at 3 weeks an increased and early onset of ferritin 
deposition was found. Kidney nuclear abnormalities were found and dilated tubules 
with leaked proteinaceous material, which is indicative of renal disfunction. FACS 
showed increasing octaploidy in the liver, and increased nuclear size by nuclear area 
measurements. It was observed that the ERCCl null hepatocytes have eosinophilic 
nuclear inclusions, which have been frequently observed in cells of aging animals. 
There was no clear increase in apoptotic nuclei seen in the liver. Subsequent analysis 
of the original ERCCl null line has since revealed the features found in the other 
three lines. The longer life span of the two Hoejimakers ERCCl lines is probably due 
to differences in genetic background.
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Other NER Knockouts
The phenotype of the ERCC1 null mouse became more interesting when compared 
to mouse lines that were defective in other NER genes (de Boer and Hoeijmakers, 
1999). These indicated further that ERCC1 had an extra function beyond NER.
XPA null mice appear normal until 13 months. However they are highly susceptible 
to UVB induced skin and eye tumours and to skin tumours induced by DMBA (de 
Vries et al., 1995). They also suffer from increased spontaneous hepatocellular 
carcinoma rates. This strongly mimics the human phenotype. Fibroblasts derived 
from XPA null mice are also UV sensitive.
CSB knockout mice are sensitive to UVB, developing erythema at low doses (van 
der Horst et al., 1997). They are also slightly smaller and they have possible 
neurological changes. Unlike CS patients they also display an increased cancer 
incidence. They have a TCR defect and an inability to resume RNA synthesis after 
UV treatment, although global genome repair is unaffected. Perhaps in humans 
GGR is more efficient than in mice resulting in the lack of increased cancer 
incidence in humans. This illustrates how although there is great conservation of the 
mechanisms and general regulation of NER between species, there may be 
differences in the degree of regulation depending on the requirements of the animal.
XPD knockout mice die before birth (de Boer et al., 1998). Mice with an XPD point 
mutation, that mimics a TTD patient, suffer brittle hair, developmental abnormalities, 
reduced lifespan, UV sensitivity, skin abnormalities and mild cancer predisposition 
(deBoeretal., 1999).
XPC knockout mouse lines have extreme UV sensitivity and are extremely 
susceptible to UV induced skin cancer, but show no obvious clinical defect or organ 
pathology (Sands et al., 1995).
XPG patients are rare with a wide variety of symptoms. XPG null mice have 
recently been made (Harada et al., 1999). These mice show growth retardation and
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death before weaning (similar to the CS phenotype), probably because of failure of 
digestion in the abnormal intestines. These mice display no liver abnormalities 
beyond small cells probably resulting from starvation. The early death is probably 
due to the loss of the structural role of XPG in repair of oxidative damage.
The liver phenotype is unique to ERCCl null mice amongst the other NER deficient 
mice that have been produced. This implies that the liver phenotype is due to the 
absence of ERCCl in its roles outside NER, rather than the loss of NER. ERCCl is 
probably required for the processing of 3' non-homologous tails in recombination 
and is involved in the repair of DNA interstrand crosslinks, of these two roles it 
seems probable that the loss of ICL repair is causing the phenotype in the mice. 
There are several candidates for endogenous ICL agents in the liver including 
malondialdehyde, the major byproduct of arachidonic acid metabolism and lipid 
peroxidation (Chaudhary et al., 1994). Adducts caused by malondialdehyde have 
been found in liver DNA (Smith and Pereira-Smith, 1996).
P21
Wildtype mice that had a transgene for the overexpression of p21 in the liver have 
been made (Wu et al., 1996). The p21 overexpression causes a phenotype 
remarkably similar to that displayed by the ERCCl null line. That is: hepatocyte 
proliferation is severely inhibited and there is a reduction in the overall number of 
adult hepatocytes giving aberrant tissue organisation, runted liver and body growth 
and increased mortality. The mice have a population of grossly enlarged hepatocytes 
similar to those seen in old liver. The similarity of the p21 transgenic and ERCCl 
null mice phenotypes was so great that it was decided to examine the ERCCl null 
animals for increased p21 levels in the liver and other tissues and cell lines. 
Northern blot analysis revealed that levels of p21 mRNA were increased in ERCCl 
null liver compared to wild type (Nunez et al., 2000).
57
Chapter 1 - Introduction
Due to the role of p53 in p21 control and the increase in p53 levels in ERCC1 null 
liver, it was decided to investigate whether the removal of p53 would affect the 
phenotype of the null animals. A p53 null line and the ERCC1 null line were cross 
bred and the few resulting p53-ERCCl double nulls were examined. Only three of 
these animals were generated because they had to be bred from p53 and ERCC1 
heterozygotes. Mendel predicts that 1 in every 16 of the offspring should be double 
null, but the frequency at three weeks was far lower than this. A similar deficiency 
was not observed at day 19 of gestation, indicating very high perinatal mortality 
(Nunez et al., 2000). This is similar to the high perinatal mortality reported in the 
ERCC1 null animals (Me Whir et al., 1993). Measurement of the p21 mRNA levels 
in the double null animals showed an increase similar to the ERCC1 null animals, 
and the double nulls also had high levels of polyploidy in the liver.
A Model for the ERCC1 Null Mouse
A possible model for what occurs in ERCC1 null mouse hepatocytes has been 
proposed (Melton et al., 1998). The deficiency in ERCC1 leads to a defect in repair 
so more damage accumulates. The accumulating damage will be damage that is 
normally repaired by NER and damage that is repaired by non-NER pathways that 
are dependent on ERCC1. However the crucial damage is probably that which is 
repaired by non-NER ERCC1-dependent pathways. According to the model, due to 
the failure of some ERCC1-dependent repair or tolerance recombination mechanism 
cells accumulate double stranded breaks during replication. These double stranded 
breaks then cause cell cycle arrest in G2, mediated by p21 through a p53 independent 
pathway, although p53 levels also increase. This leads to liver polyploidy. This 
model results in several questions. Why is polyploidy seen in liver and not other 
organs? What recombination role is ERCC1 playing? What is the mechanism for 
the cell cycle arrest? I have investigated several of these questions in this thesis and 
they and the model will be discussed.
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I have further investigated the role of p21 and p53 in the cell cycle arrest of ERCC1 
null hepatocytes. I have studied the polyploidy development in ERCC1 null liver 
and have compared it to aging wt liver. I have also examined the role of ERCC1- 
XPF in the formation of UV-induced chromosome aberrations and in arrest of DNA 
replication, in order to examine the molecular causes of the ERCC1 null phenotype.
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Suppliers of Laboratory Reagents
Restriction Endonucleases and other Nucleic Acid Modifying 
Enzymes
Boehringer Mannheim Pic 
Gibco BRL Life Technologies 





Gibco BRL Life Technologies
ICN Flow Ltd
Sigma Chemical Co
New England Biolabs Inc
Reagents for Cell Culture
Gibco BRL Life Technologies 
ICN Flow Ltd 
Sigma Chemical Co
Radioactive Reagents
[a-32P]dCTP 3000 Ci/mmol, Amersham RediVue
3[methyl- H] thymidine 25 Ci/mmol, Amersham Life Science
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Antibiotics
Penicillin G, Sigma Chemical Co 





Chapter 2 - Materials and Methods
Ceil Culture Studies
Cell Lines
CHO9: Immortalised wt Chinese Hamster ovary cell line, which is a subclone of the 
CHO-KK cell line (Burki et al., 1980). Cells were kindly donated by Richard Wood, 
ICRF, Clare Hall.
CHO 43-3B: Immortalised ERCC1-deficient Chinese hamster ovary cell line, 
derived from the parental CHO9 cell line (Wood and Burki,1982). Cells were kindly 
donated by Richard Wood, ICRF, Clare Hall. 43-3B has a mutation V98E at the 
98th residue of ERCC1, this protein is unable to bind to XPA in vitro and is highly 
unstable in vivo, although it will bind XPF (Hayashi et al., 1998).
CHO AA8: Immortalised wt Chinese hamster ovary cell line (Thompson et al., 
1980). Kindly donated by S. Squires and R. Johnson, Zoology Department, 
Cambridge University.
CHO UV5: Immortalised XPD (ERCC2)-deficient Chinese hamster ovary cell line, 
derived from the parental CHO AA8 cell line (Thompson et al., 1981). Kindly 
donated by S. Squires and R. Johnson, Zoology Department, Cambridge University.
CHO UV41: Immortalised XPF (ERCC4)-deficient Chinese hamster ovary cell line, 
derived from the parental CHO AA8 cell line. Kindly donated by R.Wood, Imperial 
Cancer Research Fund, Clare Hall Laboratories.
CHO UV135: Immortalised XPG (ERCC5)-deficient Chinese hamster ovary cell 
line, derived from the parental CHO AA8 cell line. Kindly donated by J.Hartley, 
Department of Oncology, Royal Free and University College Medical School, 
London and M.Stefanini, Istituto di Genetica ed Evoluzionistica, Pavia, Italy.
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CHO UV23: Immortalised XPB (ERCC3)-deficient Chinese hamster ovary cell line, 
derived from the parental CHO AA8 cell line. Kindly donated by J.Hartley, 
Department of Oncology, Royal Free and University College Medical School, 
London and M.Stefanini, Istituto di Genetica ed Evoluzionistica, Pavia, Italy.
Growth of Immortalised Mammalian Cell Cultures
Cells were maintained in supplemented GMEM (10% (v/v) Foetal Calf Serum 
(PCS), Ix non-essential amino acids, 25 U/ml penicillin, ImM sodium pyruvate, 25 
[ig/ml streptomycin) at 37°C in a 5% CO2 atmosphere in a humidified tissue culture 
incubator (Forma Scientific). To passage cells, medium was aspirated, the bottom of 
the flask rinsed with 1-2 mis of trypsin (0.25% (w/v) trypsin (ICN Flow, Cat No. 
043-5090), 1 mM EDTA in IxPBS), then a further 1-2 mis of trypsin was added and 
the flask was incubated at 37°C until cells were detached. Then 5 volumes of 
medium were added, and cells were subjected to 5 min centrifugation at 1,300 rpm. 
Supernatant was discarded and the cells resuspended in an appropriate volume of 
medium, and an aliquot was transferred into a flask. For long term storage, cells 
were kept in liquid nitrogen. Cultures were trypsinised, centrifuged, the supernatant 
was removed, and cells were resuspended in 1ml of ice cold freezing medium 
(supplemented GMEM with 10 %(v/v) DMSO and 20 % (v/v) PCS). 1 ml aliquots 
were left at -20°C for 2 hours, then transferred to -70°C overnight before removal 
into liquid nitrogen. Aliquots were thawed rapidly at 37°C and diluted in 9 ml of 
medium, before being pelleted by centrifugation at 1,300 rpm for 5 min. The 
supernatant was discarded, the cells resuspended in an appropriate volume of 
medium, and transferred into a flask.
Chromosome aberration studies
Cells were plated the day before the experiment to allow them time to recover. They 
were then UV irradiated at 254 nm, using a handheld UV lamp to the required UV 
fluence and samples were taken 15, 27 and 35 hrs later for CHO9 and 433B cells and 
20, 27 and 35 hrs later for AA8, UV5, UV41, UV135 and UV23 cells. Four hours
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before taking the samples a 1:200 dilution of colcemid (10 jxg/ml) was added. At the 
time point, shaded cells were scraped off around the periphery of the dish and 
removed. Cells were then trypsinised, resuspended in 5.6 g/1 KC1 (0.075 M) and 
placed in a 37°C water bath for 15 min. Cells were resuspended in Carnoy Fixative 
(methanol:acetic acid (3:1)) and left for 20 min, this was repeated and cells were 
dropped onto slides from a height, left to dry and stained with crystal violet before 
washing, drying and mounting with DePex. Slides were examined on an Olympus 
BX60 with a ccd camera and images were analysed using analySIS (Norfolk 
Analytical). At least 200 pictures were taken of random metaphases, selected good 
quality metaphases were then scored for aberrations. Well spread metaphases were 
selected that had between 17 and 28 chromosomes, where all the chromosomes could 
be distinguished and counted and the two chromatids could be resolved. Scoring was 
derived from Savage, 1976.
Survival Curves
Cells were plated at a calculated density with two plates for each dose. The next day 
plates were UV irradiated and left for 4 or 5 days in order to allow cells to grow. 
When the zero UV control plate became confluent, plates were fixed with Carnoy 
Fixative and washed in water, after drying overnight, plates were stained with crystal 
violet and washed with water. After overnight drying dye was extracted with 70% 
ethanol. Using a stained and extracted blank plate as a zero the OD was measured at 
575 nm using a Perkin-Elmer, Lambda 15, UV/VIS Spectrophotometer. Taking the 
zero UV as 100%, survival was calculated using the OD measurements. These were 
then plotted on a loglO scale against dose. Duplicates were used for each dose.
Replication Arrest Studies
Cells were plated out at calculated densities and were allowed to settle overnight at 
37°C. The following day they were arrested in the Gl-phase of the cell cycle with 
overnight incubation in isoleucine-deprived medium (Galavazi et al., 1966). The 
cells were released from the Gl block, 6 hours before irradiation, by putting them
65
Chapter 2 - Materials and Methods
back into normal growth medium. After 6 hours, the cultures, which were well into 
S phase, were treated (F Nunez; personal communication). They were either mock 
irradiated or irradiated with a handheld UV lamp with the required UV fluence, or 
mock treated or treated with the appropriate dose of MMC for 1 hour. The cells were 
then processed immediately or incubated in normal medium and processed at 
different times after UV. Cells were rinsed in serum deprived medium and pulsed 15 
min in [3H]thymidine-containing (1 uCi/ml) serum deprived medium at 37 °C. After 
15 min, the cells were rinsed in sterile PBS (8 mM K2HPO4, 1.5 mM KH2PO4 , 150 
mM NaCl), lysed in a 1% SDS solution and TCA precipitated with 0.5 volumes of 
20% (v/v) TCA pre-chilled at 4°C. Samples were kept at 4°C until needed. Samples 
were vacuum-filtered by passing them through 2.4 cm GF/C microfibre filters 
(Whatman). Each filter was put into a plastic scintillation vial and 2 mis of 
scintillation liquid was added to it. [3H]incorporation was measured as DPM counts 
using a scintillation counter (scintillation fluid (2.5 1 Toluene, 15 g PPO (2,5- 
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Mouse Studies
Mouse Breeding
The ERCC1 null animals and littermates were on an outbred background segregating 
for 129/Ola and BALB-c (MeWhir et al., 1993). ERCC1 null animals were 
produced by cross-breeding of two ERCC1 heterozygous animals. No difference has 
been observed between female and male animals with respect to liver phenotype and 
so no discrimination was made between the sexes when selecting animals for 
experiments. The p53/ERCCl null animals were on an outbred background, derived 
from the ERCC1 129/Ola and BALB-c background and an extremely outbred 
background from the p53 stock. The ERCCl/p53 null animals were produced from a 
crossbred ERCC1 het/p53 heterozygous stock.
PCR qenotypinq of mice
In order to determine the genotype of an individual, PCR reactions were performed 
on genomic DNA samples extracted from tail. 0.5 cm of tail was incubated 
overnight in 2 ml of Tail buffer (10 mM Tris pH8, 0.4 M NaCl, 1 mM EDTA pH8, 
1% SDS) with 280 |ig/ml proteinase K at 37°C. Visible debris was removed by 
centrifugation and 1 ul of supernatant was used as substrate for a genotyping PCR 
reaction. Cycle conditions employed for different primer pairs are outlined in Table 
2.1. 20 ul of each reaction was subjected to agarose gel electrophoresis, and 
products visualised by ultra-violet illumination.
Electrophoresis of DNA in agarose gels
DNA was separated in 0.7-2% (w/v) electrophoresis grade agarose with 0.5 ug/ml 
ethidium bromide in 1 xTBE buffer (0.9 M Tris-HCl, 0.9 M boric acid, 20 mM 
EDTA, pH 8.0). Prior to loading, DNA samples were mixed withl/5 volume of 5> 
sample buffer (20% (w/v) glycerol, 100 mM EDTA, 0.1% bromophenol blue) and 
heated at 65°C for 5 min. Electrophoresis was carried out horizontally across a
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potential difference of 1-10 V/cm. Bacteriophage lambda DNA cut with Hindlll and 
OX 174 DNA cut with Haelll were used as size markers. DNA was visualised with 
short wave UV illumination, except for DNA in preparative gels which was 
visualised with long wave UV from a handheld lamp.
FAGS Analysis
About 8 mm3 of tissue was cut into small pieces and suspended in 100 pi of citrate 
buffer (sucrose (85.5 mg/ml), trisodium citrate (11.76 mg/ml), DMSO 0.05% (v/v), 
pH 7.6). This was incubated for 10 min at room temperature with 0.45ml solution A 
(trypsin (0.03 mg/ml) in stock solution (trisodium citrate (1 mg/ml), Tris (0.06 
mg/ml), spermine tetrahydrochloride (0.5 mg/ml), NP40 (1 ul/ml)) was added to 
separate the tissue into individual cells and to lyse plasma but not nuclear 
membranes. Then 0.325 ml solution B (Trypsin inhibitor (0.5 mg/ml) and 
ribonuclease A (0.1 mg/ml) in stock solution) was added and the preparation was 
incubated for a further 10 min at room temperature to inhibit trypsin and digest RNA. 
Finally 0.25 ml propidium iodide (0.42 mg/ml) and spermine tetrahydrochloride (1 
mg/ml) in stock solution was added and incubated for 10 min on ice to stain DNA 
before filtration through gauze. Samples were analysed on a Coulter EPICSXL or a 
Becton-Dickinson FACScan machine. The percentage of cells in each distinct peak 
was calculated.
The Coulter EPICS-XL FACS machine was set up as follows. The Becton- 
Dickinson FACScan machine was set up in a very similar way.
The preparative method used prepares individual nuclei. To eliminate background 
from RNA, an RNAse was used during the preparation as described. For each 
sample preparation the same amount of tissue was used (8 mm3) in order that the 
flow and number of nuclei would be the same for each sample. This ensures that the 
dye/DNA ratio does not vary greatly, which means greater reliability in terms of 
peak positions from experiment to experiment. Low flow rates were used to ensure 
consistency.
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Before each use of the machine, fluorescent Flowcheck beads (Beckman Coulter) 
were used. These confirm that the machine is functioning as expected and that all 
fluorescence collectors are working. A 3 week old wild type control sample was 
used to set the GO peak to the same red fluorescence value, each time the machine 
was used, by altering the appropriate settings. The 3 week old wild type liver 
sample, as a relatively quiescent tissue, has a pattern with a high Gl/GO peak and a 
small G2 peak and so is effective for calibrating the machine. The Flowcheck beads 
also allow further confirmation that the machine is attributing the same fluorescence 
value to a certain fluoresence each time.
The instrument used can focus the laser beam used for detection down to an ellipse
*y
with a cross-section of less than 10 um , this means that the difference between two 
nuclei stuck together and one larger nuclei can be revealed by pulse shape analysis, 
i.e. by comparing the shape/size of the absorbance to the intensity. Two Gl nuclei 
stuck together will have a greater cross section than one G2 nuclei, although the 
same DNA content. Most cytometers enable two parameters the pulse height and 
width to be measured, the pulse area can be calculated from this. A G2 cell will have 
the same DNA content and hence peak area as a doublet Gl, but will have a greater 
peak width because the two cells take longer to traverse the laser, the total DNA 
content is the same but the two cells have a high fluorescence in the beam for longer. 
A dot plot of DNA peak against DNA area, FL3 peak against FL3 as used in this 
system shows that singleton nuclei fall in a constant straight line slope, whereas 
doublet nuclei fall off this slope, from this plot only singleton nuclei were selected. 
Smaller debris were also gated effusing this plot, the debris falls at the smaller end 
and by comparison of previous plots and controls was be selected for removal.
Logarithmic scales were used on some of the plots to illustrate peaks that were not 
visible on some of the linear scale plots. The logarithmic plots compress the peaks 
on a plot, as they display a greater range of fluorescence, this means that smaller 
peaks are more visible. Due to the way that logarithmic plots are calculated using a 
digital to analogue converter and then displayed it is not always easy to compare the
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positions of peaks. Unlike with linear plots, where it is easy to say that the nuclei in 
one peak have twice the amount of DNA as those in another peak due to their 
positions on the X axis, with logarithmic plots it is not easy to be sure of this. In 
order to establish that peaks were allocated properly control samples of young wild 
type liver were used.
Preparation of RNA from cells and mouse tissues
The following method is adapted from Chomczynksi and Sacchi, 1987. Fresh cells 
or tissue were placed in a sterile polycarbonate centrifuge tube containing up to 7 ml 
of RNAzol solution (Biogenesis Ltd., Bournemouth, UK) and homogenised. 
Subsequently, 0.1 volumes of chloroform was added, the tube was shaken vigorously 
for 30 sec and stored on ice for 5 min and then centrifuged for 15 min at 10,000 rpm 
in an HB4 rotor precooled to 4°C in a Sorvall RC5 Centrifuge. The aqueous phase 
was transferred to a fresh tube and RNA precipitated by the addition of 1 volume of 
isopropanol. The sample was stored at 4°C for at least 15 min before a 15 min 
centrifugation as above. The RNA pellet was washed in 75% ethanol, centrifuged 
for 8 min at 5,000 rpm and resuspended in sterile HiO. RNA was stored at -70°C.
RNA Concentration
RNA was diluted in distilled water and the OD of absorbance at wavelengths 260 nm 
and 280 nm was measured by a spectrophotometer (Perkin-Elmer, Lambda 15, 
UV/VIS Spectrophotometer). An OD260nm value of 1.0 represents a concentration of 
40 mg/ml. A ratio of ODieo nm/ OD2go nm over 2.0 represents a pure preparation of 
nucleic acid.
Electrophoresis of RNA in aqarose gels
RNA samples were electrophoresed through 1.4% (w/v) agarose gels made with 
1 xMOPS (a dilution of IQxMOPS (200 mM MOPS, 50 mM sodium acetate, 10 mM 
EDTA, pH 7.0)), 0.66 M formaldehyde and 0.5 |ag/ml ethidium bromide. Samples
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were prepared by the addition of 30 ug of total RNA (in 20 ul d.H20) to an equal 
volume of FSB (100 ul lOxMOPS, 200 ul formamide, 120 ul de-ionised 37% (w/v) 
formaldehyde) and one quarter volume of standard sample buffer (20% glycerol, 
lOOmM EDTA, 0.1% bromophenol blue) was also added and the sample heated for 5 
minutes at 65 °C then cooled on ice prior to electrophoresis for 3-4 hours at 100V.
Following electrophoresis, gels were washed three times for 20 mins in IQxSSC (a 
dilution of 20 SSC buffer (3 M NaCl, 0.3 M tri-sodium citrate, pH 7.0)) at room 
temperature to remove formaldehyde and ethidium bromide. The RNA was 
transferred to Genescreen Plus nylon membrane (Du Pont; Stevenage; UK) by 
capillary action using IQxSSC as the transfer buffer. Transfer was for 12 to 24 
hours. On completion of transfer the membrane was washed in 2><SSC for 10 mins 
then baked at 80°C for 2 hours.
DNA labelled to high activities was obtained using the randomly primed DNA 
labeling method (Feinberg and Vogelstein, 1983). DNA probes were denatured, 
annealed to random hexamer primers and extended by the Klenow fragment of E.
 3 f\
coli DNA polymerase I in the presence of [a- P]dCTP. Probes were labelled as 
follows: 100 ng of double stranded DNA was made up to 32 (il with HiO then 
denatured by boiling for 5 min and allowed to cool at 37 °C for 10 min. 10 (ol of 
OLE (0.025 M MgCl2, 5 mM p-mercaptoethanol, 0.1 mM each of dGTP, dTTP and 
dATP, 0.25 M Tris HC1, 1 M HEPES buffer and 0.3 ml of random hexanucleotides 
(OD260nm=90) per ml of final OLE), 2 ml of 10 mg/ml BSA, 5 ul (50 uCi) of 
cc[32P]dCTP (3000 Ci/mmol) and 10 units of Klenow enzyme were then added. The 
reaction was incubated overnight at room temperature. Probes were purified with TE 
buffer (10 mM Tris-HCl, 0.1 mM EDTA, pH 8.0) through a Nick Column, Sephadex 
G-50, DNA grade (Pharmacia Biotech).
Pre-hybridisations were performed in a temperature controlled rotisserie in 30 ml of 
prehybridisation buffer (6xSSC, 1% SDS, 10%(w/v) dextran sulphate, lOOmg/ml of 
denatured herring sperm DNA). Blots were prehybridised for a minimum of 2 hours 
at 65°C. DNA probes (10 ng) were heat denatured with 300 ul of 10 mg/ml herring
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sperm DNA and added to the prehybridisation solution. For p21 Northerns, a cloned 
PCR product of the mouse p21 cDNA was used. After overnight hybridisation the 
solution was discarded and blots were rinsed for 2x5 min in 2xSSC at room 
temperature, followed by 2x30 min in 2xSSC, l%(w/v) SDS at 65° C then 2x30 min 
in 0.1 xSSC at room temperature. Membranes were autoradiographed at -80°C, 
typically overnight, using Cronex X-ray film (DuPont) in a cassette with intensifying 
screens (Cronex Lightning plus, DuPont). Signals were also visualised using a 
Molecular Dynamics Phosphorlmager and analysed with ImageJ software.
Radiolabelled probes were stripped from Northern Blots by washing for 4x 5 mins in
boiling 0.01 xSSC, 0.01% (w/v) SDS. Blots were autoradiographed to confirm that
stripping was complete. The membrane was reprobed after prehybridisation as
above.
Reprobing was with a 1.2kb cloned fragment of glyceraldehyde-3-phosphate
dehydrogenase cDNA (Fort et al., 1985).
Cloning of p21 probe
Total mouse embryonic cDNA was used for a PCR reaction with two primers 
designed to anneal within the p21 coding region to generate a product of 
approximately 490 base pairs. The sequence of one primer was 5' 
ACCATGTCCAATCCTGGTGATGTCCG. The sequence of the other primer was 
5' GGGCACTTCAGGGTTTTCTCTTGCAG. Primers were derived from the 
complete mouse p21 cDNA sequence (GenBank Ace. No. U09507).
A product of the expected size was purified from a 1% agarose gel. DNA was 
electrophoresed using low melting point agarose in 1 xTBE and 0.5 mg/ml ethidium 
bromide. The desired fragment was visualised by long wave UV illumination and 
excised and recovered from the agarose by phenol extraction. The gel slice volume 
was estimated, then 0.5 volumes of TE, 1 ul glycogen (Boehringer Mannheim) and 5 
ul 20% SDS was added to the gel slice and heated to 1Q°C until the agarose melted. 
Liquified agarose was extracted 3 times with 1 volume of Tris buffered phenol (pH 
8.0) and once with 1 volume of choloform. The aqueous phase was retained and
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DNA precipitated by the addition of 0.1 volume 3 M sodium acetate and 1 volume of 
isopropanol. DNA was pelleted by a 10 min centrifugation at 13 krpm and the DNA 
pellet was resuspended in distilled H20.
pBluescript was used as a cloning vector (Thummel, 1988). The vector was cleaved 
with EcoRV to produce a blunt end. Typically for restriction enzyme digests 2-5U of 
restriction endonuclease were used per ug of DNA. Manufacturers buffers and 
recommended conditions were used. Reactions were terminated with the addition of 
DNA sample buffer and 10 min heating at 65°C. The PCR product was treated with 
a T4 polynucleotide kinase to add a 5' phosphate to each end.
Between 100 and 200 ng of insert DNA was incubated with linearised vector DNA at 
an insert to vector molar ratio of 5:1. Ligation was in a 10-20 ul volume with 50 
mM Tris-Cl pH 7.6, 10 mM MgC12, 1 mM DTT, 1 mM ATP and 5% (w/v) 
PEG8000. This was incubated overnight at 15°C with one unit of T4 DNA ligase.
The p21 vector was then used to transform E coli. The method used was a 
modification of Nishimura et al. (1990). A 500 ul aliquot of an overnight culture of 
the DH5a E coli strain (supE44AlacUl69 fcP80/flc2AM5;
hsdR\lrecA\endA\gyrA96thi-\relAl) (Gibco BRL) was used to inoculate 50 ml L 
broth (1% (w/v) Bactotryptone, 0.5% (w/v) Bactoyeast extract and 0.5% NaCl) 
supplemented with MgSO4 (lOmM) and glucose (0.2% (w/v)). This culture was 
incubated at 37°C until the culture reached mid-logarithmic phase whereupon it was 
chilled on ice for 10 min and pelleted by centrifugation at 1500g for 10 min at 4°C. 
Cells were resuspended in Transformation Buffer (50mM CaCb, 10 mM Tris, 
pH7.5) and left on ice for 30 min. Cells were then pelleted and resuspended in 
Transformation Buffer. Cells were transformed by the addition of approx 100 pg of 
plasmid DNA to 100 ul of competent cells followed by mixing and a 15 min 
incubation on ice. Cells were heat shocked for 3 min at 37°C then placed on ice for 
1 min. Then 0.4 ml of 37°C L broth was added and the cells incubated for 1 hr in the 
absence of antibiotic selection. A number of aliquots were then plated to dryness on 
L broth agar 90mm petri dishes, with appropriate antibiotic selection (ampicillin to
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100 jig/ml) and 30 jal of 2% (w/v) X-Gal (in dimethylformamide) and 20 ul of 100 
mM IPTG to aid the identification of recombinants. Plates were incubated at 37°C 
for at least 20 hr before scoring or picking of colonies. Typical transformation 
efficiencies were between 105 and 108 transformants per jug of DNA. Recombinant 
colonies appeared white and non-recombinant colonies were blue using IPTG/X-Gal.
p21 vector was purified as follows. A single bacterial colony was used to inoculate 
50 ml of TB containing an appropriate antibiotic and grown overnight at 37°C with 
vigorous aeration. The cells were pelleted by centrifugation for 15 min and 4°C in 
an HB4 rotor in a Sorvall RC5 centrifuge at 10,000 rpm. The bacterial pellet was 
resuspended in 10 ml of solution PI (50 mM Tris-HCl pH 8.0, 10 mM EDTA, 100 
mg/ml RNase A), then 10 ml of solution P2 was added (20 mM NaOH, 1% (w/v) 
SDS). The sample was stored at room temperature for 5 min. Then 10 ml of P3 
(2.55 M potassium acetate, pH 4.8) was added and the cell preparation was left on 
ice for 10-15 min. Then chromosomal DNA, SDS and protein was sedimented by 
centrifugation at 13, 000 rpm in an HB4 rotor for 30 min at room temperature. A 
Qiagen500 column was equilibrated with 10 ml buffer QBT (750 mM NaCl, 50 mM 
MOPS, 15% ethanol, 0.15% (w/v) TritonXlOO, pH 7.0). The supernatant was 
applied through a Whatman filter. After washing twice with 30ml buffer QC (1 M 
NaCl, 50 mM MOPS, 15% ethanol, pH 7.0), the DNA was eluted with 15 ml buffer 
QF (1.25 M NaCl, 50 mM MOPS , 15% ethanol, pH 8.2). DNA was precipitated 
with 0.6 volumes of isopropanol and centrifuged at room temperature. Pelleted DNA 
was washed with 70% ethanol, air dried and redissolved in water and stored at - 
20°C. Diagnostic restriction enzyme digests were used to confirm that the correct 
cDNA fragment was present in the plasmid.
It was then cleaved with EcoRI and Hindlll, and gel purified as above.
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Centromeric staining of hepatocytes
Livers were gently pressed onto a glass coverslip after dissection. This method 
allows single hepatocytes to detach from liver in a non-disruptive manner so that 
their nuclei remain intact. Liver cells prepared in this was were allowed to air dry for 
5 minutes and they were then fixed in 4% (v/v) formaldehyde in PBS (IQxPBS (100 
mM NaPO4 pH7.4, 1.5 M NaCl, 10 mM EGTA)). After washing in PBS the cells 
were permeabilised in KB buffer (1 OxKB (100 mM Tris.HCl pH 7.7, 1.5 M NaCl, 
1% BSA)) with 0.1% Triton (v/v), washed twice in PBS and incubated for 30 min in 
the primary antibody diluted optimally (NR antibody (a gift of Professor W. 
Earnshaw, ICMB (Earnshaw and Rothfield, 1985)), 1:1000 in PBS/1% BSA/0.1% 
Sodium Azide). The coverslips were washed again twice in PBS/1% BSA/0.1% 
Sodium Azide and subsequently incubated in a 1:1000 dilution of the biotinylated 
secondary antibody (anti-human IgG) in the same solution for 30 min at room 
temperature. After this they were washed again and incubated for a further 30 min in 
Streptavidin/Texas Red-complex, 1:1000 dilution in PBS/1% BSA/0.1% Sodium 
Azide at room temperature. Finally the cells were washed and stained with DAPI 
(0.5 ja,g/ml in PBS) for 5 min, mounted on slides with Vectashield mounting medium 
and sealed with nail varnish.
Red dots within the nucleus of the hepatocytes corresponding to the centromeres in 
the chromosomes were scored using a fluoresence microscope (Axioplan 2, Zeiss) 
usinga 100x/NA 1.4 oil immersion objective lens. The images presented in this 
thesis were acquired by F. Nunez, Dr Sally Wheatley and Professor Bill Earnshaw 
using deconvolution, a technique to compress many focal planes into one image and 






































































Table 2.2 Antibodies and conditions for immunohistochemistry. All 
antibodies were polyclonal rabbit anti-mouse.
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Hepatocvte Nuclear Area Measurement
Liver samples were collected, fixed overnight (4% formaldehyde in PBS), and 
embedded in paraffin. Sections (3 um) were cut and these were stained with 
haemotoxylin and eosin. The AxioHOME system (Zeiss) was used to measure the 
area of hepatocytes. The software used, BASIC Morphometry, allows the drawing 
around the periphery of each nucleus in a field and the area of each hepatocyte 
measured is calculated automatically in um2. Typically, a lOOx/NA oil immersion 
objective lens was used for the measurements and all of the nuclei in a given field 
would be measured. Results were analysed using Microsoft Excel and Sigma Plot 
software. For some experiments an Olympus BX60 with a ccd camera was used with 
analySIS (Norfolk Analytical) to measure hepatocyte areas. The two systems were 
compared and gave equivalent results.
In all studies, except those comparing the truncation and complete knockouts, results 
from both knockouts were pooled and treated as one.
Immunohistochemistry
General protocol - variations in Table 2.2. Liver samples were collected, fixed 
overnight (formalin (4% formaldehyde in PBS) or methacarn
(methanol:chloroform:acetic acid, 3:2:1)), and embedded in paraffin. Sections (3um) 
were cut and mounted on poly-L-lysine coated slides. Sections were dewaxed in 
xylene and rehydrated in an ethanol-water series. Endogenous peroxidase activity 
was blocked in H2O2:Methanol:Water (1:50:50). After washing in water, antigen 
retrieval used about 250 ml of a pH6 citrate buffer with 3x5 min in a plastic tub in a 
700 W microwave. Sections were allowed to cool for 20 min and washed in a TBST 
buffer (pH 7.6, 0.145M NaCl, 12.5mM TrisHCl, 0.5% Tween20). Sections were 
then blocked for 5 min in Donkey serum (1:5 in PBS) (Diagnostics Scotland, Law 
Hospital, Carluke, Scotland) before incubation in primary antibody in TBS (TBST
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without Tween20) overnight at 4°C. Sections were washed for 4x 10 min in TBST 
before incubation for 1 hr in 1:50 biotinylated donkey anti-rabbit in TBS 
(Diagnostics Scotland). After washing for 2x10 mins in TBST, sections were 
incubated for 1 hr in StreptABComplex/HRP solution prepared according to the 
manufacturers instructions (Dako Ltd). After washing in TBST colour was 
developed in DAB solution prepared according to the manufacturers instructions 
(Dako Ltd). Sections were counterstained in 50% acidified haematoxylin (16 ml of 
glacial acetic acid per 350 ml undiluted stain) (Sigma Diagnostics) and Scott's Tap 
Water (l%(w/v) K2CO3 , 10% (w/v)MgSO4). They were then dehydrated using an 
ethanol-water series and cleared in xylene, before mounting in DePex.
All primary antibodies were acquired from Santa Cruz Biotechnology 
(www.scbt.com). Except for p53 which was acquired from Novocastra Laboratories 
Ltd (www.novocastra.co.uk).
PCNA immunohistochemistry was carried out using both formalin and methacarn 
fixed samples. Whilst formalin fixation acts on the entire population of PCNA, 
methacarn fixation may possibly only fix the active PCNA bound to DNA (Bravo et 
al., 1987; Burford-Mason et al., 1994).
All histology images presented here were acquired on an Olympus BX60 with a ccd 
camera and images were analysed using analySIS (Norfolk Analytical). Except 
where noted all image were taken with a 20x objective. The camera compensates 
automatically for lighter images so that immunohistochemistry images with light 
staining appear relatively darker than they appear down the microscope.
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Chapter Summary and Background
ERCCl null mice have high levels of hepatocyte polyploidy and their appearance is 
similar to aged wt animals (MeWhir et al., 1993; Weeda et al, 1997). The levels of 
polyploidy increase in wt mice as they age. This indicates that the ERCCl null 
mice maybe suffering from accelerated ageing. I have confirmed that the 
development of polyploidy in the ERCCl null mouse is accelerated compared to the 
development of polyploidy in the ageing wt mouse. The enlarged hepatocytes in 
both ERCCl null and ageing wt mice are arrested in G2/M. The increased 
polyploidy is not a side effect of the runting observed in the ERCCl null animals and 
the development of polyploidy is the same in the original insertion null animal and in 
a deletion knockout.
ERCC1 null hepatocytes have accelerated 
development of polyploidy and enlarged nuclei 
are detectable from birth
Nuclear Area Measurements
In order to document the development of polyploidy in ERCCl null hepatocytes and 
to compare it to ageing wt samples, measurements were made of nuclear area to 
calculate area distributions. The area of hepatocyte nuclei is proportional to their 
volume and the volume is proportional to the DNA content (Bohm and Noltemeyer, 
1981; Brasch, 1980; Epstein and Gatens, 1967; Kudryavtsev et al., 1993; Medvedev, 
1986). Measurements of nuclear area can therefore be used to study changes in the 
DNA content of nuclei. This gives a semi-quantitative method of comparing the 
level of polyploidy.
The liver is composed of hepatocytes (parenchymal cells) and non-hepatocytes (non- 
parenchymal cells, such as lymphocytes and structural cells). The hepatocytes 
perform the metabolic functions of the liver and are roughly hexagonal in shape 
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Figure 3.1 Hepatocyte Nuclear Area Distributions for ERCC1 null and wt 
animals from birth to death. The number of animals examined, total 
number of nuclei and percentage of the nuclei over 50 urn2 is indicated. 
Each bar covers a range from 9.99 below the stated value to the value 
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Figure 3.2 Distribution of the nuclear area of hepatocyte nuclei 
for ERCC1 null and wt animals for d16.5, d18.5 embryonic and 
birth. Number of animals studied, number of nuclei measured and 
percentage of those nuclei over 50 ]nm2 .Each bar covers a range 
from 9.99 below the stated value to the value, e.g. 20 nm2 is 10.01 
to 20 |im2.
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hepatocytes and non-hepatocytes because non-hepatocytes have condensed nuclei 
which take up stain strongly, whereas hepatocytes have much larger weakly staining 
nuclei, with a non homogenous staining pattern. The cytoplasm of hepatocytes often 
appears to have many small gaps in the tissue. This is because of the presence of 
lipid storage droplets in the liver, which can be often extracted by histology 
preparation protocols. The number and size of droplets/gaps depends on the 
nutritional status of the animal. Nuclear area measurements were only made of 
hepatocytes as there is no indication that non-hepatocytes display the polyploidy 
phenotype. Measurements were not made in the areas around the portal veins, as 
these areas have a high proportion of non-hepatocytes, or of the areas immediately 
adjacent to the edge of sections, as hepatocytes in those areas do not display the 
polyploidy phenotype so distinctly.
At birth, it is already possible to distinguish a difference between ERCCl null and wt 
area distributions (Figure 3.1). There is clearly a higher proportion of large nuclei in 
the ERCCl null samples than the wt sample. Less than 1% of wt nuclei at birth are 
over 50 um2, compared to 9% of ERCCl null nuclei. 50 jam2 has been chosen as a 
good cutoff mark for so called "normal" nuclei as the great majority of the nuclei in 
the 3 week old wild type samples are smaller than this. The relative proportion of 
large nuclei develops in the ERCCl null samples over the three weeks after birth, 
until at 3 weeks old, 33% of ERCCl null nuclei are over 50 um2, whereas only 7% of
^wt nuclei are over 50 um . However, at 6 weeks old, 40% of wt nuclei appear to be
0 1
over 50 um and at later ages the percentage of nuclei over 50 um stays between 
32% and 62%. The nuclear area distributions indicate that by 6 weeks the level of 
polyploidy in wt hepatocytes is equivalent to that seen in 3 week old ERCCl null 
hepatocytes. Before birth, less than 1% of nuclei are larger than 50 um2 in both 
ERCCl null and wt samples and there appears to be no difference between the 
genotypes (Figure 3.2). These results work confirm and extend the results of 
Me Whir and Weeda, who showed that enlarged nuclei were present in ERCCl null 
hepatocytes (Weeda et al, 1997; Me Whir et al., 1993).
84
birth wt birth ERCC1 null
56% 32% 12% 58% 36% 6%
1 weekwt 1 week ERCC1 null
86% 14% 65% 24% 11%








Figure 3.3 FACS profiles of ERCC1 null and wt liver from birth to 3 weeks 
old. The position of nuclei with 2n, 4n and 8n DMA content is indicated, as is 
the percentage of cells in each peak. These are typical examples of profiles 
taken from at least 4 animals for each age and genotype.
85
Chapter 3 - Cell Cycle Studies in ERCC1 null liver
Although a proportion of the nuclei drastically increase in size, the vast majority stay 
about the same size. This means that the difference between the ERCC1 null, aged 
wild type and young wild type size distributions is not as obvious as when examining 
a picture of a section. A comparison of the percentage of nuclei that are greater than
*\
50 urn shows explicitly how the proportion of enlarged nuclei increase with age in 
both genotypes.
It might be expected that the distributions would show a smooth increase in the 
number of enlarged cells with age, however only a trend is obvious, and there is quite 
a large variation about the trend. This variation reflects the fact that the exact 
development of polyploidy varies between individual animals. The distributions 
shown are averages taken from a number of animals but the variation is still obvious. 
There is also a large variation in the proportion of enlarged nuclei between the 
different areas of the same liver, the large numbers of nuclei measured should correct 
for this, but it may still contribute to the variation in distributions.
FAGS Profiles
FACS profiles have also been used to compare the development of polyploidy during 
ageing in wt and ERCC1 null liver. The FACS profiles measure the incorporation of 
propidium iodide into individual nuclei. This gives a direct way to precisely 
compare DNA content. The method used prepares individual nuclei. The FACS 
profiles tell a slightly different story to the nuclear area distributions. For all 
profiles, except the log profiles, at least 4 animals were tested and the samples shown 
are typical of those tested. Variation between animals was high especially in animals 
with high levels of polyploidy, but a trend could always be clearly distinguished 
from animals of one age to those of the next shown.
At birth, in both wt and ERCC1 null liver over 30% of nuclei have 4n DNA content 
and around 10% have over 4n DNA content (Figure 3.3). In 1 week old ERCC1 null 
liver, 24% of nuclei have 4n DNA content and 11% have 8n DNA content. In 1 
week old wt liver however, only 14% of nuclei have 4n DNA content and none have 
greater than 4n. The proportions of nuclei with different DNA contents stays the
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Figure 3.4 FACS profiles of ERCC1 null and wt liver from 3 
weeks to 2 years. The position of nuclei with 2n, 4n and 8n DMA 
content is indicated, as is the percentage of cells in each peak. 
These are typical examples of profiles taken from at least 4 
animals for each age and genotype.
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same at about 2 weeks old, but at 3 weeks old 36% of ERCCl null nuclei are 4n and 
27% are 8n, whereas about 94% of wt nuclei are 2n and only 6% are 4n. Figure 3.3 
shows how over the 3 weeks from birth the ploidy level of ERCCl null liver 
increases, with an increased proportion of 4n nuclei and the appearance of an 8n 
peak. This contrasts strongly with the wt samples which stay roughly the same 
throughout the 3 weeks. Although the trend can clearly be seen from 1 week old to 3 
weeks, there appears to be an anomaly at birth. These profiles show an increased 
number of 4n nuclei. It is clear from the nuclear area distributions and examination 
of sections that there are no enlarged hepatocytes in the wt samples at birth. The 
FACS profiles measure all the cells in the liver, which around birth has a large 
number of rapidly dividing cells involved in haematogenesis. A high proportion of 
these cells will be in G2 leading to a high 4n DNA content peak. This means that the 
birth FACS profiles provide a picture of the ploidy status in the liver as a whole, but 
are not informative about hepatocyte ploidy. The increased 4n peak at birth is due to 
haematogenic cells. The birth samples may have a small peak at greater than 4n due 
to the presence of polyploid megakaryocytes.
After 3 weeks when the ERCCl null animals die, the ploidy level continues to 
develop in wt liver (Figure 3.4). In 6 week liver 34% of nuclei are 4n and by 1 year 
old 24% of nuclei are 4n and 10% are 8n. At 2 years old 46% of nuclei are 4n and 
24% are 8n. The wt liver seems to attain the same level of polyploidy as the 3 week 
ERCCl null liver at between 1 and 2 years old.
There seems to be some discrepancy between the nuclear area distributions and the 
FACS profiles. The nuclear area distributions indicate that by 6 weeks old, the wt 
samples have a similar area distribution to that seen in 3 week ERCCl null samples. 
However, the FACS profiles indicate that level of polyploidy only becomes 
comparable to a 3 week ERCCl null in 2 year old wt samples. I can give no 
comprehensive explanation for this discrepancy, but I believe the FACS profiles 
probably give a more accurate view of the polyploidy development as FACS profiles 
measure the DNA content in a nucleus directly. Nuclear area distributions measure 
DNA content indirectly by measuring the area of nuclei in a section and assuming
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that the area of a nucleus is proportional to volume which is proportional to DNA 
content. Nuclear area measurements also do not measure the area of a nucleus at its 
widest point but at a thin slice taken at random through the nucleus. This means that 
the profiles are more flattened than they would be if only the true mid-cross-sectional 
area was measured. If the liver were composed of nuclei of one particular size only, 
the distribution would be stretch between the true mid-cross-sectional area of the 
nuclei and the smallest areas measured and all sizes would have the same value. 
When sections were analysed, below a certain size it was not possible to differentiate 
nuclei and this puts a lower limit on the areas measured.
The larger 8n cells only form a small proportion of the total even in the 3 week old 
ERCC1 null and 2 year old wt FACS profiles, which should give a true 
representation of the proportions of cells of different ploidy levels. The larger cells 
form a small proportion of the total and so they will not appear to a significant 
degree in the nuclear area distributions. The tendency of the nuclear area 
distributions to be flattened will also disguise the presence of increased numbers of 
very large cells. Perhaps the fact that the FACS profiles take a non-specific piece of 
liver, which includes the edge of the tissue, whereas the nuclear area distributions 
only take measurements from the centre of the tissue contributes. If the development 
of aging related polyploidy started in the middle of the tissue and then proceeded to 
the outside, then the nuclear area distributions measurements would detect this 
polyploidy earlier and the FACS profiles would detect it later. However, the FACS 
profiles nevertheless give a better description of the polyploidy development.
It would be interesting to use statistical testing to compare the nuclear area 
distributions. However, the most often recommended test to compare non- 
parametric distributions is the Kolmogorov-Smirnov test, which has not proved 
useful in this case. This test gives a significant difference to pairs of samples, even 
when by eye no difference can be seen.
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Figure 3.5 Linear and Log FACS profiles of ERCC1 null and 
wt liver at 3 weeks and 1 year old. The position of nuclei with 2n, 4n and 
8n DMA content is indicated, as is the percentage of cells in each peak. 
The same sample was used for both log and linear profiles. Due to 
time constraints only one animal was examined for each type under log 
conditions, however the linear profiles are typical for animals of the 
ages and genotypes shown.
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The settings used to acquire most of the FACS profiles show only three peaks for the 
3 week ERCC1 null and old wt samples, however some other samples were 
measured using both logarithmic settings and the normal linear settings. Figure 3.5 
shows how the logarithmic setting compresses the peaks and shows the presence of a 
16n peak clearly visible in the 1 year old wt sample, this peak is however not clearly 
visible in the ERCC1 null sample. Unfortunately, this particular ERCC1 null sample 
does not display a particularly high level of polyploidy. There are differences 
between the percentages of cells in a particular peak between the log and linear 
profiles. This reflects both the fact that they are taken from slightly different parts of 
the tissue and differences in measuring peak areas between the log and linear 
profiles.
Both FACS profiles and nuclear area distribution measurements have been made as 
the two methods highlight different aspects of polyploidy development. The nuclear 
area distributions have the advantage that they are specific to hepatocytes and show 
how the distributions change over time. The FACS profiles allow one to see how the 
specific ploidy levels in the liver change, however they are not specific to 
hepatocytes.
The nuclear area distributions and FACS profiles show that the rate of development 
of polyploidy in the ERCC1 null mice is much faster than that seen in wild type 
mice. In fact, by birth there are already signs of polyploid nuclei in the ERCC1 null 
hepatocytes. However, the levels of polyploidy in the ERCC1 null mice do not 
exceed those in the aged wild type mice, in fact 16n nuclei have been seen in wt but 
not in ERCC1 null liver (although the sample tested was atypical). As the aged wild 
type mice are not dying of liver failure, but have a greater or equal polyploidy level 
than the ERCC1 null liver, it appears that the accelerated polyploidy, whilst a 
symptom of the phenotype, is not the cause of death.
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ERCC1 null hepatocytes and enlarged 
hepatocytes in aged wild type animals are 
arrested in G2/M
Correction of FAGS profiles
The FACS profiles and nuclear area distributions show clearly that the development 
of liver polyploidy is accelerated in the ERCC1 null liver, however, they give no 
information on hepatocyte cell cycle status. Further study of the FACS profiles 
reveals some information about the cell cycle status of the hepatocytes. Examination 
of FACS profiles of the ERCC1 null livers indicates that there is an increased 4n 
peak and the appearance of an 8n DNA content peak (Figure 3.4). However there 
still appears to be a significant proportion of nuclei in Gl/2n. This is probably 
deceptive, as discussed earlier, because the FACS analyses include all of the cells 
from the liver; the hepatocytes that display the phenotype and various types of non- 
hepatocytes, including vascular tissue and white blood cells. The presence of these 
non-hepatocytes will increase the relative height of the Gl peak, as like most mature 
cells in the body they will be quiescent and have 2n DNA content.
In order to gain a more accurate reflection of the cell cycle status of the hepatocytes 
the relative proportions of non-hepatocytes and hepatocytes were calculated by 
examining liver sections. The calculations were made based on measurements from 
the central part of the tissue, avoiding any large blood vessels, and so these 
proportions probably underestimate the contribution of non-hepatocytes to FACS 
profiles. Non-hepatocytes are more common around the periphery of the liver and 
around blood vessels. The vast majority of non-hepatocytes in liver will tend to be in 
Gl/GO, for these calculations it has been assumed that 100% are in Gl/GO. About 
35% of the cells in ERCC1 null livers were non-hepatocytes, compared to about 22% 
in wt livers. The difference in these figures is because the hepatocytes in ERCC1 
null liver tend to be larger, so there are less hepatocytes in a given area, whereas the 
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Figure 3.6 Corrected and uncorrected FACS profiles for 3 week old 
ERCC1 null and wt liver. Each genotype is the average of 2 animals. 
Corrected FACS profiles were calculated by subtracting the percentage of 
non-hepatocytes from the G1/GO fraction. Fractions were then 
recalculated to total 100%.
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Figure 3.7 Percentage of small and enlarged nuclei in G2/M 
from centromeric immunostaining assay. Binding of the NR 
antibody to centromeres was visualised with a Texas Red- 
conjugated tertiary antibody. Each centromeric structure is 
represented by a red spot. The DNA is stained with DAPI and 
presents a blue colour. In normal size nuclei (mostly G1) the 
majority of structures appear as single spots, in enlarged 
nuclei (mostly G2) they appear as double spots. Nuclei were 
scored as G1 or G2 by eye and at least 50 nuclei were 
counted per sample. SD is the standard deviation.
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hepatocytes were combined with the relative numbers of 2n, 4n and 8n nuclei 
derived from the FACS profiles to produce a profile that did not include the Gl 
contribution from non-hepatocytes. Figure 3.6 shows the corrected FACS profile for 
the ERCC1 null samples, this shows an increased relative proportion of 4n and 8n 
nuclei in the corrected sample. After correction for non-hepatocytes 34% of 3 week 
ERCC1 null nuclei have 2n DNA content, 46% have 4n and 20% have 8n DNA 
content. For 3 week wt nuclei 82% have 2n DNA content, 15% have 4n and 3% 
have 8n DNA content. This shows that only a small number of ERCC1 null 
hepatocytes are diploid and in Gl. The majority of ERCC1 null hepatocytes are 
either diploid and in G2 or tetraploid and in Gl. In order to distinguish between 
these two alternatives, and to study the cell cycle status in more detail, a more 
complex assay was required.
Centromeric Staining Assay
To further investigate the cell cycle status of the hepatocytes, a trial of a fluorescense 
immunostaining assay was carried out by F. Nunez. This used a primary antibody 
(NR) which recognises the cenpA, cenpB and cenpC antigens of the centrosome 
(Earnshaw and Rothfield, 1985). Cells in Gl/GO and S have single centromeres 
which can be seen as single dots whereas those in G2 have double centromeres 
which can be resolved as individual paired dots (Brenner et al., 1981). This trial 
showed that around 70% of 3 week wt hepatocytes were at Gl and 30% at G2/M, 
whereas in 3 week ERCC1 null samples 75% of the hepatocytes were in G2/M. This 
seemed to indicate that the ERCC1 null hepatocytes are arrested in G2/M.
I have extended this assay to study whether the enlarged or normal nuclei or both are 
arrested in G2/M (Figure 3.7). There is no significant difference between the normal 
sized nuclei in the ERCC1 null and 3 week old wild type samples (by Student's t 
test), and -30% are in G2/M. However, the enlarged nuclei in the ERCC1 null 
sample have a statistically significant increase in the number of nuclei in G2/M when 
compared to normal sized wt samples (p=0.01) and 62% of nuclei are in G2/M. The 
aged wild type nuclei have the same spread of cell cycle status as the ERCC1 null 
nuclei (p=0.01), 29% of the small nuclei are in G2/M, whereas 84% of the enlarged
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nuclei are in G2/M . These results show two populations of hepatocytes in the 
ERCC1 null and aged wild type liver; smaller hepatocytes that are spread through the 
cell cycle in the normal proportions and enlarged hepatocytes that are largely 
arrested in G2. Thus the increased 4n peak in FACS profiles of 3 week ERCC1 null 
liver is probably due to a mixture of diploid G2 and tetraploid Gl nuclei.
The interpretation of these results depends crucially on the division of nuclei into 
enlarged and normal classes. It is not possible to draw a clear division between 
enlarged nuclei and normal nuclei. The great majority of nuclei are a very similar 
size and are easy to differentiate from the grossly enlarged nuclei, but the split is 
somewhat subjective. When analysing preparations only cells that were clearly 
normal size were taken as normal, and only cells that were clearly enlarged were 
taken as enlarged. This inevitably leaves a small number of nuclei unassigned 
between the two classes. As normal sized nuclei in G2 would be expected to be 
larger than their brethren in Gl, there may be a propensity to select against normal 
G2 cells. This would tend to reduce the percentage of cells scored in G2 in the 
normal population. However, as the corrected FACS profiles reveal, there are a large 
number of cells with 4n DNA content compared to 2n in the ERCC1 null sample, 
this means that as long as the vast majority of nuclei were taken as normal, it is 
unlikely that the result was skewed badly for the normal nuclei.
Even if the cell cycle status of the classes of nuclei is skewed slightly, it is still 
possible to say that the overall proportion of nuclei in G2 is greater in the ERCC1 
null than in the wildtype. Measurement of the cell cycle status in the trial 
experiments still show an increased G2 percentage in the ERCC1 null samples, when 
no attempt was made to separate the normal and enlarged nuclei. Non-hepatocytes 
were easy to distinguish from hepatocytes because of the relatively condensed nuclei 
and were not scored.
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Figure 3.8 Wt runt liver has the same FACS profile as normal wt liver, 
not the same as ERCC1 null liver. All samples are ~3 weeks old. The 
position of nuclei with 2n, 4n and 8n DMA content is indicated, as is the 
percentage of cells in each peak. These are typical examples of profiles 
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Figure 3.9 Hepatocyte Nuclear Area Distributions for ERCC1 null, wt and 
wt runt. The number of animals examined, total number of nuclei and 
percentage of the nuclei over 50 ^m2 is indicated.
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Figure 3.10 Hepatocyte Nuclear Area Distributions comparing 3 week 
old insertion and deletion ERCC1 null. The number of animals examined 
and total number of nuclei is indicated.
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The ERCC1 null phenotype is not a feature of 
runted animals
As the ERCCl null mice are runted, it was possible that the high level of polyploidy 
and G2/M arrest seen in the hepatocytes was an aspect of the runting, rather than a 
direct result of the ERCCl deficiency. To test this a study was made of several wt 
runts of a similar genetic background to the ERCCl null animals. A comparison of 
the wt runts with the ERCCl null runts and normal wt animals, shows that the FACS 
profiles, nuclear size distributions and centromeric staining assay results are the same 
for wild type runts as for normal wt animals (Figure 3.7, 3.8, 3.9). Wt runts have a 
tight nuclear area distribution, a low level of 4n nuclei and a low level of G2/M 
nuclei, the same as normal wt animals. This result indicates that the gross cell cycle 
and polyploidy phenotype seen in the ERCCl nulls is not a side effect of runting but 
is due to other reasons.
The original ERCC1 insertion null phenotype is 
not significantly different from a deletion 
knockout
The original ERCCl null line was an insertion knockout (MeWhir et al., 1993). A 
deletion ERCCl null line has also been constructed in order to see if this displayed 
an altered phenotype (KT Hsia; personal communication). Nuclear area distributions 
have been used to compare the phenotypes of the two different knockouts. Figure 
3.10 shows that there appears to be no difference in distribution between insertion 
and deletion ERCCl null liver. This indicates that the original insertion ERCCl null 
animal is effectively the same as the deletion knockout. In the rest of this thesis, 
results from the two lines have been combined and treated as one. However, results 
for all experiments showed no difference between the two lines.
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Discussion
Just as ERCC1 null hepatocytes display an increase in polyploidy with age, so do wt 
hepatocytes (Epstein and Gatens, 1967). At 2 weeks old about half of all the 
hepatocytes are binuclear and by 4 weeks old about 80%. This level of binucleation 
stays the same until at least 1 year old. Nuclei are predominantly 2n and 4n at 4 
weeks old, but 8n nuclei appear and numbers increase rapidly, whilst the levels of 2n 
nuclei decrease. From 6 weeks old 16n nuclei are found, although the levels never 
increase above 8% (Bohm and Noltemeyer, 1981). Whilst in ERCC1 null 
hepatocytes there is a high level of polyploidy by 3 weeks when the animals die, in 
wt animals it takes more time to reach a similar state of ploidy. The wt mice do not 
die when they reach the same level of polyploidy as the ERCC1 null mice, which 
indicates that the increased polyploidy is not directly causing death in the ERCC1 
nulls. In fact, a development of polyploidy is seen in many organs as they age, 
including blood, muscle, cornea, thyroid, pancreas, endometrium, placenta, urinary 
bladder and neural tissues (Brodsky and Uryvaeva, 1977; Harris, 1971; Kudryavtsev 
et al., 1993). In wt mouse liver development the number of binucleate cells also 
increases with age, interestingly, ERCC1 null livers have a lower rate of binucleation 
than wt liver (Nunez et al., 2000). In 3 week old ERCC1 null liver 3% of 
hepatocytes were binucleate (n=13), compared to 8% of hepatocytes in wt liver 
(n=7), this was a significant difference (p=0.05) (Nunez et al., 2000). It would seem 
likely that there is a connection between polyploidy and binucleation. Binucleate 
cells, in a similar way to polyploidy nuclei, have arrested before the completion of 
mitosis. It could be suggested that binucleate cells have escaped the particular arrest 
in G2/M of polyploidy nuclei and have progressed further, only to meet a block 
before the completion of cytokinesis. Perhaps this represents a further way to 
increase/maintain liver metabolic function without cell division and the concurrent 
cancer risk.
The polyploidy in old wt hepatocytes is associated with increased accumulation of 
the lipid peroxidation product lipofuscin and increased cytoplasmic complexity (Hall 
et al., 1989; Sigal et al., 1995). Interestingly, increased levels of disruption of 
mitochondrial membranes and increased levels of lipid accumulation are seen in the
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ERCC1 null mouse when compared to wild type (KT Hsia; personal 
communication).
The accelerated polyploidy in the ERCC1 null hepatocytes could be caused directly 
by increased levels of DNA damage, or by non-specific damage to the liver due to 
the effects of DNA repair deficiency. The ploidy of hepatocytes tends to increase 
with any sort of liver damage, for instance alcohol. Polyploidy is associated with 
hypertrophic responses in tissues and with cell aging, as observed in cultured 
fibroblasts undergoing senescence (Biesterfeld et al., 1994; Katz, 1994). It is thought 
that the development of polyploidy may be to increase the effectiveness of the liver 
under stress. Hepatocytes may accumulate damage more quickly than other cells 
because of their role in metabolising toxins.
Liver polyploidy develops as mice age and the development of polyploidy tends to 
be greater in mice than in other mammals, such as humans. Polyploidisation is 
restricted to the periods of active growth and development in human liver and does 
not attain as great a level as in mouse and there is no rapid increase in binucleation 
and polyploid cells in post natal growth (Kudryavtsev et al., 1993). Polyploidy in rat 
liver only develops until 12-14 months old and does not continue like in mouse, the 
ploidy level generally only reach tetraploidy. In mice, polyploidy development 
continues until death and accumulation of up to 32N nuclei is seen. Mouse liver 
mass declines near death, but polyploidy still continues to develop (Medvedev, 
1986).
Polyploidy maybe a mechanism to allow the liver to preserve its full metabolic 
function under toxic load, without cell division of damaged cells, which could lead to 
cancer (Medvedev, 1986). Liver function is important for metabolism of proteins, 
carbohydrates and fat. Hepatocytes that are damaged by toxins cannot be replaced 
by new hepatocytes because the mitosis of cells with damaged DNA would increase 
cancer risk. Polyploid hepatocytes have redundant extra copies of vital genes and 
this is thought to increase toxin and carcinogen resistance. In fact, hepatocytes do 
not readily undergo apoptosis after DNA damage (Bellamy et al., 1997). The
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increased size of polyploid cells allows the liver to adapt to ageing related cellular 
loss and still preserve function. Cell size is generally proportional to DNA content 
and so polyploid cells can have more functional capability than diploid cells 
(Gregory et al., 2001). Polyploidy may be a defence mechanism against intrinsic 
DNA damage in order to preserve at least one good copy of essential genes as liver 
ages.
Polyploidy occurs by endoreduplication, in which there are three possibilities which 
could occur in liver, either continuous rounds of DNA replication, with distinct gap 
phases, occur in the absence of mitosis, S phase reoccurs without a gap or there are 
multiple initiations within a given S phase (Grafi, 1998). Hepatocytes have unusual 
proliferative abilities for somatic cells, although normally relatively quiescent, after 
partial hepatectomy the liver mass is restored rapidly by the development of 
polyploidy with most hepatocytes undergoing two or three rounds of DNA synthesis 
(Brodsky and Uryvaeva, 1977; Gerlyng et al., 1993). Hepatocytes from adult 
animals can divide repeatedly after transplantation into reduced liver, suggesting 
extensive replication potential in hepatocytes, however it is unknown whether all 
transplanted hepatocytes participate in this replication, or merely a subset (Laconi et 
al., 1998; Mignon et al., 1998; Overturf et al., 1997; Sigal et al., 1999). Liver 
regenerative capacity is decreased in older animals with greater proportions of 
polyploid hepatocytes (Brodsky and Uryvaeva, 1977). After mild insults to liver, 
hepatocytes can regenerate, however where the regenerative capacity of hepatocytes 
is compromised it is proposed that oval cells that may be derived from the biliary 
cells can serve as progenitors (Alison, 1998; Dabeva et al., 1995).
The enlarged hepatocyte nuclei in both ERCC1 null and ageing wt samples are 
arrested in G2-M. As the nuclei are undergoing endoreduplication to become 
polyploid, they must be cycling but missing out M phase. As they probably suffer 
from accumulated DNA damage, they probably arrest naturally in G2 before the 
mechanism activates that allows them to skip mitosis.
103
Chapter 4 - Changes in protein expression in ERCC1 null liver
Chapter 4 - Changes in protein expression in 
ERCC1 null liver
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Chapter Summary and Background
The accelerated development of liver polyploidy in ERCC1 null mice is very similar 
to that of transgenic mice that overexpress p21 in the liver, and in fact the ERCC1 
null mice have increased p21 mRNA levels in the liver (Nunez et al., 2000). Thus it 
seems likely that the p21 increase in the ERCC1 null livers is the cause of the 
accelerated polyploidy. If the increase in p21 levels is causing the accelerated 
polyploidy then the increase should be found mainly in those nuclei which are 
polyploid. In order to test this, and to confirm that the levels of p21 protein are 
increased in ERCC1 null liver, immunohistochemistry has been used. This shows 
that there are increased levels of p21 protein in the ERCC1 null hepatocytes and that 
this increase is mostly in the enlarged nuclei. A small increase in p21 levels was 
seen in old wt liver samples. p53 levels have been shown to be slightly increased in 
ERCC1 null hepatocytes, but the ERCC1 null phenotype is p53-independent. REF1 
and MSH2, DNA repair proteins, are also upregulated in ERCC1 null hepatocytes.
Increased p21 levels in ERCC1 null hepatocytes
In order to confirm that the staining seen was specifically for p21, a UV irradiated 
skin sample was used as a positive control. This was from a time course of skin 
samples after UV irradiation where the p21 immunochemistry staining conformed to 
that seen in a published time course (Lu et al., 1999). Preliminary Western analysis 
of ERCC1 null and wild type tissue using the p21 antibody suggests that the antibody 
mainly detects a protein corresponding to the expected molecular weight for p21 (D. 
Melton; personal communication). The variability in increases in staining levels in 
ERCC1 null liver corresponds well to that seen in Northern analysis of p21 levels in 
ERCC1 null liver. High levels of increases are also seen in both 
immunohistochemistry and Northern analysis. This all suggests that the antibody 
being used detects p21 and that the vast majority of signal seen is derived from 
increases in p21 levels rather than other proteins. It would be an extreme 
coincidence if another protein (not p21) that was specifically detected by the 
antibody was also expressed in greatly increased levels in ERCC1 null liver. The
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Figure 4.1 p21 immunohistochemistry on 3 week old ERCC1 null and 
wild type liver. Typical staining patterns are shown for ERCC1 null, wild 
type and control samples without primary antibody. The percentage of 
nuclei that stain positive for p21 is also shown, both as an average and 
for individual samples from different animals.
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highly nuclear specific nature of the immunohistochemistry staining indicates that 
the antibody is specifically detecting one protein.
Preliminary immunohistochemistry studies showed that p21 expression in individual 
hepatocyte nuclei tends to be either on (at a high level) or off (at a low level) and that 
it is relatively easy to segregate nuclei by eye into those which stain positive for p21 
and those which do not. Scoring in this way showed that whilst -4% of the 
hepatocyte nuclei in 3 week wt sections were stained, -27% of hepatocyte nuclei in 
the 3 week ERCC1 nulls stained positive for p21 (Figure 4.1). This confirms that 
p21 protein levels are increased in the ERCC1 null liver and that the increase is 
specifically associated with hepatocytes rather than just with other cell types. On a 
visual inspection, the larger nuclei in the ERCC1 null samples appear to be stained 
more often than the small nuclei.
Figure 4.1 shows a large variation in the amount of staining between samples of the 
same genotype. Some of the heterogeneity in staining may possibly be artifactual. 
Due to technical constraints it was only possible to stain 5 samples at once, including 
a positive control. Although the percentage of stained nuclei in the positive control 
was calculated to confirm that the level of staining was the same, there were small 
differences between staining sets. The level of staining would vary by perhaps 10%, 
i.e. if a sample normally had 30% of nuclei staining this would vary between about 
27% and 33%. This may contribute somewhat to the heterogeneity, however as will 
be discussed later the heterogeneity in staining may be connected to heterogeneity in 
nuclear area distribution
In general, the background cytoplasmic staining in the ERCC1 null samples was 
stronger than in the wt samples, this is slightly unexpected as p21 is mainly a nuclear 
protein. If this is merely background then it could be making the ERCC1 null 
samples appear more strongly stained than they really are, however this cytoplasmic 
staining is probably due to the nature of the ERCC1 null sections in having more p21 
present rather than true background. An increase in nuclear p21 levels means higher
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Figure 4.2 Nuclear size distribution graphs for p21 stained liver. p21 
stained nuclei tend to be larger than the total population average. 
Distributions are shown for a summary of all 8 ERCC1 null animals 
tested (A), a summary of 5 wt animals (B), a d17 ERCC1 null animal 
with a high level of p21 staining (C) and a summary of 2 ERCC1 null 
animals with a low level of p21 staining (D).
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levels of translation, perhaps increased levels of newly translated p21 are being 
detected before transport into the nucleus.
p21 stained nuclei are restricted to the enlarged 
ERCC1 null hepatocytes
In order to test whether the p21 staining is directly associated with the polyploid 
nuclei, measurements were made of nuclear area in the ERCC1 null and wt samples 
that had been stained for the presence of p21. The area distribution of the stained 
nuclei was calculated and also the area distribution of all the nuclei in a sample; both 
stained and unstained.
Figure 4.2 shows a graphical comparison of the nuclear area distributions for the 
ERCC1 null nuclei; for all nuclei and for stained nuclei. Most of the stained nuclei
r\ r\
are over 40 um whereas most of the total nuclei are under 40 um . This 
demonstrates that the stained nuclei tend to fall within the larger part of the 
population. The example shown in panel C illustrates this particularly well, but it is 
also apparent in the summary graph in panel A. The increased p21 levels are 
associated with the increased polyploidy in the ERCC1 null hepatocytes.
In light of the apparent tendency of the p21 stained nuclei in the ERCC1 null liver to 
be restricted to the enlarged nuclei, nuclear area distributions have also been 
measured for the p21 stained and total populations in the 3 week wt samples. Using 
a graphical analysis it appears that the p21 stained nuclei in the wt samples also tend 
to fall in the larger part of the nuclear area distribution (panel B). This is despite the 
fact that the wt samples do not have a high percentage of enlarged nuclei.
There is a large degree of heterogeneity in the percentage of p21 staining in different 
ERCC1 null samples (Figure 4.1). Heterogeneity in p21 mRNA levels in ERCC1 
null liver has been observed before (Nunez et al., 2000). The two ERCC1 null 
samples in Figure 4.2 (panel D) with a low level of p21 staining appear to have less 
exaggerated accelerated polyploidy development. Only 12 % of the total nuclei in
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the samples in panel D are over 50um2 , whereas 19.2% of the total nuclei from all 8 
samples tested are over 50um2 . This confirms that the presence of increased p21 
levels does correlate with polyploid nuclei.
_ >-\
The percentage of ERCC1 null nuclei in the enlarged (over 50 jam ) class and normal
0
(below 50 um ) class that stain positive for p21 has been calculated. This shows that 
53% of the enlarged nuclei stain positive for p21, compared with 23% of the normal 
sized nuclei. The percentage of p21 stained nuclei in wt samples is so low that the 
comparative figures for wt samples are insignificant. This correlation between 
enlarged nuclei and increased p21 levels seems high but there are a significant 
proportion of enlarged ERCC1 null nuclei without increased p21 levels and there are 
also a significant proportion of small wt nuclei with increased p21 levels. This 
makes it difficult to say whether p21 is causing the increase in ploidy. p21 maybe 
causing the increase in ploidy for at least some of the enlarged nuclei. Perhaps the 
activation of other factors, as well as p21, is necessary to increase the ploidy. This 
would explain why some of the normal sized nuclei stained positive for p21. Perhaps 
there are also other pathways that activate the increase in ploidy. This would explain 
why some of the enlarged nuclei do not stain positive for p21. Alternatively, it may 
be the case that p21 levels are only increased at certain stages in polyploidy 
development. After stimulation of liver polyploidy by partial hepatectomy, p21 
levels are increased in Gl phase and following S phase, but not during S phase 
(Albrecht et al., 1997). Perhaps the normal nuclei with increased p21 levels are close 
to entering an endoreduplication cycle and the enlarged nuclei without increased p21 
levels have past the stage where p21 is involved.
The wt samples also seem to have more p21 staining in the larger cells, although they 
have few enlarged cells (Figure 4.2 (panel B)). This is unexpected. I believe this is a 
real result and not due to some bias. It could be imagined that in the nuclear area 
measurements the stained nuclei are measured as slightly bigger than they actually 
are, because the stain could diffuse beyond the boundaries of the nucleus and make it 
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Figure 4.3 FACS profiles of old wt liver. Ages between 18 and 
27 months old. Samples 1-3 were measured on a Coulter 
XPICS XL machine. Samples 4-7 were measured on a 
Beckman Dickinson FACScan machine
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Figure 4.4 p21 immunostaining patterns for old wild type and ERCC1 null 
liver. The old wt section was 1 of 4 from a total of 7 that had low levels of 
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Figure 4.5 p21 northern autoradiography of total mRNA extracted from old wild type, 3 
week old wild type and 3 week old ERCCl null liver. Blots were reprobed with GAPDH 
for a loading control and the ratio of p21/GAPDH signal was calculated using a 
phosphorimage analysis system. Ratios were normalised to 1 using a 3 week ERCCl 
null sample used in both blots
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have distinct boundaries and the boundaries appear the same in both the stained and 
unstained nuclei (Figure 4.1).
It is not possible to say if the p21 is really causing the liver polyploidy, it is possible 
that it is merely a side effect of some other process that causes the polyploidy. 
However, the increased p21 levels are certainly associated with the polyploidy.
There is no increase in p21 levels in aged 
wildtype liver
The ERCC1 null livers display an accelerated polyploidy compared to wild type 
animals and appear to be the same as aged wild type by measurements of nuclear 
area, centromeric status and FACS. However, it is important to know whether the 
polyploidy in aged wild type animals is also correlated with an increase in p21 levels. 
To investigate this, immunohistochemistry has been used to investigate the p21 
levels in 7 old wt animals aged between 18 and 27 months old. All of which had 
high levels of polyploidy (Figure 4.3). FACS profiles were measured on two 
different machines because of a move of laboratory. Although 4 out of the 7 samples 
(old wt 1-4) appeared to have no increase in p21 levels, 3 of the samples (old wt 5-7) 
seemed to have increased staining (Figure 4.4). These 3 samples were all processed 
at the same time, although with one other sample that does not show increased p21. 
The 3 samples may have slightly higher polyploidy levels than the other samples. 
Unfortunately, the background was very high for the 3 samples which appeared to 
show increased levels of staining and it did not prove possible to obtain sections that 
did not show high levels of background. This indicated that the apparent increase in 
staining could be artifactual.
In order to test, whether there really is a p21 increase in some of the old wt samples, 
Northern blot analysis was used to study the levels of p21 mRNA (Figure 4.5). The 
old wt samples were between 18 and 27 months old. Out of four ERCC1 null 
samples tested, three had a p21/GAPDH ratio between 0.72 and 1, one other had a 
ratio of 0.08. Old wt samples 1-4 had a ratio of 0 and old wt 5, 6 and 7 had ratios of 
0.54, 0.15 and 0.11 respectively. Four 3 week wt samples had ratios of 0 and two
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had ratios of 0.07 and 0.09. The Northern Blots, which were done in parallel, show 
that 4 out of 7 old wt samples have no detectable increase in p21 mRNA levels. 
However, the three old wt samples, which showed apparent increases in p21 staining 
do show a small increase in p21 levels. Some old wt liver samples appear to have 
increased p21 levels whereas some do not.
Discussion
The increase in p21 levels and the polyploidy could be caused by accumulated DNA 
damage, although I have not shown a direct link. ERCC1 null liver will accumulate 
damage faster and hence have increased levels of p21 earlier and so this may trigger 
increased ploidy. In young wt liver there is no accumulated DNA damage and so no 
polyploidy. In old wt liver damage accumulates in some nuclei but not in others and 
so there is variablity in p21 expression.
The stochastic nature of DNA damage may explain why some nuclei develop 
polyploidy and others do not. Presumably some nuclei suffer more DNA damage 
than others and thus polyploidy development is stimulated. This could perhaps be 
explained if ICL were causing the crucial damage in ERCC1 null liver. These are 
rare enough that the stochastic nature of their formation could become apparent in 
the ploidy development. ICL, even at a very low frequency, can also arrest the cell 
cycle in G2.
There may be two explanations for the small increase of p21 levels in some old wt 
liver samples, but not others. Possibly there are two different mechanisms that cause 
liver polyploidy, one dependent on p21 and one not. ERCC1 null liver polyploidy 
would be mostly caused by the p21 dependent pathway whereas polyploidy in old wt 
samples could be caused mainly by the p21 independent pathway and possibly 
sometimes by the p21 dependent pathway. p21 is not necessary for G2 arrest and 
polyploidy development, as has been demonstrated in p21 null cells (Bates et al., 
1998; Niculescu et al., 1998; Waldman et al., 1996). Alternatively, the lack of p21 
increases may be connected to the fact that p21 is probably not increased during S
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phase and that the polyploidy in wt hepatocytes develops very slowly compared to 
ERCC1 null samples. Perhaps S phase in the old hepatocytes lasts a long time 
relative to ERCC1 null hepatocytes and so p21 levels are not increased in most 
nuclei or possibly endoreduplication is not always active and the nuclei are mostly 
dormant with p21 only activated when endoreduplication occurs. Polyploidy 
development may be coordinated across the tissue, perhaps in old wt liver some cells 
induce p21 due to increased DNA damage and these cells then communicate with 
and promote polyploidy development in other cells that do not have increased DNA 
damage.
The old wt liver samples seem to have small increases in p21 levels, apart from one 
sample, which has an increase comparable to some ERCC1 null samples. Is the size 
of the relatively small increase in p21 levels in some old wt liver samples important? 
This may be due to variation between animals and the small number of old wt 
animals tested. However, the low p21 increase may be connected to the idea of a 
p21 independent and dependent polyploidy development pathway. Hepatocytes are 
normally quiescent except in aging and after damage. p21 is required for the 
formation of various cdk complexes in the cell cycle, however in high levels it 
inhibits them, perhaps the small increases in old wt liver are necessary for one form 
of polyploidy development, but the higher levels seen in ERCC1 null samples are 
necessary for the other.
As discussed earlier the polyploidy may be described as being part of a protective 
terminal differentiation pathway. p21 is important in the differentiation of several 
cell types (Elbendary et al., 1994; Jiang et al., 1994; Parker et al., 1995). p21 is 
upregulated in various human liver diseases, such as alcoholic cirrhosis and chronic 
active hepatitis (Albrecht et al., 1997).
The level of p21 in rodent liver has been investigated before using 
immunohistochemistry. This work showed that in normal rat liver, only rare 
hepatocytes stain positive for p21, whereas by 5 days after partial hepatectomy, 
which induces polyploidy, there was a considerable increase in the number of p21
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stained nuclei (Sigal et al., 1999). Although an increase in the level of p21 staining 
was demonstrated, this did not approach the levels seen in the ERCC1 null 
hepatocytes. This demonstrates the similarity between the induced polyploidy in 
livers after partial hepactectomy and that seen in normal liver. Mice with a p21 liver 
transgene for overexpression of p21 have accelerated liver polyploidy development 
(Wu et al., 1996). In these mice, p21 complexes with cyclin Dl and cdk4 leading to 
inhibition of hepatocyte entry into S phase during postnatal growth and partial 
hepactectomy. p21 overexpression after partial hepactectomy is in agreement with 
roles for p21 in G2/M arrest, polyploidisation and terminal differentiation, similar to 
other systems.
p21 null mice are viable, with no increased cancer incidence however p21 null 
fibroblasts cannot arrest in Gl after DNA damage (Brugarolaset al., 1995, Deng et 
al., 1995). Human fibroblasts and tumour cells deficient for p21 also cannot arrest in 
Gl, these cells show p21 is involved in p53 mediated G2 arrest and coupling of DNA 
synthesis and mitosis (Brown et al., 1997; Waldman et al., 1995). In the absence of 
p21 endoreduplication often occurs. This would seem a contradiction as increased 
levels of p21 lead to endoreduplication and so does a deficiency in p21. However, 
this my be due to the role of p21 in both inhibiting CDKs and promoting their 
formation. With high levels of p21 CDKs are inhibited but without p21 their 
formation is reduced. Both situations lead to reduced CDK activity.
Several other proteins belong to the same CIP/INK family as p21 and they have 
similar roles. Perhaps some of these proteins may play a role in the polyploidy in 
ERCC1 null liver, pi6 could not be detected in rat liver and no evidence has been 
found for activation after partial hepatectomy (Awad et al., 2000; Sigal et al., 1999). 
p27 and pi8 levels are constant throughout development, pi9 expression is low in 
adults, pi5 levels are high in adults but low in embryos and p57 levels were high in 
embryos and low in adults (Awad et al., 2000). This indicates that pi5 and p57 play 
a role in liver development, perhaps pi5 is involved in the maintenance of 
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Figure 4.6 p53 immunostaining patterns for ERCC1 null and wt liver 
sections. The arrow indicates the stained nucleus.
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hepatectomy (Albrecht et al., 1998). It may be interesting to study the levels of the 
other CIP/INK family members in ERCC1 null liver.
Although there is an increase in p53 expression 
in ERCC1 null livers the phenotype is p53 
independent
It has previously been shown that p53 levels are increased in ERCC1 null 
hepatocytes (MeWhir et al., 1993). These experiments showed large increases in p53 
staining in ERCC1 null hepatocytes, however I have been unable to repeat this. 
Although some increase in p53 staining is visible this is at the level of occasional 
nuclei in a section rather than the staining of about 10% of nuclei seen previously 
(Figure 4.6). Possibly my detection is not sufficiently sensitive, but positive controls 
from UV irradiated skin showed the expected level of staining, so this seems unlikely 
(F Nunez; personal communication).
Increases in p21 levels may cause the polyploidy in ERCC1 null hepatocytes. The 
major mechanism for p21 induction is through p53. Although p53 levels may not be 
greatly increased in the ERCC1 null hepatocytes, it was of interest to see whether 
p53 was causing the p21 increase and hence the polyploidy.
In order to test this, an ERCCl-p53 double null mouse was bred from heterozygotes 
for the ERCC1 null allele and heterozygotes for a p53 null allele (Purdie et al., 
1994). The assumption was that as the ERCCl-p53 double null could not produce 
p53 in response to the enhanced DNA damage, so there would be no increase in p21 
levels and thus the accelerated polyploidy might be corrected. However, the 
ERCCl-p53 null mouse still suffers from the accelerated polyploidy, as shown by 
nuclear area measurements, and in fact, may die on average a few days earlier than 
the typical ERCC1 null mice (Nunez et al., 2000). The simple p53 null mouse does 
not have a liver phenotype. p53 null mice generally die from lymphomas before 6 
months old but appear relatively normal before then and certainly no gross liver
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Table 4.1 Percentage of small and enlarged nuclei in G2/M. Calculated 
from results of centromeric immunostaining assay. SD is Standard 
Deviation.
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abnormalities are reported (Donehower et al., 1992; Purdie et al., 1994). ERCCl-p53 
null liver also has increased p21 mRNA levels (Nunez et al., 2000). In order to 
confirm that the liver phenotype of the ERCCl-p53 double null was the same as that 
of the ERCC1 null, the cell cycle status of the hepatocytes was studied using FACS 
analysis and the centromeric staining assay. The FACS profile of ERCCl-p53 
double liver is very similar to an ERCC1 null sample and the p53 null sample is very 
similar to a wt sample (Figure 4.7). The cell cycle distribution of ERCCl-p53 
double null hepatocytes, measured using the centromeric staining assay, is very 
similar to that from ERCC1 null hepatocytes and the p53 null is very similar to wt 
(Table 4.1). This data confirms that ERCCl-p53 null liver has the same accelerated 
polyploidy phenotype as the ERCC1 null liver. This confirms that the increase in 
p21 levels in ERCC1 null hepatocytes is not caused by p53. Other models have also 
shown that p21 activation can be p53 independent (Michieli et al., 1994).
REF1 is upregulated in ERCC1 null hepatocytes
REF1/APE l/H API/APEX (apurinic/apyrimidinic endonuclease/redox effector 
factor) is an apurinic/apyrimidinic (AP) endonuclease involved in BER, a redox 
regulator of DNA binding proteins and bioreductive drugs and it binds in a complex 
to the negative response element of the parathyroid hormone gene (Evans et al., 
2000). AP sites arise naturally and are the consequence of spontaneous hydrolysis 
of the bond between base and deoxyribose sugar, of some forms of oxidative damage 
and of exogenous agents. They are also formed by the action of DNA glycosylases 
in BER. REF1 hydrolyses the phosphodiester bonds at AP sites to remove the 
damaged nucleotide from the backbone. REF1 is the major if not exclusive 
endonuclease for this purpose in mammalian cells (Friedberg, DNA repair and 
mutagenesis; Barzilay, 1996). REF1 can also rescue inactivation by cysteine 
oxidation of various transcription factors (Xanthoudakis et al., 1992; Xanthoudakis 
and Curran, 1992). A REF1 knockout is lethal and the REF1 protein is required for 
the redox-independent activation of p53 in vitro (Jayaraman et al., 1997; 
Xanthoudakis et al., 1996). REF1 is translocated to the nucleus and is upregulated in 











Figure 4.8 Typical Refl staining patterns 
for 3 week ERCC1 null and wild type liver. 
ERCC1 sample with no 1° antibody shows 
no staining. Samples side by side were 
littermates. Each sample was from a 
different animal.
ERCC1 null - no 1° antibody
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of recombinant NF-Y heterotrimeric transcription factor is stimulated by REF1 or 
DTT (Nakshatri et al., 1996). REF1 also mediates AP-1 activation after heat shock 
(Diamond et al., 1999) There is some indication that REF1 may have roles outside 
the nucleus, immunohistochemistry shows that in some populations of cell staining is 
mainly cytoplasmic however this may be just inactive REF1 in unstressed cells 
(Kakolyris et al., 1998).
I have used immunohistochemistry to examine whether REF1 levels are up regulated 
in ERCC1 null hepatocytes. REF1 might be upregulated to compensate for the DNA 
repair functions of ERCC1. All the hepatocyte nuclei display some level of REF 1 
staining, mostly in the nucleus, however it appears that the staining is significantly 
stronger in ERCC1 null liver (Figure 4.8). There appears to be no difference in the 
amount of staining between the enlarged and normal size nuclei. Western blot 
analysis has also shown that REF1 levels are increased in ERCC1 null liver (Kan-Tai 
Hsia; personal communication).
REF1 appears to have two roles, regulation of the redox state of some transcription 
factors and as an AP endonuclease. Why it is upregulated in ERCC1 null 
hepatocytes? It is highly likely that BER is upregulated in ERCC1 null liver. There 
is some overlap between BER and NER in repair of alkylation damage and recent 
evidence suggests that NER is also involved in the repair of oxidative damage. In 
fact, HPLC shows that levels of 8-oxoguanine, a major product of oxidative damage, 
are increased in ERCC1 null liver compared to wildtype (D Melton; personal 
communication; Grollman and Moriya, 1993). This is similar to an aspect of the 
phenotype of the mouse OGG1 knockout. OGG1 is the DNA glycosylase that 
repairs 8-oxoG. No histological abnormalities were detected in the livers of OGG1 
null mice, but increased levels of 8-oxoG were detected. Extracts from OGG1 null 
mice tissues cannot excise 8-oxoG but there there is significant slow removal in vivo 
from proliferating cells, this may be by MMR or NER (Klungland et al., 1999). 
However, some studies have found no influence of NER on 8-oxoG repair, this may 
be because BER is the main repair process and NER only becomes important under 
heavy load (Dianov et al., 1998).
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Figure 4.9 Typical MSH2 staining patterns for 3 week ERCC1 null and wild 
type liver. ERCC1 null sample with no 1° antibody shows no staining. 
Samples side by side were littermates. Each sample was from a different 
animal.
Chapter 4 - Changes in protein expression in ERCC1 null liver 
It is not known whether the increased levels of oxidative DNA damage in ERCC1 
null mice are caused by decreased repair due to the loss of NER or by increased 
amounts of oxidative radicals caused by the breakdown in cellular systems. ERCC1 
null liver has increased amounts of disruption to mitochondrial membranes compared 
to wt and this could allow more oxidative radicals to attack DNA. The increased 
mitochondrial disruption is probably caused by reduced production of mitochondrial 
proteins from the nucleus. However, there is no increase in levels of HO-1 
(haemoxygenase), a marker for oxidative stress, in ERCC1 null liver (Melton; 
personal communication). This indicates that there is no overall increase in oxidative 
stress in ERCC1 null liver and that REF1 levels are probably increased due its role in 
HER.
In order to confirm whether the BER pathway as a whole is upregulated, further 
study of different markers is necessary, perhaps such proteins as the DNA 
glycosylases.
MSH2 is upregulated in ERCC1 null 
hepatocytes
As discussed earlier, MSH2 is involved in MMR and recombination. I have 
investigated the levels of MSH2 in ERCC1 null hepaptocytes. MSH2 staining tends, 
like that of REF 1, to be homogenous, however more MSH2 staining is evident in 
ERCC1 null hepatocytes than in wild type (Figure 4.9). There appears to be no 
difference in staining between enlarged and normal sized nuclei. Western blot 
analysis has also shown that there are greater levels of MSH2 protein in ERCC1 null 
liver than wt liver (KT Hsia; personal communication).
Why are the levels of an MMR protein increased in ERCC1 null liver? Obviously 
ERCC 1 and MSH2 are connected in their recombination associated roles and it is 
possible that MSH2 levels are increased to compensate for the loss of ERCC 1 in this 
aspect, but the link is more probably between MSH2 and the loss of NER. MMR 
seems to have roles in the processing of both UV lesions and oxidative damage.
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Whilst NER will repair some small looped mismatches, MMR will repair some UV 
damage where the recognition system mistakenly recognises a mismatch. MMR is 
also involved in regulatory responses to DNA damage. MSH2 levels are upregulated 
in response to UV light and this upregulation is dependent on p53 and c-jun and their 
interaction (Scherer et al., 2000).
The MMR system is thought to be involved in the recognition of DNA lesions such 
as those caused by UV and then the transmission of a signal to the apoptotic 
machinery (De Weese et al., 1998; Hickman and Samson, 1999). Cancer cell lines 
from XPA null mice show reduced levels of MMR proteins such as MSH2 and 
reduced MMR activity and it is proposed that the absence of MMR proteins may 
mean that no signal is passed to the apoptotic machinery on UV damage and thus the 
cells survive longer (Ichikawa et al., 2000). Double XPA and MSH2 mutant cells 
derived from the human XP12RO cell line are not more UV sensitive than the simple 
XPA mutant (O'Driscoll et al., 1999). MSH2 and ERCC1 double mutant cells 
derived from ERCC1 mutants CHO9 43-3B show highly elevated levels of UV 
induced mutation rates compared to wild type and simple ERCC1 mutants, however 
the UV sensitivity is not greatly increased (Nara et al., 2001). However in the 
absence of MMR alone, UV-induced mutation rates are not much influenced (Tobi et 
al., 1999). This implies that in the absence of NER, MMR is required for the 
reduced mutation rates but its absence does not affect survival. MSH2-ERCC1 
double null mice die before birth with high levels of necrosis in the liver whereas 
MSH2 null mice are healthy until 2 months old when they start to suffer from a high 
frequency of lymphoid tumours and ERCC1 null mice die at 3 weeks old of liver 
failure (D Melton, personal communication; Reitmair et al., 1995; Weeda et al., 
1997).
However, MSH2, as part of MMR, also has another connection to NER. MMR 
seems to be involved in the processing of oxidative damage. The majority of 
replication associated mismatches are probably caused by mispairing with 
oxidatively damaged bases rather than mispairing with normal bases (Earley and 
Grouse, 1998). The ERCC1 null liver has increased amounts of oxidative damage
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and although the ERCC1 null hepatocytes are quiescent in terms of cell division, 
they are going through cycles of DNA synthesis as the ploidy levels increase and this 
will induce the formation of mismatches and mutations. Consistent with the 
involvement of MMR in this process, synergistic mutator effects were observed 
when OGG1 and MSH6 were simultaneously eliminated from yeast cells and 
purified MSH2-MSH6 strongly binds to oligonucleotides containing mismatches of 
SoxoG with either A or C (Ni et al., 1999). Presumably the increased oxidative 
damage in the ERCC1 null hepatocytes is causing increased mismatches and general 
damage and MSH2 is overexpressed to deal with this. This sharing of substrates will 
contribute to the overexpression of MSH2.
c-FOS
c-FOS and c-JUN are members of a multigene family implicated in a number of 
stress induced signal transduction cascades. They associate in homo or hetero dimers 
to form the transcription factor API. API may regulate expression of downstream 
target genes in cellular responses to oxidative stress. Regulation of API probably 
depends on the redox state of the cell. Both c-FOS and c-JUN have a conserved 
cysteine located in the DNA binding domain. These will only allow DNA binding in 
the sulphydryl state, so these cysteines act as a switch depending on the redox state 
of the cell. REF1 regulates the redox state of these cysteines. Both c-FOS and c- 
JUN are induced following heat shock (shown to cause increased oxidative stress 
levels), the API DNA binding activity also increases, however this increase is 
prevented by the immunodepletion of REF1 from extracts. Levels of c-FOS might 
be increased if ERCC1 null liver has increased levels of oxidative DNA damage. 
Western blot analysis may show that c-FOS is upregulated in ERCC1 null liver (KT 
Hsia; personal communication). However, I have been unable to confirm this by 
immunohistochemistry. I have shown staining of c-FOS in both ERCC1 null and wt 
but no difference in intensity could be detected.
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PCNA
PCNA (Proliferating Cell Nuclear Antigen) is involved in DNA synthesis where it 
acts as a processivity factor. Although PCNA upregulation in ERCC1 null liver has 
been observed by Western, I have been unable to confirm an increase in PCNA 
levels by immunohistochemistry. I have shown strong nuclear staining of PCNA in 
both formalin and methacarn fixed samples, but no difference in intensity of staining 
is seen between ERCC1 null and wt samples.
CDC2
CDC2 is an essential cell cycle regulator in all eukaryotes. In mammalian cells 
CDC2, in a complex with cyclin B, is essential for the G2-M phase transition. In 
yeast, CDC2 complexes with different cyclins to control entry to S-phase and 
mitosis. After IR, changes in CDC2 activity in human diploid cells have been found 
and this is associated with altered phosphorylation activity. CDC2 mRNA and 
protein levels are also found to be down regulated by ionising radiation in a p53- 
dependent, p21-dependent manner. As CDC2 is important in regulation of the G2-M 
transition in mammalian cells and ERCC1 null hepatocytes are arrested in G2 it was 
decided to investigate levels of CDC2 protein in the ERCC1 null hepatocytes using 
immunohistochemistry. However, although nuclear CDC2 was detected in 
hepatocytes, no change was observed between ERCC1 null and wt hepatocytes.
Future Work
14-3-3 a is a protein that is involved, similarly to p21, in the response downstream of 
p53 activation (Hermeking et al., 1997). 14-3-3a is also induced by various forms of 
DNA damage. The exogenous expression of 14-3-3a results in a G2 arrest similar to 
that seen in irradiated cells, however it is followed by polyploidy. 14-3-3 a 
sequesters cyclinB-cdc2 complexes in the cytoplasm during a DNA damage induced 
G2 arrest, this is a complementary role to p21 which inactivates cdc2-cyclinB in the
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nucleus. Cells lacking both p21 and 14-3-3cr are significantly more sensitive to 
DNA damage or exogenous p53 than cells deficient in either p21 or 14-3-3a, this 
implies that p21 and 14-3-3a have complementary roles in the G2/M checkpoints. 
Cells lacking 14-3-3 a can arrest in Gl but cannot maintain a stable G2 arrest after 
adriamycin treatment. The above work shows the close connection between p21 and 
14-3-3a in the mechanics of G2 arrest, it is highly likely that 14-3-3a is upregulated 
in the ERCCl null hepatocytes. It would be interesting to test this. However, at 
present only mouse derived antibodies are commercially available for 14-3-3a, 
introducing technical challenges.
Discussion
Although immunohistochemistry does allow the pinpointing of increases in protein 
levels to individual cells there are some disadvantages to the technique. One of these 
is the "edge effect", when sections are stained more staining is apparent at the edges 
of the section than in the centre. Presumably this is due to antibody and reagents 
diffusing into the section more easily at the edge, although it is difficult to see how 
this could work given the fact that the sections are essentially two dimensional 
anyway. In general this is no great disadvantage because it does not extend more 
than a few cell widths from the edge of the section, however in my experiments it 
must be considered. The comparison of the wild type and ERCCl null samples relies 
on them both staining to the same degree. The wild type livers because they are 
much bigger obviously result in bigger sections and so it is always easily possible to 
find an area well away from the edge of the section, however the ERCCl null 
sections are much smaller because the livers they are taken from are much smaller. 
This means that it is much harder to find areas well away from the edge of the 
section. Could this mean that some of the areas taken have been close enough to the 
edge to have the staining increased artifactually? It is possible, but I have been 
careful to always select areas well enough away from the edges not to have the 
staining increased by the edge effect.
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Another disadvantage to immunohistochemistry is that staining is often 
heterogeneous in nature. To combat this sections have only been measured when the 
staining is reasonably homogeneous.
Whilst immunohistochemistry is ideally suited to quantifying large increases in 
protein levels in particular nuclei as is seen in p21 staining, and in fact in this case is 
probably more useful than Western analysis, it is not very useful where there is an 
increase in the amount of protein across all of the nuclei, which is only detectable in 
the case of a large increase.
The question I am really trying to ask in the latter part of this chapter is what 
pathways in the hepatocyte change when ERCC1 is not functional? I have tried to 
address this by examining the levels of various proteins, hoping to use them as some 
sort of indicator for the relative activities of various pathways. However, it is very 
difficult to do this for DNA repair. The sheer interconnectivity of all of the pathways 
means that often, as with MSH2 and REF1, the most interesting proteins are those 
which are involved in more than one pathway. Despite the difficulties of trying to 
use individual protein levels as markers, I believe it is probably one of the best ways. 
Other possible methods might be to perhaps use protein extracts to measure the 
levels of in vitro repair using an artificial substrate. Or to examine the levels of DNA 
damage directly by HPLC, however this bears the disadvantage of not knowing are 
the increased or decreased levels of damage compared to wt because of changes in 
damage caused or changes in the level of the repair process, and because repair 
substrates overlap between pathways, which pathway is repairing the damage? All 
of these methods suffer from disadvantages and perhaps only by using them all can 
we gain a clear picture of what is really going on in the ERCC1 null liver.
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Chapter Summary and Background
Cells that progress through S phase and into mitosis with unrepaired UV lesions can 
form chromosome aberrations that are visible in condensed metaphase chromosomes. 
ERCC1 and XPF null cells have a higher ratio of breaks to exchanges than wt and 
other NER null cells.
Introduction
DNA damaging agents promote the formation of chromosome aberrations, which can 
be seen by examination of stained metaphase chromosomes, i.e. after chromosome 
condensation and before separation (Evans, 1962).
Chromosome aberrations take the form of a variety of different structures. There are 
various ways to assign these to different classes and there is some debate over which 
class certain aberrations fall into. Structures can be first classified by whether they 
are chromosome or chromatid-type aberrations depending on whether they involve 
both chromatids of a chromosome, in which case they are called chromosome type 
aberrations, or involve just one chromatid, where they are known as chromatid type 
aberrations.
S independent agents, like IR and a few chemical agents (eg. bleomycin and 
neocarzinostatin), can cause aberrations when cells are treated at any stage of the cell 
cycle. They induce chromosome type aberrations when cells are treated in Gl phase 
and chromatid-type in cells treated in S or G2. S dependent agents like UV, can 
cause aberrations only when cells are treated and allowed to proceed through S 
phase. They cause chromatid type aberrations after Gl or early S phase treatment.
Both chromosome-type and chromatid-type aberrations can be further subdivided 
into breaks (which result in an acentric fragment) and exchanges (the rearrangement 
of chromatids or chromosomes). A break can be defined as: the apparent complete 
severance of a chromatid (Savage, 1990). Exchanges can be either complete, where
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all of the ends are joined, or incomplete where 2 or more ends remain unjoined. An
exchange can be defined as: any aberration resulting from the interaction of two or 
more lesions, and includes interchanges (different chromosomes) and intrachanges 
(same chromosomes) (Savage, 1990).
Chromosome aberrations visible with crystal violet staining are only part of the 
spectrum of chromosome rearrangements. For instance, events like inversions are 
only seen where they occur across a centromere and so affect the length of 
chromosome arms. The chromosome aberrations studied here are primary 
aberrations, formed in the first S phase after DNA damage. Some primary 
aberrations will result in structures which cannot be separated by the cell, resulting in 
terminal arrest. However, aberrations which progress successfully through to the 
next stage of the cell cycle are often changed into secondary aberrations, which are 
stable enough to be transmitted through the generations.
Formation of Chromosome Aberrations
There are two theories to explain the formation of chromosome aberrations, the 
breakage-reunion theory and the exchange theory. The breakage reunion theory 
states that all exchanges are formed from a primary break in the chromosome and 
that whether intrachanges, interchanges or no exchanges are seen depends on how 
breaks rejoin, i.e. 4 ends from two breaks can rejoin to form no aberration (original 
partner ends), an exchange where the ends are rejoined with the wrong end, or a 
break can form where no rejoining occurs. The exchange theory proposes that 
exchanges are formed from a primary lesion which is not a break, these lesions 
interact to form exchanges and all breaks are the result of incomplete exchanges. 
These two models are still current. Recent data comes out in support of the breakage 
reunion theory; using model predictions, breakage reunion fits best with observed 
patterns (Sachs et al., 2000). However, indirect evidence suggests that DSBs are the 
ultimate lesion involved in aberration formation (Natarajan and Zwanenburg, 1980). 
The formation of exchanges relies on lesions on both interacting chromosomes, as
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shown by nuclear fusion experiments with non-irradiated and irradiated HeLa cells
(Cornforth, 1989).
It is possible that both the breakage-reunion and exchange theories are correct to 
some degree depending on the original lesion. As these two models are largely based 
on data from IR studies, they may not be entirely applicable to UV induced 
chromosome aberrations. UV lesions tend to not cause strand breaks, at least 
directly, thus one would think that they cause lesions according to the exchange 
theory (Savage, 1976). However, there is evidence that the breakage-reunion theory 
applies. After treatment with wormiannin, an inhibitor of DNA-PK, in G2, the 
number of breakage type aberrations was enhanced whereas the yield of chromatid 
type exchanges was almost completely suppressed (Ishii and Ikushima, 1999). 
DNA-PK is crucial for the NHEJ pathway of DSB repair. This indicates that NHEJ 
is crucial in the formation of exchanges. They suggest that in the presence of 
wortmannin, NHEJ or another DNA-PK dependent pathway, cannot function and 
exchange formation is inhibited leaving more breaks to go through to metaphase. 
Other inhibitors of DNA synthesis and repair used in G2 will also potentiate S- 
dependent agent induced chromosome aberrations (Palitti et al., 1983). Perhaps there 
are multiple routes to form chromosome aberrations, this might explain how NHEJ 
genes and NER genes could be both involved in aberration formation. Possibly the 
exchange theory reflects the repair of DSGs, whereas the breakage-reunion theory 
reflects the repair of DSBs that form from some DSGs.
Recent evidence suggests that CPD lesions in active genes are important in triggering 
the formation of aberrations (De Santis et al., 2000). CSB null CHO cells suffer a 
high frequency of aberrations even at low doses of UV. This is despite the fact that 
wt hamster cells display little or no repair of CPDs outside active genes. Wt hamster 
cells would be expected to have large numbers of CPD lesions during S phase but 
these do not trigger high levels of aberrations. However, in wt cells CPDs are 
repaired well in active genes. In CSB cells this repair does not happen and high 
levels of chromosome aberrations are seen.
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Chromosome Aberrations in NER Deficient Cells
The frequency of S phase dependent chromosome exchanges induced by UV light is 
dramatically reduced in ERCCl null cells when compared to the frequency of breaks 
(Melton et al., 1998). In wt hamster cells there were 6.15 exchanges/breaks and in 
ERCCl def. hamster cells there were 0.36 exchanges/breaks. This implies that 
ERCCl has some role in the formation of chromosome exchanges. Is this due to the 
lack of NER function in ERCCl null cells or due to the loss of the role of ERCCl in 
recombinational pathways? In order to test this the ratio of exchanges to breaks has 
been studied in ERCCl, XPF, XPD, XPB and XPG def. cell lines. If, as expected, 
the reduction in the rate of exchanges is due to the loss of a recombinational function 
of ERCCl-XPF, then the rate of exchanges should be reduced in ERCCl and XPF 
def. cells, but the same as wt in XPD, XPB and XPG def cells.
In order to induce aberrations, unsynchronised cultures were UV irradiated and 
allowed to grow for a sufficient time so that cells that were in Gl when irradiated 
might progress through S phase to metaphase. Then chromosome spreads were 
prepared. In all experiments spreads were prepared at three different time points 
after UV. This is necessary, both in order to ensure a large number of cells are 
caught at metaphase, and because use of just one fixation point may select for cells 
that were at one particular part of Gl during irradiation and this could prejudice the 
results.
Obviously the higher the number of UV lesions in a cell, the higher the number of 
chromosome aberrations that might be expected to form. It was decided to irradiate 
cultures with equitoxic doses rather than equal doses because otherwise the number 
of aberrations seen in the highly UV sensitive mutants would be extremely high and 
the number seen in wt and less UV sensitive mutants would be very low. This would 
make it very difficult to make a real comparison between the different cell lines. In 
order to make a true comparison between the different cell lines the effective damage 
must be the same for all of them. Using equitoxic doses should ensure that a wt and 
mutant line have the same effective amount of damage. Although the damage 


















Figure 5.1 UV survival curves for NER def. and wt cell lines. Cultures were plated 
at calculated densities, allowed to rest overnight and then UV irradiated at a 
selection of doses. After about 4 days growth the zero UV plate reached confluence. 
Cells were then dyed with Crystal Violet, the dye was extracted and OD575 nm 
values were compared to the zero UV sample to calculate % survival. Survival 
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repair the damage at a much greater rate than the mutant, so that by the time the
aberrations are formed the amount of damage should be equal in each cell line.
Initially, UV survival curves were used to calculate the dose at which about 30% of 
the cells were still able to grow (Figure 5.1). All of the NER mutants except XPG 
were very sensitive to UV. Trial experiments were then used to find a dose at which 
about two thirds of cells had aberrations, although as aberration formation is random, 
some cells had many events where others had none. The source was roughly 
calibrated by comparing published survival curves with those obtained in our 
laboratory. The doses given should be relatively consistent through the experiments 
but comparisons with published work are difficult. There will be some error in dose 
across these experiments as the UV emission of the bulb varies over time. 
Fortunately the real basis for equitoxicity in these experiments is that the number of 
aberrations per cell is about the same across all cell lines, if this is so, as can be seen 
in Table 5.1, then the doses may be assumed to be equitoxic. In order to study cell 
lines where the ratio of exchanges to breaks changes, it is probably best to compare 
the total aberrations per cell rather than just exchanges or breaks.
As can be seen in Table 5.1, there is only a rough correspondence, between the 
percentage survival and the number of aberrations per cell at the UV dose, for each 
cell line. It might be expected that the lower the survival, the greater the number of 
aberrations, however, for instance UV5 has a particularly low survival but no more 
aberrations than UV41 which has a greater survival at the given dose. An 
explanation for this might be that the survival curves are not particularly accurate 
especially for the highly UV sensitive cell lines. Where the curve is steep, a small 
difference in dose can make a large difference in the calculated survival, and so 
errors in the curves are amplified. The survival curves were only used to calculate a 
rough starting dose for trial experiments on each cell line so these errors are not of 
concern. There may be a further discrepancy due to the fact that survival curves are 
calculated from the fraction of cells still growing about 5 days after UV treatment, 
whereas the chromosome aberrations are studied only 24 hours after UV. The errors
139
breaks






Figure 5.2 Pictures and Diagrams of typical UV-induced 
chromosome aberrations. Cells were UV irradiated, allowed to 
proceed to metaphase and chromosome spreads were prepared 
and stained with Crystal Violet. Pictures were acquired at 
400times magnification using a ccd camera.
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in survival curves may possibly affect the interpretation of the experiments and mean
it is possible that they do not reflect the true situation. When comparing the rate of 
aberrations I have summed the rate of breaks and exchanges to calculate a total rate 
of aberrations. This may be flawed if these aberrations are produced by unconnected 
processes and changes in one do not affect and reflect changes in the other.
There is a theory that proposes that the rate of exchanges and breaks changes in a 
different fashion with increasing dose (Sachs et al, 2000). This is based on IR data 
that shows that the rate of breaks increases linearly with increasing dose and that the 
yield is unaffected by altering the dose rate or by splitting the dose into two different 
doses. The data also shows that the rate of exchanges increases in proportion to the 
square of the dose, provided the doses are given in the same relatively short period of 
time. This fits with the idea that breaks (one hit aberrations) are caused by one lesion 
and exchanges (two hit aberrations) are caused by two lesions. This implies that the 
ratio of breaks and exchanges would alter quite naturally with increasing dose. The 
theory predicts that a higher dose would give a greater increase in the number of 
exchanges than the increase in the number of breaks.
This data and the corresponding theory should not affect my analysis, because the 
UV doses given to the different mutants are equitoxic and because the UV doses are 
given over minutes rather than the hours that are relevant to the IR based theory and 
to the repair process. If the theory was affecting these experiments than as the 
number of exchanges increases with a higher effective rate of irradiation and the 
433B line is subjected to an effective higher rate than its parental line, CHO9, so it 
should have more exchanges, which is the reverse of what is observed.
Scoring of Chromosome Aberrations
Aberrations have been scored using five different classes: breaks, interchanges, 
intrachanges, incomplete interchanges and incomplete intrachanges (Figure 5.2). 
Incomplete structures have been recorded separately from the complete exchanges 
and the "breaks" in the incomplete exchanges in a separate class from normal breaks.
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There is some controversy over what exactly constitutes a break for scoring 
purposes. A reasonable consensus is that a break exists where a space between two 
stained ends can be seen in a chromatid and the two ends are misaligned. Otherwise 
the space between the ends is classified as a gap. This controversy exists because it is 
thought that some spaces, i.e. gaps, are merely where chromosome decondensation 
has occurred and are not really breaks in the DNA strand. Obviously using the 
classification above, some breaks will be classified as gaps and not scored, but as 
long as the classification is consistent for all these experiments it should not affect 
the results.
For the purposes of analysis aberrations have been divided into two classes: all the 
exchanges and all the breaks. Breaks from incomplete exchanges have been included 
with breaks, as it is not, in reality, possible to tell which breaks are derived from 
incomplete exchanges and which are not. Although some publications use more 
detailed scoring systems, many simply score into either breaks or exchanges (De 
Santisetal.,2001).
One of the problems of studying chromosome aberrations is that scoring by its 
essence is subjective and this can bias results. Even with a rigorous selection of 
good metaphases and a scoring criteria there is still the possibility of bias. It is 
sometimes recommended that two independent investigators score experiments and 
then collate the results, however this has not been possible here. To try and combat 
possible bias, some experiments have been blind scored, these gave similar results to 
those which were not blind scored and this is a reasonable confirmation that any 
systematic bias is not too extreme and should not affect these results.
For each cell line, a zero UV control was scored for about 50 metaphases. All of the 
non-irradiated cell lines had only one or two aberrations in the 50 metaphases 































































Table 5.2 Ratio of total exchanges to total breaks for UV-induced 
chromosome aberrations using various wt and NER def. cell lines. One 
experiment was blind scored for AA8 and UV41 cell lines. Results for AA8 
and UV41 are given as total results (blind and normal summed), blind 
scored and normal.
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ERCC1 def. cells have a higher ratio of breaks 
to exchanges than wt
An ERCC1 def. cell line shows a lower ratio of exchanges to breaks than a wild type 
cell line (Melton et al., 1998). So for every exchange event more breaks will be seen 
in the ERCC1 def. cells than in wt cells. If this effect is due to the loss of NER then 
it would be expected that other NER deficient cell lines would display the same 
effect. However, if the effect is due to the loss of the roles of ERCC1-XPF outside 
NER then it would be expected that other NER deficient cell lines would have the 
same ratio as wt.
In order to test the experimental method and method of scoring, it was decided to 
repeat published work studying the ERCC1 null 433B cell line and its wt parent 
CHO9 (Melton et al., 1998). The results suggest that the ERCC1 def. cell line has a 
ratio of 0.43 exchanges to breaks as compared to 1.57 for the wt parent (Table 5.2). 
This confirms the previous work and validates my method. However, the new data 
only shows a 3 fold difference between wt and ERCC1 null rather than the published 
10 fold difference. This is probably due to different scoring methods. However, 
even a 3 fold difference between wt and ERCC1 def. is enough to merit investigation 
of other NER genes.
Although both new and published data was obtained using the same cell lines the
f\
doses used are rather different. In the published experiments 6.5J/m were used for 
the wt line and 1.5 J/m2 for the ERCC1 def. line, whereas my experiments used 12 
and 3 J/m2 respectively. This is surprising and may reflect the lack of a calibrated 
UV source in these experiments.
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XPF def. cells have a higher ratio of breaks to 
exchanges than wt
After confirmation of the ERCCl result it was decided to investigate an XPF def. cell 
line. This cell line and the XPD, XPB and XPG def. cell lines are derived from the 
wt AA8 parent rather than CHO9 and so AA8 has been used as the wt control. Both 
parental lines are derived from CHO cells and so the results should be relatively 
comparable, however because there may be unknown differences between the 
parents, the results have initially been analysed separately.
The experiment was repeated twice for the XPF def. cells and one of the experiments 
was scored blind in order to test whether there was any systematic bias in the scoring 
used. The wt cell line was tested in the same experiments, using blind scoring. The 
wt cell line had a ratio of 1.27 exchanges to breaks whereas the XPD def. cell line 
had a ratio of only 0.60, i.e. a greater than 2 fold difference (Table 5.2). The XPD 
def. cell line has a lower ratio of exchanges to breaks than the wt cell line, a similar 
result to that observed for ERCCl def. cells.
The studies on ERCCl and XPF def. cells confirm the work of Melton at al. (Melton 
et al., 1998). That is, the ratios of exchanges to breaks are higher in wt than in 
ERCCl and XPF def. cells. This implies that ERCCl-XPF has some role in the 
formation of either breaks or exchanges, or both. Loss of ERCCl-XPF may promote 
the formation of breaks and/or inhibit the formation of exchanges. Obviously if the 
formation of breaks and exchanges is explicitly connected then changing one would 
naturally effect the other.
XPD, XPB and XPG def. cells have the same 
ratio of breaks to exchanges as wt
To test whether ERCCl-XPF is involved in aberration formation via its role in NER 
or its role in recombination, cell lines def. for XPD, XPB and XPG were tested. Two
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experiments were performed for the XPD def. cell line and one each for the XPB and
XPG cell lines. The ratios of exchanges to breaks are 1.19, 1.67 and 1.63 for the 
XPD, XPB and XPG def. cell lines respectively, these are close to the 1.27 ratio seen 
in wt cells. This shows that simple NER defective cell lines have about the same 
ratio of exchanges to breaks as wt.
Analysis of Results and Conclusions
By inspection there appears to be quite a difference in the ratio of exchanges to 
breaks between the wt (AA8) and XPF def. (UV41) cell lines and statistical testing 
confirms this. Using a T-test a significant difference was found between wt (AA8) 
and XPF def. (UV41) (p=0.034, 95% confidence interval -0.245 to 1.575). The 
nature of these experiments makes effective simple statistical testing difficult. 
Although over a hundred metaphases have been studied for each experiment, only a 
few independent experiments have been performed due to time limitations and this 
means it is difficult to show strong statistical significance.
The XPD, XPB and XPG def. cell lines all show very similar ratios of exchanges and 
breaks when compared to wt (AA8). The data was pooled for the simple NER def. 
cell lines and T-testing shows no significant difference from wt (p=0.38, 95% 
confidence interval -0.631 to 0.32). However a strongly statistically significant 
difference was found between the simple NER def. cell lines and the XPF def. cell 
line (p=0.0048, 95% confidence interval 0.38 to 1.259).
If the results for the XPF def. (UV41) and ERCCl def. (433B) cell lines are collated 
and compared to the other NER def. cell lines a strong statistical difference is seen 
(p=0.02, 95% confidence interval 0.47 to 1.285).
This work has shown that an XPF and an ERCCl def. cell line have a lower ratio of 
exchanges to breaks than simple NER def. cell lines and a wt cell line. This indicates 
that the reduction in the exchange over break ratio is due to the roles of ERCCl-XPF 
outside NER. What are the possible mechanisms by which ERCCl-XPF might be
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involved in the formation of chromosome aberrations? Evidence indicates that
ERCC1 is involved in the removal of non-homologous tails in SSA and homologous 
recombination. It may also be involved in the cleavage of ICL. So how is the loss of 
these roles likely to affect chromosome aberration formation? UV induced 
chromosome aberrations probably form when unrepaired damage is present during 
DNA replication in S phase. Replication past damage will result in a DSG opposite 
the damage and to repair these, or the DSBs formed from them, without error, may 
involve a recombinational event. Normally and ideally DSGs will be repaired by 
recombination using the sister chromatid as a template, failure of this could result in 
a break. This recombinational repair is analogous to NER in that it uses the 
information from the original complementary strand before replication for repair. 
The roles of ERCC1-XPF seem to be in processing non-homologous ends during 
recombination, and there should be no need for this in recombination between 
entirely homologous sister chromatids. Exchanges are probably formed when a 
partially homologous region of a non-homologous chromosome is used incorrectly to 
repair a DSG. ERCC1-XPF may be required for the processing of non-homologous 
ends formed in these recombination intermediates. The absence of ERCC1-XPF 
may mean that these intermediates cannot be processed and so a break is created. 
This would explain why ERCC1-XPF null cells have a higher ratio of breaks to 
exchanges than wt. Alternatively, perhaps breaks form at replication forks and SSA 
can sometime be used to repair these. If 4 ends rejoin incorrectly, using SSA to form 
an exchange, then ERCC1-XPF would be required to process the 3'ends. In the 
absence of ERCC1, SSA will fail and the breaks will not be repaired.
As mentioned earlier there is a possibility that the changed ratio of exchanges and 
breaks varies merely with the amount of UV, and has nothing to do with genotype. 
However this is extremely unlikely when the doses that I have used are considered. 
The dose for the XPF def. cell line falls between those for the wt AA8 line and the 
XPB and XPD def. cell lines, if the ratio of events changed merely with dose then 
one would expect there to be a trend however the XPF cell line has clearly different 
results to those found for the wt and XPB cell line.
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The formation of chromosome aberrations has been studied previously using NER
def. cell lines. Although there are no studies involving multiple NER def. cell lines 
there are various studies with one deficient line and a wt control and it is necessary to 
consider my results in light of these. Published work has seen an increased number 
of UV induced chromosomal aberrations in UV61; a CSB deficient cell line 
(defective in TCR) compared to wt (De Santis et al., 2001). A summation of their 
data across all doses shows 27 breaks and 11 exchanges for the AA8 wt cell line and 
146 breaks and 123 exchanges for the UV61. Other work provides data on 
chromosome aberrations in wt cells alone (Palitti et al., 1983). It shows 18 breaks 
and 2 exchanges studying UV induced chromosome aberrations in a CHO cell line. 
The induction of chromosomal aberrations has also been previously studied in the 
433B cell line (Darroudi and Natarajan, 1985). The results show that 433B cells 
have a higher (about 4 times) incidence of spontaneous chromosome aberrations and 
this is mainly due to breaks. It is difficult to say whether the above results contradict 
or support these current results. Scoring methods and hence results differ between 
researchers and so it is difficult to compare separate experiments. There have been 
no studies published with a comparison across several cell lines and without this, it is 
difficult to compare my work with others.
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Chapter Summary and Background
Cell cycle arrest can occur at various points after DNA damage. In order to study 
this in ERCC1 and other NER def. cell lines it was decided to examine how the level 
of replicative DNA synthesis changes after DNA damage in S phase. These 
experiments were prompted by results which indicated a possible difference between 
the UV response of ERCC1 def. 433B cells, XPD def. UV5 cells and wt (AA8 and 
CHO9) cells (F. Nunez, 1999). The response of 433B and UV5 cells to treatment 
with UV and MMC in S phase has been examined by using the incorporation of 
tritiated thymidine as a measure of DNA synthesis. MMC is a bifunctional DNA 
alkylating agent that causes DNA adducts, DNA intrastrand crosslinks and DNA 
interstrand links. Although the interstrand crosslinks form a small proportion of the 
overall damage, they have the largest effect on the cell. One unrepaired interstrand 
crosslink can be enough to arrest the cell cycle.
Introduction - UV induced arrest of DNA 
replication
In order for a cell to progress through the cell cycle it must pass various checkpoints, 
these ensure that the cell is in a suitable condition to proceed. There are 4 main sets 
of checkpoints: those at the Gl to S phase transition, those within S phase, at the G2 
to M transition and within M phase. Several of the checkpoints respond to DNA 
damage. If a cell has large amounts of DNA damage it will not proceed into S phase. 
DNA damage will also delay the completion of S phase and the transition from G2 
into M phase.
Enlarged ERCC1 null hepatocytes arrest in G2, this indicates that they bypass the 
normal Gl/S DNA damage checkpoint and that there maybe altered cell cycle 
regulation in ERCC1 null cells. This altered regulation maybe due to special 
characteristics of hepatocytes but may also be due directly to the ERCC1 deficiency.
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This makes it interesting to study the response to DNA damage in the 433B (ERCC1
def.) cell line.
Previously published work using the tritiated thymidine incorporation assay has 
detected no unexpected features of the response of DNA replication in 433B 
(ERCC1 def.) and CHO9 (wt) cells to DNA damage in S phase (Wood et al., 1982). 
However, possible abnormalities in the response of 433B cells have been recently
_ s*
detected (F Nunez, 1999). Two assays were used one at a low dose (10 J/m ) and
-^
one at a higher dose (20 J/m ). The low dose assay relied on the enzyme DenV, 
which cuts the damaged strand of DNA at thymidine dimer sites. By using 
radioactive labelling of replicating DNA by nucleotide incorporation, it is possible to 
differentiate replicating DNA from the bulk DNA. Samples from irradiated cells at 
various time points after irradiation were digested with DenV and electrophoresed on 
an alkaline gel. The size of the tail that is produced from digested nuclei gives an 
indication of the amount of digestion. This gives a measure of the number of 
thymidine dimers by the number of enzyme sensitive sites. This assay showed poor 
removal of dimers after UV in both ERCC1 def. and wt cells. DenV will also cut at 
thymidine dimers opposite DSGs leading to a DSB, which can be detected using 
AFIGE (Asymmetric Field Inversion Gel Electrophoresis). The rationale was that 
DSGs would be formed where a replication fork stalls at damage and this gives a 
measure of replication arrest. This relies on the proportion of DSGs that form DSBs 
being stable whatever the dose or genotype.
The results of this assay were interpreted as indicating that there was very little arrest 
of DNA replication after UV as the numbers of DSBs decreased rapidly in both wt 
and ERCC1 def.. However this assay is not really measuring arrest of replication 
directly, merely an after effect of the stalling of replication. The number of DSBs 
formed reflects the kinetics of formation and survival of the DSGs, not directly the 
arrest or stalling of replication forks. This makes the experiments very hard to 
interpret. The more complex an experiment is, as is the DenV AFIGE assay, the 
more assumptions must be made to interpret the results, and the more assumptions 








Figure 6.1 Incorporation of Hthymidine after UV during S phase.
Cells were synchronised in GO, released and allowed to proceed
into S phase. They were then given a dose of 10 J/m2 of UV.
15 minute pulses of tritiated thymidine were used to assay for DNA
synthesis. Points are plotted as a percentage relative to a
non-irradiated sample. Each curve is the mean of at least 3 experiments.
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Figure 6.2 Incorporation of H-thymidine after UV during S phase 
(F Nunez, 1999). Cells were synchronised in GO, released 
and allowed to proceed into S phase. They were then given a dose of 
20 J/m2 of UV. 1 5 minute pulses of tritiated thymidine were used to 
assay for DMA synthesis. Points are plotted as a percentage relative 
to a non-irradiated sample.
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interpretation of the experiments will be wrong. The AFIGE assay also indicated
that the ERCC1 def. cells might possibly arrest for a shorter time than wt after DNA 
damage.
On the basis of the above experiments, and their original interpretation, further 
experiments were performed using a simpler assay and a higher dose (F Nunez, 
1999). Cells were arrested in Gl using isoleucine deprivation, released from arrest 
and allowed to proceed in synchrony into S phase. S phase cells were UV irradiated 
and then the level of DNA synthesis was measured at various time points after 
irradiation, by using pulses of tritiated thymidine. The incorporation in the UV 
irradiated samples was taken as a percentage of incorporation in unirradiated cells to 
study the effect of the irradiation. These experiments showed a terminal arrest of 
replication in the ERCC1 def. cells and a nearly terminal arrest of wt cells. This 
appeared to contradict the results of the DenV assays, which appeared to show very 
little arrest of replication as measured by DSB formation. Although the thymidine 
assay used a higher dose than the DenV assay, it seems unlikely that little arrest
r\ ry
occurs at 10 J/m and yet both genotypes are arrested at 20 J/m .
ERCC1 deficient cells arrest DNA replication at 
low doses
In order to try and resolve the difference between the results of the two assays, I 
investigated the arrest of 433B (ERCC1 def.) and CHO9 (wt) cells using the 
thymidine incorporation assay at the low dose originally used with the DenV assay 
(Figure 6.1). The percentage incorporation of thymidine in 433B (ERCC1 def.) cells 
compared to unirradiated controls falls to around 30% by 4 hrs after irradiation and 
does not recover by 10 hours. The percentage incorporation of thymidine in CHO9 
(wt) cells compared to unirradiated controls falls to around 75% by 4 hours and 
recovers to 100% by 7 hours. This can be compared to the results of F Nunez 
(Figure 6.2). Measurements at 0 hrs after irradiation do not show 100% 
incorporation because incorporation is detected over 15 minute pulses, so arrest has 
some time to take effect. These results show that 433B (ERCC1 def.) cells do arrest
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DNA replication at low doses of 10 J/m and suggests that the results from and 





wt (CHO9) - 0.05 jig/ml 
wt (CHO9) - 2.5 ng/ml 
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Figure 6.3 Incorporation of Hthymidine after Mitomycin C during S phase. 
Cells were synchronised in GO, released and allowed to proceed 
into S phase. They were then given a dose of either 2.5 or 0.05 jig/ml of 
Mitomycin C. 15 minute pulses of tritiated thymidine were used to assay 
for DMA synthesis. Points are plotted as a percentage relative to a 
non-irradiated sample. Each curve is the mean of 2 experiments. Error 



















XPD def. (UV5) - 2.5 ng/ml 
wt (AA8) - 2.5 |ig/ml
0 8
Time/hrs
Figure 6.4 Incorporation of H-thymidine after Mitomycin C treatment 
during S phase. Cells were synchronised in GO, released and allowed 
to proceed into S phase. They were then given a dose of 2.5 n,g/ml 
of Mitomycin C. 15 minute pulses of tritiated thymidine were used to 
assay for DNA synthesis. Points are plotted as a percentage relative 
to an untreated sample.
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Introduction - MMC induced arrest of DNA 
replication
ERCCl deficient cells are hypersensitive to ICL agents and ERCCl is involved in 
the repair of this type of damage. The thymidine incorporation assay has been used 
to study the responses of ERCCl def. and XPD def. cells to ICL damage in order to 
see if arrest of DNA synthesis occurred in the same way in an ERCCl mutant and 
another NER mutant. This assay also allows the investigation of the dose of 
crosslinking agent required for arrest in S phase. It is known that cells treated with 
low doses of ICL agents arrest in G2, however it was interesting to investigate the 
question of whether cells would arrest in S phase and what dose would be required 
relative to that needed for arrest in G2.
ERCC1 and XPD def. cells show replication 
arrest after DNA crosslinking treatment only at 
extremely high cell killing doses
Two doses of MMC were used for these experiments, 0.05 and 2.5 ug/ml (Figure 
6.3, Figure 6.4). There is no clear reduction in thymidine incorporation after MMC 
treatment except in 433B (ERCCl def.) cells and UV5 (XPD def.) cells, where 
incorporation reduces to about 60% by 4 and 2 hours respectively, after treatment 
with 2.5 (ag/ml. This is unexpected if compared to the amount of MMC required to 
kill these cells. The D50 (dose required for 50% survival) for MMC was 0.325 
fag/ml for CHO9 (wt) and 0.0075 jig/ml for 433B (ERCCl def.) (Melton et al., 
1998). The dose required to significantly arrest replication is 300 times greater than 
that required to kill half the cells. XPD def. (UV5) cells have a sensitivity to MMC 
between those of 433B and CHO9. It is unexpected that XPD and ERCCl def. cells 
both arrest replication to about the same degree after the same dose of MMC, even 
though ERCCl def. cells are much more sensitive to MMC than XPD def. cells.
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Discussion
These results show that a far greater dose of MMC is required to arrest cells in S 
phase than to kill them and this dose is the same for hypersensitive ERCC1 def. cells 
and less sensitive XPD def. cells, ie. the response is not affected by ERCC1 
deficiency. Perhaps the main process of repair occurs after S phase as there is no 
sensitive checkpoint in S phase to allow repair of ICL. Published data suggests that 
ERCC1-XPF is probably involved the repair of DNA interstrand crosslinks, but the 
other NER genes, including XPD, are not.
Vastly higher doses of ICL agents are required to arrest cells in S-phase than to kill 
cells. It only requires one unrepaired ICL to kill a cell, but it seems that many ICL 
are required to arrest a cell in S-phase. At the doses used ERCC1 def. cells arrest to 
about the same degree as other NER def. cells, this may reflect the fact that MMC 
forms mostly single stranded adducts, as well as the cell killing ICL adducts.
These results are interesting given that the ERCC1 null hepatocytes arrest in G2/M. 
Perhaps the G2 arrest is caused by a small number of crosslinks that are not enough 
to arrest the cell in S phase but are detected in G2/M.
Previous experiments have shown that cisplatin DNA crosslinks do not inhibit S 
phase and cause only a G2/M arrest in both S. cerevisiae and mammalian cells 
(Grossmann et al., 1999; Grossmann et al, 2000; Sorenson et al., 1990; Sorenson and 
Eastman, 1988). My results have shown that MMC can only arrest DNA replication 
in mammalian cells at hyper cell killing doses.
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I have shown that:
  ERCC1 null hepatocytes have accelerated development of polyploidy and 
that the enlarged ERCC1 null hepatocytes are arrested in G2/M, as are 
enlarged old wt hepatocytes.
  ERCC1 null liver has increased levels of p21 and that the p21 tends to be 
found in the enlarged nuclei.
  Most old wt liver samples do not have greatly increased levels of p21.
  The phenotype of the ERCC1 null mouse is p53 independent and that BER 
and MMR genes are overexpressed in ERCC1 null hepatocytes.
  ERCC1-XPF is involved in the formation of chromosome aberrations, but 
that other NER proteins are not. In ERCC1 and XPF def. cells there are less 
exchanges and more breaks.
  ERCC1 def. cells respond in the same way as other NER def. cells to UV 
treatment during S phase and that a hyper cell killing dose of interstrand 
crosslinks is required to arrest a cell in S phase, whereas it is known that just 
one crosslink will arrest a cell in G2.
These results allow a greater understanding of the causes of the ERCC1 null 
phenotype. Other NER def. mice display no similar liver phenotype implying that 
the loss of NER is not causing the ERCC1 null liver phenotype.
Considering my data and previous data, I propose a model to explain the hepatocyte 
phenotype of the ERCC1 null mouse. DNA damage accumulates in ERCC1 null 
hepatocytes due to the loss of DNA repair pathways that depend on ERCC1-XPF. 
This damage is likely to be DNA interstrand crosslink damage as well as other 
damage that is normally repaired by NER. The increased DNA damage leads to 
increased activity by the MMR and BER pathways. The loss of ERCC1 means that 
interstrand crosslinks cannot be repaired. The load of crosslinks and associated 
damage is not high enough to arrest DNA replication. The formation of chromosome 
exchanges may be an error prone way for cells to repair DNA damage, at least to 
tolerate the damage to allow DNA replication. Without ERCC1 this repair cannot 
function and the increased number of chromosome breaks, i.e. DSBs, formed is a
161
Chapter 7 - Overall Conclusions
strong signal for polyploidy development in the liver. The increased DNA damage 
promotes the induction of p53 and p21 in nuclei, although p21 induction in this case 
does not require p53. The increase in p21 levels is a response to DNA damage and 
may also trigger polyploidy. Increased levels of p21 only appear at certain stages in 
the development of polyploidy and appear before the polyploidy is apparent, thus 
explaining why p21 increases are not seen in some enlarged nuclei and are seen in 
some small nuclei. The polyploidy development is accelerated compared to the 
normal polyploidy development in ageing wt liver. Small p21 increases are only 
seen in old wt liver because either the development of polyploidy is extremely slow, 
over 2 years, and p21 only appears at certain stages or because p21 is not involved in 
the normal development of polyploidy. The small increases are expected if p21 
levels are increased due to DNA damage, because of the stochastic nature of that 
damage and because there will be low levels of DNA damage in old wt animals 
compared to ERCC1 null. The ERCC1 null polyploid nuclei arrest in G2, like old wt 
polyploid nuclei, as part of the normal process of polyploidy development.
This model comes with the caveat that I have not shown that there is a direct link 
between ERCC1 deficiency, increased levels of DNA damage, increased levels of 
p21 and accelerated polyploidy, but I have shown some association between these, at 
least in the case of the ERCC1 mouse liver that I have studied.
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Nucleotide excision repair gene (ERCC1) deficiency 
causes G2 arrest in hepatocytes and a reduction in 
liver binucleation: the role of p53 and p21
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ABSTRACT A wide range of DNA lesions, both UV 
and chemically induced, are dealt with by the nucleo- 
tide excision repair (NER) pathway. Defects in NER 
result in human syndromes such as xeroderma pigmen- 
tosum (XP), where there is a 1000-fold increased 
incidence of skin cancer. The ERCC1 protein is essen- 
tial for NER, but ERCC1 knockout mice are not a 
model for XP. In the absence of exogenous DNA- 
damaging agents, these mice are runted and die before 
weaning, with dramatically accelerated liver polyploidy 
and elevated levels of p53. Here we present a morpho- 
logical, immunological, and molecular study to under- 
stand the mechanism for the unusual liver pathology in 
ERCCl-deficient mice. We show that the enlarged 
ERCCl-deficient hepatocytes are arrested in G2 and 
that DNA replication and the normal process of 
binucleation are both reduced. This is associated with a 
p53-independent increase in expression of the cyclin- 
dependent kinase inhibitor p21. The most dramatic 
feature of the ERCCl-deficient liver phenotype, the 
accelerated polyploidy, is not rescued by p53 defi- 
ciency, but we show that p53 is responsible for the 
reduced DNA replication and binucleation. We con- 
sider that the liver phenotype is a response to 
unrepaired endogenous DNA damage, which may 
reflect an additional non-NER-related function for 
the ERCC1 protein. Nunez, F., Chipchase, M. D., 
Clarke, A. R., Melton, D. W. Nucleotide excision 
repair gene (ERCC1) deficiency causes G2 arrest hi 
hepatocytes and a reduction hi liver binucleation: the 
role of p53 and p21. FASEBJ. 14, 1073-1082 (2000)
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arrest
UNREPAIRED DNA LESIONS can give rise to muta- 
tions, genome instability and carcinogenesis, or cell 
death. Nucleotide excision repair (NER) deals with a 
wide range of lesions, from UV-induced thymine 
dimers and (6-4) photoproducts to lesions caused 
by a variety of chemical agents (1, 2). NER is a
multi-step process that involves damage recognition, 
dual incision of the damaged strand, followed by the 
removal of the lesion as part of an oligonucleotide, 
gap filling, and strand ligation (1, 2). Defects in the 
proteins involved in this mechanism are associated 
with three human disorders: xeroderma pigmento- 
sum (XP), which is characterized by a high incidence 
of skin cancer in sun-exposed areas of the body; 
Cockayne's syndrome (CS); and trichothiodystrophy 
(TTD). ERCC1 (excision repair cross-complement- 
ing gene 1) was the first mammalian NER gene to be 
cloned by virtue of its ability to complement a 
UV-sensitive Chinese hamster ovary cell line (3). 
ERCC1 failed to correct the repair defect in any of 
the human NER-deficient cell lines tested (4, 5). 
Nevertheless, the ERCC1 gene product is known to 
play a critical role in NER, where it acts in a complex 
with XPF to make an incision 5' to the damage site 
(6). This led to speculation that mutations in ERCC1 
may be developmentally lethal. Alternatively, ERCC1 
deficiency may be associated with a different human 
phenotype not represented among the known NER 
deficiency diseases. Some NER proteins, such as XPB 
and XPD, have additional non-NER-related func- 
tions, and defects in these have been linked to the 
neurological and other not obviously NER-related 
problems, such as retarded physical or sexual devel- 
opment and brittle hair, seen in some XP, CS, and 
TTD patients (reviewed in ref 7). There is evidence 
that ERCC1 may also have other key functions. Based 
on homology studies (8, 9), the ERCC1/XPF com- 
plex has been proposed to play a role in mitotic 
recombination as well as in NER. In addition, many 
ERCC1 and ERCC4(XPF) mutants are extremely 
sensitive to agents, such as mitomycin C, which cause 
interstrand cross-links and are repaired by a process 
involving homologous recombination (7). ERCC1
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has also been implicated in the processing of hetero- 
duplex recombination intermediates in mammalian 
cells (10). However, recent experiments suggest that 
in mouse cells ERCC1 is not essential for the recom- 
bination-mediated repair of interstrand cross-links, 
but instead may have a role in S-phase-dependent 
chromosome exchange (11).
p53 has been studied extensively in relation to DNA 
repair and its role in cell cycle regulation. On the 
detection of DNA damage, p53 levels are elevated 
through an increase in the protein half-life. p53 in- 
duces the transcription of downstream genes, such as 
the cyclin-dependent kinase inhibitor p21 (12), result- 
ing in cell cycle arrest at both GX /S and G2/M check- 
points; in some cell types it can also lead to apoptotic 
cell death (13, 14). p53 and p21 have also been 
implicated in cellular aging: p53 levels accumulate as 
diploid fibroblasts age, with a corresponding increase 
in p21 levels, which in turn correlate with a slowing of 
cellular growth (15,16). Fibroblasts from p21 null mice 
cannot arrest in Gl after DNA damage (17, 18), and 
human p21-deficient cells show similar characteristics 
(16,19, 20). From studies of these human p21-deficient 
cells, another role for p21 has emerged in p53-medi- 
ated G2 arrest and coupling of DNA synthesis and 
mitosis (19, 20).
Contrary to some expectations, the absence of 
ERCC1 did not result in an embryonic lethal pheno- 
type (21, 22). However, unlike XPA and XPC knockout 
mice (23-25), animals deficient in ERCC1 do not 
present the typical phenotype associated with XP. Our 
ERCC1 knockout mice are severely runted at birth and 
die before weaning, probably due to hepatic failure, 
with elevated levels of p53 in their liver, brain, and 
kidney (21). The most striking pathology was seen in 
the liver, where there was a dramatic increase in 
hepatocyte nuclear size. FACS analysis showed that this 
was due to nuclei with greater than the normal diploid 
(2n) content, with both polyploid (4n, 8n) and aneu- 
ploid nuclei being present (21). Increased liver ploidy 
is normally only seen in older mice (see below) and 
increased p53 levels have been found in senescing 
fibroblasts (15), so the phenotype in our ERCCl- 
deficient mice is reminiscent of premature aging. We 
wanted to understand how such a phenotype can arise 
in the absence of exogenous DNA-damaging agents. A 
clue to the involvement of cell cycle arrest in the 
ERCCl-deficient phenotype came from a report that 
similar liver abnormalities occurred in mice overex- 
pressing p21 in their liver (26). We also investigated the 
role of p53 in the phenotype. If elevated p53 levels are 
responsible for the increased DNA content, then the 
ERCCl-deficient liver phenotype might be rescued in 
mice deficient in both ERCC1 and p53. We carried out 
studies on 3-wk-old mice of the following genotypes: 
wild-type (wt), ERCCl-deficient, p53-deficient, and 
double null. The age of the mice for this study was
determined by the severe phenotype of the ERCCl- 
deficient animals, which do not survive longer than 3 
wk (21). Incorporation of 5-bromo-2'-deoxyuridine 
(BrdU) (as a marker for DNA synthesis) and morpho- 
logical studies (nuclear area measurement and binu- 
cleate cell count) of liver sections were used to investi- 
gate the cell cycle status of the hepatocytes. The 
nuclear area of the hepatocytes is directly related to 
DNA content (27, 28), with the area increasing with 
increasing ploidy as the animals age.
MATERIALS AND METHODS
Mice
The origin of the ERCC1 (21) and p53 knockout (13) mice 
has been described. Both strains were maintained as heterozy- 
gotes and were crossed to produce double heterozygous mice. 
These were intercrossed to obtain the mice used in this study, 
which were genotyped for ERCC1 (21) and p53 (13) as 
described. All the animals were maintained on an outbred 
background segregating for several different genomes. To 
determine the DNA replication index, mice were injected 
intraperitoneally with a 10 mM BrdU solution (0.1 ml/lOg 
body weight) and livers were removed 24 h later.
Northern analysis
Liver RNA samples (30 |xg), prepared using the RNAzol 
method (Biogenesis Ltd., Bournemouth, U.K.), were sub- 
jected to Northern analysis as described (29). A 490 bp 
fragment of mouse p21 cDNA, produced by PCR amplifica- 
tion of total mouse embryonic cDNA with the following p21 
primers, was used as a probe: p21F (5') ACCATGTCCAATG- 
CTGGTGATGTCCG; p21R (5') GGGCACTTCAGGGTTT- 
TCTCTTGCAG. Primers were derived from the complete 
mouse p21 cDNA sequence (GenBank Ace. No. U09507). 
The filter was then stripped and reprobed for glyceraldehyde- 
3-phosphate dehydrogenase (GAPDH) mRNA as a loading 
control using a 1.2 kb cloned fragment of GAPDH cDNA 
(30). Signals were visualized using a Molecular Dynamics 
(Sunnyvale, Calif.) Phosphorlmager and analyzed with Im- 
ageQuant software.
Immunohistochemistry
Livers were removed and immersion fixed for 24 h in 
methacarn, followed by storage in 70% ethanol. For the 
morphometry studies, 3 (Jim sections were stained with hema- 
toxylin/eosin (H&E). For immunohistochemistry, 3 (jum sec- 
tions were mounted on slides that had been coated with 
poly-L-lysine. For the BrdU antibody, cells were rendered 
permeable by incubating slides in IN HCI at 60°C for 1 h. The 
slides were then washed in running water and rinsed in 
phosphate-buffered saline (PBS) for 5 min. The sections were 
subsequently blocked for endogenous peroxidase activity in 
3% hydrogen peroxide for 10 min at room temperature and 
incubated in a 1:5 dilution of normal goat serum (Scottish 
Antibody Production Unit) for 10 min. After this, the samples 
were incubated in the primary antibody to BrdU (MAS250, 
Harlan SeraLab), diluted (1:50) in normal serum for 30 min 
at room temperature, washed, and incubated for 30 min in 
biotinylated secondary antibody diluted (1:50) in normal 
serum. After washing the secondary antibody off, the slides
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were incubated in horseradish peroxidase-conjugated AB 
Complex (streptavidin/biotin, DAKO Ltd., Bucks, U.K) for 
30 min at room temperature. AB Complex was washed off and 
the positive nuclei were visualized in 3,3'-diaminobenzidine 
tetrahydrochloride solution. Finally, the slides were counter- 
stained lightly in hematoxylin (Sigma Diagnostics, St. Louis, 
Mo.), rinsed in Scott's tap water (1% (w/v) KgCOg, 10% 
(w/v) MgSO4), dehydrated, and mounted. Controls were 
carried out using preimmune serum in place of primary 
antibody.
Measurement of hepatocyte nuclear areas
The AxioHOME Morphometric System (Zeiss) was used to 
perform the study of BrdU incorporation and nuclear area 
size distribution (31). Typically, a 100X objective lens was 
used for the measurements; 10 fields, each containing 50-70 
nuclei, were measured for the BrdU-stained sections. For the 
area measurements and binucleate hepatocyte counts, all the 
nuclei in a field were measured and five fields were assayed 
per animal.
Centromeric staining of hepatocytes
Fresh livers were gently pressed onto a glass coverslip. This 
method allows single hepatocytes to detach in a nondisruptive 
manner so that their nuclei remain intact. Liver cells were 
air-dried for 5 min and fixed in 4% paraformaldehyde/PBS. 
After washing in PBS, the cells were permeabilized in KB 
buffer (10 mM Tris-HCl pH 7.7, 0.15 M NaCl, 0.1% bovine 
serum albumin)/0.1% Triton, washed twice in PBS without 
Triton, and incubated for 30 min at room temperature in the 
primary antibody, NR antibody (32; kindly donated by Wil- 
liam Earnshaw, Institute of Cell and Molecular Biology, 
Edinburgh University) and diluted (1:1000) in PBS/0.1% 
Triton/0.1% sodium azide. The coverslips were then washed 
twice in PBS/1% Triton/0.1% sodium azide and subse- 
quently incubated in a dilution (1:1000) of the biotinylated 
secondary antibody (anti-human IgG) for 30 min at room 
temperature. Then they were washed again and incubated for 
another 30 min in the tertiary antibody solution (streptavi- 
din/Texas red complex, 1:1000 dilution in PBS/0.1% Tri- 
ton/0.1% sodium azide) at room temperature. Finally, the 
cells were washed and stained with 4,6-diamidino-2-phenylin- 
dole (DAPI; 0.5 (xg/ml in PBS) for 5 min, mounted on slides 
with Vectashield mounting medium, and sealed with nail 
varnish. Red dots within the nucleus of the hepatocytes, 
corresponding to the centromeres, were scored on a fluores- 
cence microscope (Axioplan 2, Zeiss) using a 100XNA 1.4 oil 
immersion objective lens. The images presented here were 
acquired using a Sedat/Agard deconvolution microscope 
(Applied Precision Inc., Issaquah, Wash.) with an Olympus 
1X70 inverted microscope, a 100X/NA 1.4 oil immersion 
objective lens, and a PXL CCD camera (Photometries, Mu- 
nich, Germany). This process was performed using DeltaVi- 
sion software running on a Silicon Graphics computer. All 
pictures were processed using the Adobe PhotoShop or 
Powerpoint packages.
RESULTS
The absence of p53 does not rescue the ERCC1- 
deficient phenotype
Animals that were both ERCC1 and p53 deficient did 
not survive longer than their ERCCl-deficient coun-
terparts. This was the first indication that the ab- 
sence of p53 did not rescue the overall phenotype 
associated with ERCC1 deficiency. In total, seven 
double null mice were identified, all of which were 
runted and were either killed or died prior to 
weaning. Mice were routinely genotyped at 3 wk, 
when the number of double nulls was far below the 
expected mendelian ratio of 1:16 from doubly het- 
erozygous matings. A similar deficiency was not 
observed at day 19 of gestation, indicating very high 
perinatal mortality of the double null mice. We have 
previously reported a similar high perinatal mortality 
for ERCCl-deficient animals (21). This imposed a 
technical limitation on the number of double null 
samples analyzed at 3 wk of age.
To see whether the ERCCl-deficient liver pheno- 
type was affected by p53 deficiency, studies of nu- 
clear morphology and binucleate frequency were 
carried out on H&E-stained liver sections. In normal 
mouse liver development, the number of binucleate 
and polyploid cells increases with age, concomitant 
with a decrease of mononucleate, diploid cells. The 
appearance of both the wild-type (Fig. IA) and the 
p53-deficient (Fig. 1C) livers was normal, but this 
nuclear uniformity was lost in ERCCl-deficient (Fig. 
IB) and double null (Fig. ID) livers, with both 
showing enlarged nuclei in addition to the smaller
1 
I
Figure 1. Liver morphology and typical BrdU staining pat- 
terns from 3-wk-old wild-type, ERCCl-deficient, p53-defkient, 
and double null mice. Photographs of liver sections were 
taken from BrdU-stained/hematoxylin- counterstained sec- 
tions using a 40X objective lens. A) Wild-type, showing the 
typical uniform distribution of small nuclei seen in young 
animals. Eight-point star is situated immediately above a 
normal size binucleate cell. Arrow points toward a normal si/.e 
BrdU-stained nucleus. B) ERCCl-deficient. Arrow points to- 
ward a normal size BrdU-stained nucleus. Star is situated next 
to an enlarged BrdU-stained nucleus. (') p53-delicient. Eight- 
point star is situated immediately above a normal si/.e binu- 
cleate cell. Arrow points toward a normal-si/ed, BrdU-staincd 
nucleus. D) Double null. Arrow points toward a normal si/.e 
BrdU-stained nucleus. Star is situated next to a Bidt'-siained 
enlarged nucleus and the eight-point star is situated next to a 
BrdU-slained binucleate cell with enlarged nuclei.
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size characteristic of wild-type. Thus, the lack of p53 
also failed to rescue the ERCCl-deficient liver phe- 
notype. Despite overall similarities in the appearance 
of the ERCCl null and the double null livers, initial 
observations suggested that the number of binucle- 
ate cells was elevated in the double null compared to 
the ERCCl-deficient livers (see Fig. IB, D). To 
confirm these observations, the size of the hepato- 
cyte nuclei and the number of binucleate cells were 
determined. Only cells that were unequivocally pa- 
renchymal in origin were counted, taking care to 
avoid the areas surrounding the portal veins, where 
there is an increased number of nonparenchymal 
cells. The distribution of the nuclear areas is shown 
in Fig. 2. The wild-type profile (top panel) shows a 
distribution of areas with a mode of 20-30 |xm2 and 
a maximum area of 70 |xm2 . The number of nuclei 
that fall within the last two nuclear categories (from 
50-70 |xm2 was so low (1% of the total) that >50 
|xm2 Was the cut-off area chosen to define abnormal, 
enlarged nuclei. We have previously demonstrated 
that this category comprises both polyploid and 
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Figure 2. Hepatocyte nuclear area distribution in 3-wk-old 
wild-type, ERCCl-deficient, p53-deficient, and double null 
mice. The areas ((o-m2) were calculated as described in 
Materials and Methods. The total number of nuclei counted 
per genotype is represented by n.
showed the same size distribution as the wild-type 
(see Figs. 1 and 2), suggesting that p53 absence does 
not affect liver nuclear morphology, and this was 
confirmed by the observations made in the double 
null livers. In both the ERCCl-deficient livers and 
the double null livers the size distribution profiles 
were flatter and broader, indicating a clear shift to 
larger nuclear areas. We have previously reported 
this distribution for ERCCl-deficient mice (21) and 
it has also been observed by Weeda et al. (22). The 
mode in these two categories has increased from the 
wild-type value of 20-30 to 30-40 |xm2, and the 
biggest nuclei were up to 200 (xm2 . Also, the percent- 
age of nuclei >50 n,m2 has increased for both the 
ERCCl null and the double null genotypes from the 
wild-type value of 1% to 34%. This percentage re- 
mained low (5%) for the p53 null livers. Using the 
Kolmogorov-Smirnov test, there was no significant 
difference in the distribution of nuclear areas in 
ERCCl-deficient and the double null livers, but both 
were significantly different (P=0.0l) from wild-type.
Binucleation is inhibited in ERCCl-deficient 
hepatocytes
The older the mouse, the higher the percentage of 
polyploid (4n, 8n) binucleate cells and the lower the 
number of diploid mononucleate cells. Binucleation 
arises from consecutive rounds of replication in the 
absence of cell division and is an essential step in the 
normal development of liver polyploidization (27). 
Therefore, a change in the pattern of binucleation in 
our mice would reflect changes in the regulation of 
liver development. Binucleate cells were counted 
and divided into two categories: normal (nuclear 
area <50 |xm2 ) and enlarged (area>50 |xm2 ). The 
percentage of binucleate hepatocytes in wild-type 
(8%) and p53-deficient livers (10%) was not signifi- 
cantly different (by the Mann-Whitney U test). In 
these two genotypes, there was no evidence of binu- 
cleate cells with enlarged nuclei (see Fig. 3 and Fig. 
1). In ERCCl-deficient livers, the percentage of 
binucleate cells (3%) was significantly lower than in 
all other genotypes (P=0.05 compared to wild-type), 
with 44% of the binucleates having enlarged nuclei. 
In the double nulls the total number of binucleate 
cells (7%) was significantly increased compared to 
ERCCl-deficient livers (P=0.05), being similar to 
that of the wild-type and p53-deficient tissues, with a 
high percentage (61%) of those binucleate cells 
having enlarged nuclei. Thus, binucleation seems to 
be impaired in the absence of ERCCl and this block 
is rescued by the absence of p53.
The absence of p53 rescues the replication block 
in ERCCl-deficient liver
Sections of liver were stained with an anti-BrdU anti- 
body to establish the replication index for each geno-
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Figure 3. Percentage of binucleate hepatocytes in 3-wk-old 
wild-type, ERCCl-deficient, p53-deficient, and double null 
mice. Enlarged nuclei (when present) are represented by the 
second (gray) bar. DN, double null; WT, wild-type. Standard 
errors are shown, n, the number of animals sampled per 
genotype.
type (see Fig. 4). The DNA replication index is the 
percentage of cells labeled with BrdU during the 24 h 
before collection of liver samples. Because ERCCl- 
deficient and double null animals are always runted, it 
was decided to use rare, runted wild-type and p53 nulls 
as controls for this experiment. We have previously 
reported that the liver nuclear abnormalities in 
ERCCl-deficient mice are not observed in runted 
control animals (21). BrdU incorporation was also 
determined for normal (nonrunted) wild-type animals. 
Overall, the replication index for the runted wild-type, 
p53-deficient, and ERCCl-deficient livers was very low 
(<2%, see Figs. 1, 4), although these values were not 
significantly different (by the Mann-Whitney U test) 
from the higher value (4%) in the normal-sized wild- 
type animals. Lower values were expected since these 
groups all suffered from a growth impairment. Al- 
though replication levels in ERCCl-deficient livers 
were less than in nonrunted wild-type animals when 
compared to runted wild-type animals, there was no 
detrimental effect in terms of replication. In runted 
p53-deficient livers, the levels of replication were not 
rescued to normal wild-type (nonrunted) levels. How- 
ever, in the double null livers the level of replication 
has significantly increased compared to all other
runted genotypic classes (P=0.1 compared to ERCCl- 
deficient) , reaching normal levels and demonstrating a 
bypass of the replication arrest typical of runted 
animals.
Once the difference in the liver DNA replication 
indices was established, we determined which subpopu- 
lation of hepatocytes (i.e., normal, or enlarged nuclei) 
was responsible for the increased BrdU incorporation 
in double null livers. The size distribution of BrdU- 
positive nuclei is shown in Fig. 5. When the size 
distribution of BrdU-stained nuclei is compared to the 
general nuclear size distribution, it is clear that al- 
though the distributions of BrdU-stained nuclei in the 
wild-type, p53 null, and ERCC1 null livers correspond 
with the general area distribution for the same geno- 
typic classes, this is not the case for the double null 
livers. In this latter case, the distribution of sizes of 
BrdU-positive nuclei is significantly shifted (P=0.01 by 
Kolmogorov-Smirnov test) toward the enlarged nuclei 
(see also Fig. ID). The replicative potential of the 
double null livers is concentrated in the subpopulation 
of hepatocytes with enlarged nuclei. Taken together 
with the earlier demonstration that the percentage of 
BrdU-stained nuclei in these livers is higher than in any 
of the other runted animals and has reached levels 
equivalent to normal wild-type livers, it is reasonable to 
think that those nuclei that have 'gained' a replicative 
status are the enlarged nuclei. This 'gain of replicative 
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Figure 4. Percentage of BrdU-stained hepaioc ytcs in 3-wk-old 
wild-type, ERCCl-defuiem, p53-dHirient, and double null 
mice. DN, double null; WT, wild-type. Standard errors are 
shown, n, the number of animals sampled per genotvpe.
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Figure 5. Nuclear area size distribution of BrdU-stained 
hepatocyte nuclei from 3-wk-old wild-type, ERCCl-deficient, 
p53-deficient, and double null mice. The BrdU-stained nu- 
clear area size distribution is shown as black bars. For 
comparative purposes, the general nuclear area size distribu- 
tion (from Fig. 2) is also shown (gray bars).
Enlarged ERCCl-deficient hepatocytes are arrested 
in G2
ERCCl-deficient liver has a reduced growth rate and 
DNA replication index compared to normal control 
animals. Because of the increased hepatocyte DNA 
content and the presence of many nonhepatocyte 
cell types in young mouse livers, conventional FACS 
analysis of liver nuclear DNA content could not be 
used to obtain a simple indication of the stage of the 
cell cycle at which individual hepatocytes were; 
therefore, centromeric staining of hepatocytes was 
used to aid the determination (see Fig. 6). The 
autoimmune serum used stains mammalian centro- 
meres (32). Each centromere appears as a single 
structure until centromere duplication occurs in G2 
and the structures become double (33). Thus, the 
presence of double centromere structures identifies 
cells in G2 . Fifty nuclei were scored from each 
3-wk-old liver: six wild-type, five ERCCl-deficient, 
one p53-deficient, and one double null. The mean 
values (%) for hepatocytes in G2 were wild-type 33 ± 
2; p53-deficient 32; ERCCl-deficient, normal nuclei 
36 ± 4; enlarged nuclei 62 ± 3; double null, normal 
nuclei 20; enlarged nuclei 50. A typical wild-type
hepatocyte is shown in Fig. 6A Each red spot repre- 
sents a centromere; chromosomes appear blue. 
Since the majority of the centromeres appear as 
single structures (single red dots), it is concluded 
that this nucleus is not in G2 , but is instead in Gx (or 
G0), or S-phase. A typical enlarged ERCCl-deficient 
hepatocyte in G2 is shown in Fig. 6B, identified by a 
prominence of double centromeric structures. The 
values for wild-type and normal ERCCl-deficient 
nuclei in G2 are not significantly different (by Stu- 
dent's t test), but G2 levels are significantly higher in 
enlarged ERCCl-deficient nuclei (P=0.01). We con- 
clude there is a G2 arrest in ERCCl-deficient and 
double null hepatocytes that is restricted to the 
enlarged hepatocyte population.
p21 is a possible mediator of the G2 arrest and 
increased DNA content in ERCCl-deficient liver
A role for p21 in G2 arrest and/or increased liver 
ploidy was supported by the finding that mice 
overexpressing p21 in their liver present a similar 
liver phenotype to our ERCCl-deficient mice (26). 
To see whether elevated levels of p21 were present 
in ERCC1 null mice, liver RNA was assayed for p21 
mRNA levels. Figure 7 corresponds to a sample 
Northern auto radiograph probed first with p21 
and then reprobed with GAPDH as a loading 
control. A summary of the standardized p21 
mRNA levels is shown in Fig. 8. The level of p21 
mRNA in ERCCl-deficient and double null livers 
was 2- and 4.5-fold higher than that of the wild- 
type livers, respectively. Both values are signifi- 
cantly higher than wild-type (by the Mann-Whitney
Figure 6. Centromeric staining in 3-wk-old wild-type and 
ERCCl-deficient hepatocytes. Binding of the NR antibody to 
centromeres was visualized with a Texas red-conjugated sec- 
ondary antibody. Each centromeric structure is represented 
by a red spot. The DNA is stained with DAPI and presents a 
blue color. A) Wild-type, the majority of the centromeric 
structures, appear as single spots (arrow indicates a typical 
single spot) B) Enlarged ERCCl-deficient. Here the majority 
of the red dots appear as double spots (arrows indicate two 
typical double spots), so this nucleus is in G2 .
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p53-/- ERCC1-/- WT
P21/GAPDH 
ratio 9.92 3.08 0.8 1.3 1
.1 2.7 4.5 average = 1
Figure 7. Northern analysis of p21 mRNA levels in liver from 
3-wk-old wild-type, ERCC1 -deficient, p53-deficient, and dou- 
ble null mice. The signal corresponding to p21 mRNA is 
shown. To obtain a loading control, the filter was reprobed 
with GAPDH and the ratio of p21/GAPDH signals for each 
sample was calculated using a Phosphorlmage analysis system 
and expressed relative to the ratio for wild-type. DN, double 
null; WT, wild-type.
U test, P=0.1 for ERCCl-deficient, P=0.05 for 
double null), but not significantly different from 
each other. Since we have not measured p21 levels 
in individual hepatocytes and ERCCl-deficient 
liver contains both normal (diploid) and enlarged 
cells (arrested in G2 with increased DNA content), 
we are unable to determine whether the elevated 
p21 levels are associated with the G2 arrest, in- 
creased DNA content, or both. In p53-deficient 
livers (in the presence of proficient NER) the 
levels of p21 were equivalent to wild-type. Thus, in 
mouse liver, the expression of p21, both in the 
presence and absence of NER, is p53-independent.
Binucleation
The normal binucleation process was impaired in 
ERCCl-deficient animals, but wild-type levels of 
binucleation were observed in p53 and ERCC1 dou- 
ble null livers, indicating a role for p53 in preventing 
binucleation in the absence of ERCC1. However, in 
repair-proficient normal circumstances, p53 absence 
did not affect binucleation. This p53-dependent 
suppression of binucleation in ERCCl-deficient cells 
can be understood in the context of the protective 
role of p53. If cells that cannot repair their damaged 
DNA proceed through either replication or binucle- 
ation (which involves a round of replication followed 
by an acytokinetic cell division), this could lead to 
the fixation of mutations and the creation of chro- 
mosomal aberrations.
DNA replication index
The protective effect of p53 in suppressing DNA 
replication in ERCCl-deficient liver can be seen 
from the BrdU labeling data. Except for the double 
null mice, all runted animals have lower replication 
indices than nonrunted wild-type animals, consistent 
with their intrinsic growth retardation. The values 
obtained for normal wild-type animals agree with 
results obtained by other groups (41, 42). These low
DISCUSSION
The tumor suppressor p53 has a prominent role in 
cell cycle regulation and apoptosis in response to 
DNA damage (34, 35). Tight regulation of DNA 
repair and cell cycle progression is necessary for the 
cell to cope with genotoxic stress (36-38), and p21 
has been shown to play an important role in this 
process via both p53-dependent and independent 
pathways (39, 40). The liver phenotype in the 
ERCCl-deficient mouse reflects a profound misregu- 
lation of the cell cycle. p53 levels had already been 
found to be elevated in ERCCl-deficient livers (21), 
making this a good model for the in vivo study of the 
relationship between p53, DNA repair and cell cycle 
control. We have previously reported that 3-wk-old 
ERCCl-deficient mice have a distribution of hepato- 
cyte nuclear areas that is reminiscent of an aged 
wild-type (21), suggesting that the phenotype pre- 
sented by the young ERCCl-deficient mice may also 
be related to premature aging. We have now investi- 
gated this further by carrying out an analysis of 
aspects of the hepatocyte's life cycle, such as nuclear 
size and binucleation rates, which change during 
liver development and differentiate young from old 




















Figure 8. Summary of p21 mRNA levels in liver from 3-wk-old 
wild-type, ERCCl-deficient, p53-deficieut, and double null 
mice. The mean p21/GAPDH ratio and standard errors are 
shown, expressed relative to a mean value of 1 for wild-tvpe. 




runt-related levels in the ERCC1-deficient animals 
are rescued back to normal, higher levels in the 
absence of p53.
p21 in liver
p21 has a well-established role in cell cycle control 
and the regulation of cell growth; overexpression of 
p21 in liver has also been linked to an ERCC1 
null-like phenotype (26). Elevated levels of p21 have 
been reported in primary fibroblasts derived from 
ERCC1-deficient mice (22), although no data were 
provided to support this affirmation. Our data dem- 
onstrate that increased liver p21 mRNA levels are 
associated with either the G2 arrest or the premature 
increase in nuclear DNA content seen in ERCC1- 
deficient mice; furthermore, the p21 response is p53 
independent. Another line of evidence comes from 
studies performed in vitro using a human colorectal 
carcinoma cell line (DLD1), where a p53-indepen- 
dent role for p21 in cell growth and DNA repair has 
been proposed (43). p21 has been shown to play a 
role in the control of the initiation of mitosis (G2/M 
transition) through its inhibitory effect on cdk2 and 
cdkl-cyclin B (44). p21 has also been shown to bind 
and inhibit cdkl-cyclin A complexes, which play an 
important regulatory role in early mitosis (45). The 
ERCC1 null mouse may be a useful tool to under- 
stand the effect of p21-mediated growth arrest and 
its relationship with the DNA repair machinery in 
vivo.
Liver ploidy
The most striking feature of ERCCl-deficient liver is 
the increased hepatocyte DNA content at such an 
early age. Our previous studies have shown that the 
population of cells with enlarged nuclei comprises 
both polyploid and aneuploid cells (21). In normal 
mammals, polyploidization of hepatocytes is strongly 
correlated with age and the extent of genotoxic 
damage, but aneuploidy is not usually observed (28). 
Because hepatocytes absorb toxic products as part of 
their function, liver cells may accumulate genetic 
damage more rapidly than cells from other tissues. 
The absence of a special pool of nondifferentiated 
stem cells may make polyploidization a safer way to 
compensate for cellular losses than mitosis, which 
may result in a high incidence of chromosomal 
abnormality (28). Apart from its role in protecting 
against the deleterious cellular effects of endoge- 
nous DNA damage, polyploidization allows the liver 
to preserve its normal size and functional capability 
without the risk of accumulating through mitosis a 
large proportion of aberrant, aneuploid cells, which 
may increase the level of cellular transformation. 
Several hypotheses seek to explain the possible
mechanism by which polyploidization exerts its pro- 
tective role: by reiteration of vital genes, by making 
the cell more resistant to toxins and carcinogens, 
and by providing a morphogenetic strategy against 
aging in specialized diploid systems. However, the 
polyploidization of hepatocytes in later periods of 
life, particularly the progressive polyploidization ob- 
served in mouse liver during senescence, by forma- 
tion of nuclei up to 32n in DNA content is appar- 
ently an integral part of the aging process; more than 
representing a real protection against aging, it could 
well be a tissue-specific adaptation to age-related 
cellular loss (28).
Endoreduplication
Polyploidization comes about by continuous rounds 
of DNA replication in the absence of mitosis (a 
process known as endoreduplication). p21 has also 
been implicated in the regulation of the checkpoints 
that prevent endoreduplication (20, 46). We have 
observed endoreduplication in the presence of ele- 
vated levels of p21, as opposed to its absence, so we 
propose that misregulation of p21 expression (either 
its absence or its overexpression) results in the 
uncoupling of the normal link between S-phase and 
mitosis, leading to cells in G2 undergoing repeated 
rounds of replication in the absence of mitosis. 
Alternatively, elevated levels of p21, in response to 
nonrepaired, accumulating damage, may lead the 
hepatocytes down a terminal (and also protective) 
differentiation pathway. p21 has been reported to 
play an important part in the differentiation process 
of several cell types (47, 48). Since polyploidization is 
the natural state of 'aged' hepatocytes, the ERCC1 
null phenotype could indeed be equivalent to a 
premature aging syndrome.
Greater levels of DNA replication were observed in 
enlarged G2-arrested hepatocytes from animals defi- 
cient in both ERCC1 and p53. This observation 
would also predict higher DNA content (increased 
nuclear size) in double nulls compared to ERCCl- 
deficient, which was not observed. Perhaps the rep- 
lication is only partial and not sufficient to result in 
higher levels of endoreduplication and a detectable 
increase in nuclear volume. However, it again illus- 
trates the protective role of p53 in preventing DNA 
replication in ERCCl-deficient liver.
Model for the ERCCl-deficient liver phenotype
It is important to remember that the ERCCl-defi- 
cient liver phenotype arises spontaneously in the 
absence of exogenous DNA-damaging agents. The 
liver is required for a large number of metabolical 
processes such as lipid peroxidation, intermediate 
metabolism of carbohydrates and proteins, synthesis
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of proteins and detoxification and removal of for- 
eign material such as bacteria, drugs and other 
noxious substances. All this results in the liver cells 
being exposed to and producing large quantities of 
genotoxic agents, such as oxygen-free radicals and 
toxic metabolic byproducts. Many of these will result 
in bulky DNA adducts that are normally repaired by 
NER. However, given that the same liver phenotype 
is not observed in XPA (23, 25), XPC (24), or the 
recently reported XPG knockout mice (49), it has 
been suggested that other forms of damage, which 
are dealt with by the recombinational repair path- 
way, may be more significant (22). Probable involve- 
ment in this recombinational pathway distinguishes 
ERCC1 from most other NER proteins. The contri- 
bution that different forms of endogenous damage 
make to the ERCC1-deficient phenotype will be 
resolved when the DNA lesions are identified directly 
in ERCC1-deficient liver. The accumulation of unre- 
paired damage does not result in the normal cell 
cycle arrest at Gl /S. Instead, cells replicate and a 
population of cells arrested in G2 with increased 
DNA content accumulates. This is associated with a 
p53-independent accumulation of p21. The prema- 
ture polyploidization may be a protective response to 
the accumulation of damaged DNA. The develop- 
ment of polyploidy in young ERCCl-deficient mice is 
different from the normal situation in aging wild- 
type animals, where aneuploidy is not usually ob- 
served. ERCCl-deficient hepatocytes with increased, 
but aneuploid, DNA content may represent incom- 
plete rounds of endoreduplication where replication 
has been physically prevented by unrepaired DNA 
lesions. p53 accumulates in ERCCl-deficient liver, 
but the main features of the phenotype are indepen- 
dent of p53. However, p53 does act to prevent 
binucleation and reduce the amount of DNA 
replication. |£j]
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